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ABSTRACT 
 
In health-related behavioral decision-making, the Theory of Planned Behavior (TPB) 
posits that attitudes toward a behavior are the function of three metrics: beliefs and strengths of 
beliefs toward the behavior, subjective norms around the behavior and locus of control for the 
individual (Ajzen, 1988). The purpose of this research was to identify the extent to which 
consumers would accept the recommendation of taking weight-loss medications, based on the 
source of the recommendation. Research shows that the source of knowledge for information 
plays a significant role in health-related decision-making of consumers (Pornpitakpan, 2004). In 
comparison to traditional weight-loss methods such as diet and exercise, research studies report 
bias’ against the use of prescription (Rx) and over-the counter (OTC) weight-loss medications 
among both physicians (MD) and certified personal trainers (CPT) (Ashworth, 2002; Holcomb, 
2012). Given the current obesity epidemic in the United States (CDC, 2013), the research model 
examined two different sources of knowledge for weight-loss medications (MD versus CPT). 
The objective of the study was to examine the influence each source (MD and CPT) had on 
consumer-based decision-making, and the extent to which each source altered consumers’ 
intention to try a weight-loss medication. The internet-based research  company, Research 
Now®, administered the on-line survey instrument to qualifying participants (N=168), and 
collected data for the treatment interventions. Subjects who qualified for the treatment 
completed a validated questionnaire that collected data on attitudes about physicians, certified 
personal trainers, types of weight-loss medications (Rx and OTC) (Petty and Cacioppo, 1983, 
1986; Sewak, 2002, Sewak, et al., 2005). All eight story-based treatment scenarios were 
randomly assigned, and given to all participants. Statistical analysis consisted of a 2x2x2 design 
ii  
 (ANOVA). Analyses of source of information and type of weight-loss medication were crossed 
with source of information communication type (positive versus negative) in each scenario. Null 
hypotheses were rejected (H1 – H8). As expected, the physician was the over-all stronger source. 
However, positive CPT communication and higher credibility score, led to an increase in 
intention. This is a significant finding. If consumers perceive CPTs to be as knowledgeable as 
MDs (outside of CPT expertise in exercise planning, prescription, and training); consumers 
would view CPTs as a credible, reliable, and alternative source for weight-loss related areas of 
interest and concern. 
.
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
Obesity has reached epidemic proportions in the United States (U.S.) (CDC, 2013; 
Eknoyan, 2006; Flegal, et al., 2010). As recently as the mid-1980’s, there have been reports on 
the condition of obesity being under-diagnosed and under-treated by physicians in the United 
States (U.S.) health care system (AMA, 1986). In the U.S. clinical health care setting, obesity is 
no longer recognized by professionals as a lifestyle condition. The American Medical 
Association (AMA) now clearly defines obesity as a disease (AMA, 2013). There is evidence 
that suggests obesity continues to be under-reported and under-treated by physicians and medical 
professionals within the broadly defined U.S. health care system (Grizzard, 2002. Despite the 
newly adopted goals of the AMA to effectively report and treat this disease that has become an 
epidemic in the United States, difficulties still exist in the identification and treatment of obese 
patients (AMA, 2013; Grizzard, 2002,). 
The prevalence of obesity among U.S. adults has significantly risen since the first 
Behavioral Risk Factor Surveillance Survey (BRFSS) survey in 1995. In 1995, BRFSS survey 
reported that 15.9 percent of U.S. adults had a Body Mass Index (BMI) greater than 30, whereas 
in 2011, the percent dramatically increased to 27.8 % (BRFSS, 2013). With the estimation that 
more than one third of all U.S. adults, and approximately 17 percent of all children and 
adolescents, are overweight or obese, effective solutions to identify, manage, and intervene have 
1  
 become top public health priorities both stateside and abroad (DHHS, 2001; Ogden, 2012; WHO 
(d), 2013; Weisburg, 2002). 
The 2011 Report from the Center for Disease Control and Prevention (CDC) estimates 
that approximately 64 percent of U.S. adults are overweight or obese, indicating that 
approximately 145 million adults are believed to be impacted by this epidemic (CDC, 2013). 
Worldwide, there are (numerous) scientific research studies that generate the same conclusions: 
those adults with a BMI of 24.9 or greater have a higher risk ratio associated with the adverse 
conditions and effects of both physical and mental weight-related medical conditions; also, many 
of these conditions are preventable (Flegal, et al., 2002; Flegal, et al., 2013; Wormser, et al., 
2011). Therefore, at-risk individuals with a BMI classification of 24.9 or greater can make 
positive behavioral changes that can control for, reduce, and possibly eliminate adverse 
secondary medical conditions associated with weight-related pre-mature death (Flegal, et al., 
2007; Wang et al., 2007; WHO(c), 2013). 
In response to the current obesity epidemic in the United States, government health 
programs continue to implement research, policies, and programs to improve the health status of 
Americans. As the numbers of Americans who are overweight and obese continue to rise, the 
negative impacts of health-related factors that have a direct or indirect relationship to unhealthy 
weight also rise in a linear fashion (Danaei, et al., 2009; Reis, et al., 2009; Shields, et al.., 2012). 
When exploring how to improve over-all health status in the general population and the 
relationship between weight status and the social determinates of health, countless unfavorable 
associations are present in all social health determinants (CDC-HP, 2010, Harris, Holden, & 
Chen, 2010, WHO, 2008). The social determinants of public health have five main categories: 
societal, ecological, behavioral, genetic, and medical care; and, within the sub-categories of these 
2  
 components, a myriad of complex negative associations emerge (Marmot, 2008; Wilkinson & 
Marmot, 2006). These determinants have become the foundation for local, state, federal, and 
global health organizations to reconstruct current health-related practices, policies, and programs 
in order to provide more specialized, validated, and successful approaches to reduce the 
prevalence of overweight and obesity (CDC-HP (b), 2007, WHO, 2008). 
Health Belief Theories and Frameworks 
 
In the field of social psychology, various theories address the social determinants of 
health, and provide models, which outline methods to improve health-related behaviors. 
Specifically, health-belief change theories offer models to address weight-related areas of study. 
Health-belief change theories propose that individuals have a unique set of underlying beliefs, 
and those beliefs are based upon, created, altered, influenced and changed, depending on their 
relationships to social determinants (Ajzen, 1987; Bandura, 1986; Bronfenbrenner, 1977; 
Weiner,1980). Over the past 50 years, health-belief change theories have provided a wealth of 
knowledge and information into the fields of public health. These theories have made positive 
contributions in the many domains of health-based research, including weight-related areas of 
research in nutrition, physical activity, and exercise. Initially, these theories were able to provide 
public health researchers the opportunity to improve and implement effective strategies in 
weight-related studies, however, as the prevalence of overweight and obesity continued to rise, 
so did the complexity of addressing effective theory-based solutions. In response, theorists and 
researchers sought a better understanding of health-belief change theories, and in taking a closer 
look, determined that sub-categories within the social determinants of health can change over 
time and across the life span, affecting the health status of both an individual and society 
(Marmot, 2005; Glanz and Bishop, 2010). 
3  
 This research seeks to explore the medical care component within the social determinants 
of a public-health model, using the specific model found in the Theory of Planned Behavior. 
The specific aim of this research is to identify the decision-making processes of consumers, and 
their willingness to use a weight-loss drug therapy, prescription (Rx) or over-the-counter (OTC). 
The identification of previous health-based beliefs reported in the literature concerning diet, 
exercise, and weight-loss medications will serve as the foundation for the hypotheses. 
Specifically, the primary goal of this study is to examine the influence of source, either physician 
or personal trainer, and the type of drug therapy, either prescription or OTC, on consumers’ 
attitude/beliefs toward weight-loss medications and intention to use a weight-loss medication. 
 
Research Questions 
 
 
In the lay press, there is a significant amount of literature that defines the roles and 
responsibilities of both physicians and personal trainers in weight-loss strategies, however, it is 
unclear to what extent either source can influence or change a consumer’s beliefs and decision- 
making in the use of a weight-loss medication. Thus, in the context of consumers and weight- 
loss medication beliefs, this research proposes to: 
 
1. Determine if positive or negative source-based statements either influence or 
change consumer beliefs and intentions to use a weight-loss medication. 
 
2. Determine differences  in  the effect  of recommendations,  either positive or 
negative, based on source between physicians and certified personal trainers. 
 
3. Determine consumers’ attitudes about or intent to use a weight-loss medication 
differs by type of product. 
4  
 The results generated by this research may help to identify situations and personnel in the 
broadly defined U.S. health care system that may increase consumer participation in weight-loss 
programs that include weight-loss medications. 
5  
  
 
 
 
 
CHAPTER 2 
 
REVIEW OF THE LITERATURE 
 
 
 
 
Obesity: Definition, Classification, Health-related Risks, and Treatment Options 
 
 
Obesity has reached epidemic proportions in the United States and is an excess of both 
visceral and subcutaneous fat in humans, is known to have adverse effects in children, 
adolescents and adults, leads to an over-all decline in physical and mental health, and is 
associated with (increased) risk of death among adults (CDC, 2013; Caballero, 2007; CDC, 
2012; Danaei, et al., 2009, Flegal, et al., 2013; Haslam, 2005; NCHS, 2013; USPSTF, 2012; 
WHO,1995, WHO, 2013). The prevalence of obesity among U.S. adults is significant in all fifty 
states, supporting the need for interventions designed to treat and manage this disease (BRFSS, 
2012; BRFSS, 2013; Ogden, 2012). As of June, 2013, the AMA officially classified obesity as a 
disease, whereas prior to this date, the AMA recognized it only as a condition in which multiple 
factors contributed to the severity of the condition (AMA, 2013; Frellick, 2013). The World 
Health Organization (WHO), The National Institutes of Health (NIH), and The (CDC) also 
recognize obesity as disease (CDC, 2013; NIH, 2013; WHO, 2013). The new AMA obesity 
classification is a result of the combined efforts of medical and health leaders worldwide, to 
reduce the current prevalence of obesity, to establish preventative interventions for children, and 
improve upon the current treatment interventions for adults (AMA, 2013; Kraschnewski, 2013). 
The following summaries have been adapted from prominent health organizations, in order to 
6  
 provide a better understanding of the terminology used to describe overweight and obesity 
among adults: 
1. Centers for Disease Control and Prevention: Overweight and obesity are both labels that 
outline specific ranges of weight using Body Mass Index, weight ranges are known to be 
greater than what is generally considered healthy for a given height; and increase the 
likelihood of certain diseases and other health problems. 
2. National Institutes of Health: Overweight persons may have an excess amount of body 
weight from muscles, bone, fat, and water; obesity refers to only an excess amount of body 
fat. 
3. World Health Organization: Abnormal or excessive fat accumulation that presents a risk 
to health; overweight persons weigh in excess of normal limits for one's age, height, and 
build; obesity is a condition that is characterized by excessive accumulation and storage of 
fat in the body; adult obese persons with a body mass index of 30 or greater. 
The CDC, as well as many local, state, federal, and global health organizations have 
 
adopted (BMI) as the primary measurement tool used to determine the prevalence of overweight 
 
and obese within their respective sample populations (CDC, 2013; WHO, 2013). Comparative 
statistical analysis of scientific data on unique global population characteristics, such as weight, 
height, and body type, have been extensively analyzed to determine BMI classification that is 
generalizable across all global sample populations (WHO, 2013). Physiological conditions such 
as high blood pressure, diabetes, cardiovascular disease, stroke, arthritis, and gall bladder disease 
increase in relation to an increase in weight, as does the propensity for psychological disorders 
(AMA, 1986; AMA, 2013; CDC, 2013; McGee, 2005).   Calls for the increased treatment of 
7  
 obesity have existed globally for years and have only increased as the prevalence of the 
condition has increased (Ashworth, 2002; CDC, 2013; Galuska, et al., 1999; Ogden, 2012; 
Wooley & Garner, 1994). In a recent study of the Behavioral Risk Factor Surveillance System 
(BRFSS), only 42 percent of individuals who were obese, from a sample of nearly 13,000, 
reported that their doctor had advised them to lose weight (Campbell, 2001). Moreover, almost 
80 percent of respondents to a nationwide survey, two-thirds of which were overweight or obese, 
reported that their weight was not a health concern (Flegal, et al., 2002). An understanding of 
the history, prevalence, co-morbidities, and the myriad of factors associated with overweight and 
obesity in the United States has been documented by the U.S. government since the inception of 
Healthy People in 1979 (USDHHS, 2013). The current U.S. data on the prevalence of obesity is 
important within the context of this study, in that the likelihood of overweight and obese 
consumers included in this study is high. Gaining insights of (consumers’) beliefs, preferences, 
and willingness to use a weight-loss medication based on preferred health professional source, 
provides additional knowledge that can aid in the creation of identifying new sources and 
avenues to improve weight-loss interventions. 
Another important concept when defining overweight and obesity are the methods of 
measurement and instruments used to assess actual body weight, and if the method provided 
adequately explains, the metabolic pathology associated with different levels of adiposity. Due 
to the complexity and costs associated with other available anthropometric measures, the 
scientific community relies on BMI to approximate adiposity (ACSM, 2013; BRFSS, 2013; CDC 
(b), 2013; Eknoyan, 2007; Garrow & Webster, 1985; Gray DS, 1991). Table 1 is an overview of 
various methods and instruments used to determine adiposity (ACSM (b), 2014; Duren, et al., 
2008; Fuller, et al., 1992; Hu, 2008). 
8  
  
Table 1.  Instruments Used to Determine Adiposity Source: 
 
 
Test Test Result 
 
 
BMI Combined with US Navy 
Circumference 
Body Composition, Percentage 
of Body Fat 
 
 
Body Average Density Measurement: 
Brozak and Siri Formulas 
Percentage of Body Fat 
 
 
Caliper Skinfold Tests Combined with 
Anthropometric Formulas 
Percentage of Subcutaneous 
Adipose Tissue 
 
 
Dual Energy X-Ray Absorptiometry 
(DXA) 
Percentage of Bone Density, 
Muscle Mass, Adipose Tissue, 
 
 
In-Vivo Neutron Activation Percentage of Body Fat 
 
 
Waist-to-Hip Ratio Measurement Percentage of Body Fat 
 
 
Adapted from ACSM 2010 
 
BMI is a simple equation used to classify an individual’s weight-to-height ratio. The 
final calculated value is the ratio of weight-to height, and is associated with a pre-determined 
weight classification index.  This value is a prediction of an individuals’ adiposity.  Table 2 and 
Whole-Body Air Displacement 
Plethysmography (ADP/”BodPod”) 
Body Volume, Body Weight, 
Percentage of Body Fat 
Ultrasound Percentage of Subcutaneous 
Body Fat 
Hydrostatic Weighing (Underwater 
Weighing) 
Percentage of Bone Density, 
Percentage of Body Fat 
DXA combined with Flowing 
Afterglow Mass Spectrometry and/or 
ADP 
Percentage of Bone Density, 
Body Water, Muscle Mass, Body 
Fat 
Body Mass Index Measurement (BMI) Body Composition 
Body Adiposity Index (BAI) Percentage of Body Fat 
Bioelectrical Impedance Analysis 
(BIA) 
Percentage of Body Fat 
Methods and Instruments Used to Determine Adiposity 
9  
 Table 3 provide how BMI is calculated and categorized; Figure 1 illustrates the WHO Adult 
BMI Chart (ACSM, 2013; WHO, 2006; WHO, 2013). In 1832, Adolfe Quetelet first published 
his work on the weight to height relationship, providing the foundation of BMI (Quetelet, 1968). 
Over two-hundred years of scientific evidence validates BMI as a reliable instrument to predict 
adiposity in terms of weight classification (Eknoyan, 2007; Florey, 1970; Gray, 1991; Flegal, et 
al., 2013; Harris, Holden, & Chen, 2010; Keys, Fidanza, Karvonen, Kimura, & Taylor, 1972; 
NIH, 1998; Quetelet, 1968; WHO (d), 2013). The WHO, CDC and many other governing health 
organizations both stateside and abroad have incorporated the use of BMI as the preferable 
instrument in qualitative survey research, due to the nature of self-reported data that often 
accompanies survey research. For example, BMI is regarded as a measurement of equal 
reliability and validity, as compared to using other self-reported measurements such as waist 
circumference and waist-to-hip ratio (WTHR) (Shields, Tremblay, Connor-Gorber, & Janssen, 
2012 Vazquez, Duval, Jacobs, & Silventoinen, 2007). 
10  
  
Table 2.  Adult BMI Classification Ages 18 and above 
 
 
CLASSIFICATION BMI RANGE 
Underweight  (Very Severely) Less than 16.0 
Underweight:  (Severely) 16.0 to 16.99 
Underweight 17.0 to 18.49 
Normal:  (Healthy Weight) 18.5 to 24.9 
Overweight 25.0 to 29.9 
Obese Class I: (Moderately Obese) 30.0 to 34.9 
Obese Class II: (Severely Obese) 35.0 to 39.9 
Obese Class III:(Very Severely Obese) Greater than 40 
Adapted from The World Health Organization 2013 
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 Table 3.  Adult Body Mass Index Formulas Ages 18 and above. 
 
UNITS FORMULA AND CALCULATION 
 
 
 
Kilograms 
 
 
And 
 
 
Meters 
 
Formula: Weight (kg) / [ Height (m)] 2 
 
 
Weight in kilograms divided by height in meters squared. 
To convert height in cm, divide height in centimeters by 100 to obtain 
height in meters. 
 
 
Example:  Weight  =  60kg Height = 165cm (1.65m) 
BMI Calculation: 60 ÷  (1.65)2 =  22.00 
 
 
 
Pounds 
 
 
And 
 
 
Inches 
 
Formula: Weight (lbs.) / [ Height (in)] 2 x 703 
 
 
Divide weight in pounds (lbs.) by height in inches (in) squared, 
then multiply by 703. 
 
Example:  Weight  =  130lbs Height = 5'5" (65in.) 
BMI Calculation: [130 ÷   (65)2] x  703 = 21.60 
Adapted from CDC 2013 
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Figure 1. Example of Adult BMI Chart used in many health settings i.e. Physicians’ Offices 
Universities, Fitness Centers,. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: (Reprinted with Permission) WHO Applicable only for Adults ages 18 and above 
The “gold standard” commonly cited in research literature to determine adiposity, is the Dual 
 
Energy X-Ray Absorptiometry Scan (DXA) (Flegal, et al., 2008). A DXA scan provides gender- 
based estimates of bone density, muscle mass and adipose tissue, that are unique to each 
individual’s body height and weight. However, factors such as availability, accessibility, 
complexity, and cost of DXA scans contribute to why other instruments are more widely used by 
health experts.   There is evidence that some anthropometric methods do provide more precise 
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 over-all values of an individual’s unique body composition to determine adiposity, however, BMI 
is an accepted method for determining general adiposity. Scientific studies have validated the use 
of BMI as an accepted method by comparing BMI to other anthropometric methods for its overall 
reliability (Flegal, et al., 2008). 
 
 
The  National  Institutes  of  Health:  Obesity,  Health  Surveys,  Results,  and  Conclusions 
 
With the new classification of obesity as a disease by the AMA, there are many important 
factors to consider in health regulations and policies of the United States. Research literature 
clearly imparts that obesity is an excess of both visceral and subcutaneous fat that leads to an 
over-all decline in physical and mental health, and increased morbidity (Caballero, 2007; CDC 
(b), 2013; Haslam, 2005; NIH, 1998). The probability of an individual developing a negative 
health condition increases as his or her BMI value increases. It is important to note, as compared 
to BMI, results from cutting-edge medical devices provide specific amounts of visceral and 
subcutaneous fatty tissue. Thus, these results also indicate increases in health-related odds risk 
ratios associated with overweight and obesity, and provide additional validation of the adverse 
health-related risks, diseases, and conditions associated with elevated BMI. Examples of BMI 
associated physiological health conditions are high blood pressure, diabetes, cardiovascular 
disease, strokes, arthritis, and gall bladder disease increase in relation to an increase in weight, as 
well as the proclivity for psychological disorders (AMA, 1986; 2009, 2013; CDC (b), 2013; 
Danaei, et al., 2009). 
Relative to a person’s height-weight ratio, waist-hip circumference ratio, and lean muscle 
mass, disproportionate proportions of visceral and subcutaneous adipose tissue lead to the 
development of detrimental physical and mental illnesses/diseases, that can have both short and 
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 long-term effects on the human body (Flegal, et al., 2013). Overweight and obese BMI 
classification, for both adults and adolescents, have significant associations to an increased risk 
of having multiple illnesses and diseases. Two decades of research have identified health 
conditions that have high associations with overweight and obesity, which increase the risk of 
mortality (Allison, et al.., 1999; Danaei, et al., 2009; Flegal, et al., 2013; Mokdad, Stroup, & 
Gerberding, 2004). Cardiovascular disease, diabetes mellitus, respiratory conditions, kidney 
disease, chronic pain, depression, and anxiety are all examples of weight-related cause-specific 
risk factors that adversely affect health. 
In response to the growing obesity epidemic in the U.S., the NIH seeks to advance 
obesity-related scientific research, in order to better identify correlations between diseases, 
disease states, and health conditions related to overweight and obesity. HealthPeople2020 is the 
multifaceted government health promotion and disease prevention program that serves as the 
foundation for all government based health-related programs, initiatives and population-related 
goals. Currently, Healthy People 2020 has one (1) mission; four (4) primary goals; four (4) 
primary health foundation measures; forty one (41) focus areas; six hundred (600) specific 
objectives dispersed within the focus areas; and over thirteen hundred measures to establish 
quantifiable data within each objective (1,300). The social determinants of public health are the 
framework for the Healthy People 2020 initiatives, and the various government-based surveys 
seek to evaluate the health-related goals, foundations, objectives, and public health status 
(Wilkinson & Marmot, 2003). Table 4 provides a partial summary of health and medical based 
surveys that are used by the NIH collect information on the citizens of the United States and its 
territories, many of these surveys provide data to report on the prevalence of overweight and 
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 obesity in the U.S., as well as adverse health risk indicators associated with unhealthy weight 
status. 
Table 4.  List of U.S. Surveys Used by Healthy People 2020. 
 
Survey Data Source Sample Size 
 
 
National Ambulatory 
Medical Care Survey 
(NAMCS) 
 
 
Medical Record 
Reviews or Patient 
Visits 
Physician Interviews 
 
 
≥180, 000 
Adults 
 
 
≥20,000 
Physicians 
 
 
National Ambulatory 
Medical Care Survey- 
Physician Workflow 
Survey 
(NAMCS-WF) 
 
 
 
Survey of Physicians 
 
 
 
≥5,600 
Physicians 
 
 
National  Health  and 
Nutrition 
Examination Survey 
(NHANES) 
 
 
Personal Interviews 
Physical 
Exams 
Lab work 
Nutrition Assessment 
 
 
≥5,000 Adults 
≥5,000 
Children 
Oversample 
of ≥5,000: 
Seniors ≥60 
Selected information from each survey provides a partial summary of the information 
 
collected to report on the prevalence of overweight and obese people.   Source: CDC, 
2013 
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 Health Risks Associated with Overweight/Obesity 
 
NIH surveys identify, adopt and adapt to the most important and current health issues of 
 
U.S. citizens. These surveys help to evaluate and confirm that the mission, goals, objectives, 
and health measures of HealthyPeople stay aligned with the most important and current health 
issues. Surveys such as NHANES, BRFSS, and vital statistic data (1971 to 2011), a series of 
reports have been published on the health of the U.S citizens, and represent large national 
samples that confirm the current obesity epidemic. Data sets from 1971 to 2011, were combined 
to evaluate BMI and other health covariates, and to determine estimates of cause-specific excess 
deaths associated with underweight (BMI ≤18.5), overweight (BMI ≥24.9), and obesity (BMI 
≥30) (BRFSS, 2012). Underlying cause-specific mortality associated with overweight  and 
obesity was estimated for 2.3 million adults in the United States and U.S. territories (CDC(c), 
2001; Danaei, et al., 2009; Finucane, 2011; Flegal et al.., 2002; Flegal, et al., 2010; Flegal, et al., 
2004; NCHS, 2013). Analysis from these studies report a significant negative relationship 
between BMI to an increased risk ratio of having an obesity-related cancer and/or cardiovascular 
disease (CVD) (Flegal, et al., 2010; Flegal, et al., 2007; Flegal, et al., 2013; Wormser, et al., 
2011). When excluding cancers not related to weight status and non-CVD mortality risks, 
overweight (BMI ≥ 24.9 – 29.9) was associated with an excess (preventable) of total deaths (N = 
69, 299); and obesity (BM I≥ 30.0) was associated with significantly increased obesity-related 
CVD mortality (N = 112,159 deaths). When overweight and obesity were combined, 
associations with increased mortality from diabetes and kidney disease were also reported (N = 
61,248 total deaths). Obesity was also associated with increased mortality from certain types of 
obesity-related kidney and liver cancers. A reported (N = 13,839) total deaths were associated 
with  these  obesity-related  cancers.    Unfortunately,  many  of  deaths  attributed  to  CVD  and 
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 obesity-related cancers, could have been prevented with the maintaining a healthy body weight. 
Historically, NIH surveys have collected data through mail, in-person and telephone-based 
surveys, and have been reliable sources for health-related information of the U.S. population. 
Advances in technologies, (i.e. computers, internet, cell phones), have improved health-based 
surveys to collect data on larger and more diverse population samples using a variety of different 
survey methods (Ekma, et al., 2006; Ekman & Litton, 2007). The NIH has addressed the goal 
for implementing a variety of survey collection methods, with an aim for continuing to advance 
obesity-related research that will lead to a healthier nation (NIH, 2013). 
The Prospective Studies Collaboration, a long-term prospective follow-up collaborative 
analyses, reviewed a large adult sample population (N = 894,576) that included fifty-seven large 
studies from both Europe and the U.S. (61 percent), provided further support of BMI and cause- 
speciﬁc mortality (Whitlock, et al., 2009 ). The association of BMI to mortality was assessed 
based on gender, smoking status, and type of study. Deaths of known cause (n = 522) not 
associated BMI were excluded, which allowed for eliminating reverse causality.Eliminating age 
and actual cause of death, results yielded high associations with vascular events (n = 30,416); 
diabetic, renal or hepatic conditions (n = 22,592); neoplastic (n = 2,070); and respiratory 
conditions (n = 3,770). Mortality was lowest among both male and females with a BMI of 
approximately 2.5 – 25.0 kg/m². BMI above 25.0 indicated several speciﬁc causes associated 
with mortality, but there were no inverse associations to mortality detected. As BMI increased, 
for every 5 kg/m² increments, there was a 30 percent increase of the odds of health risk 
associated with mortality and obesity. With these BMI increments, odds percentages increased 
for vascular mortality (40); diabetic, renal, and hepatic mortality (60-120); neoplastic mortality 
(10); and respiratory mortality (20).  Results indicate that as BMI increases above 25.0 kg/m², 
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 odds of mortality from a vascular condition increased, thus the study hypothesized that BMI may 
be highly correlated as the possible root cause of vascular mortality in overweight and obese 
individuals. An alarming result purported that BMI between 30–35 kg/m², median survival is 
reduced by 2–4 years; and between 40–45 kg/m², it is reduced by 8–10 years.  Remarkably, these 
results are comparable with the eﬀects of smoking (CDC, 2010). 
Estimates of the relative mortality risks associated with weight classifications may help to 
 
improve physician-based decision making in the clinical setting. Systematic reviews reporting 
relative risks (RR’s) and hazard risk ratios (HRs) of all-cause mortality for overweight and 
obesity, relative to normal weight in the general population, consistently report adverse physical 
and mental effects, conditions, and diseases associated with weight classification as BMI 
increases (Allison, et al.., 1999; Flegal, et al., 2007; Flegal, et al., 2004; Mokdad, Stroup, & 
Gerberding, 2004; Reis, et al., 2009; Wormser, et al., 2011). 
One of the most comprehensive meta-analysis to date, evaluated the association between 
BMI and all -cause mortality in 2010 (Flegal, et al., 2013). Of the ninety-seven studies included 
for the analysis, the combined sample size included an adult sample population of over 2.88 
million, with more than 270,000 reported deaths. Coupled with the  strict  methodological 
criteria, the most rigorous statistical sensitivity analysis was executed to address issues of 
possible over and under adjustment. The analysis adjusted for random effects, factors in the 
causal pathway, as well as independent variables not adjusted, (i.e. age, sex, and smoking), and 
all-cause mortality hazard ratios for overweight (BMI of 25.0- 29.9), obesity (BMI of ≥30.0), 
grade one obesity (BMI of 30.0-34.9), and grades two and three obesity (BMI of ≥35.0) were 
calculated and compared, relative to the data grouped as normal weight (BMI of 18.5- 24.9). 
Results  from  Flegal,  et  al.,  2013,  reported  alarming  high  hazard  risk  ratios  for  all  BMI 
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 classifications. A hazard risk ratio(HR) can be used to express effects in studies that compare 
treatments across studies, that use statistics to describe time-to-event (Duerden, 2009) The HR’s 
reported in Flegal, et al., 2013, should not be confused with relative risk (RR), which are used to 
predict the statistical probability of an event occurring. Although selection bias and time-based 
endpoints can affect study results, it is important to note that in the Flegal, et al., 2013 study, the 
large sample size and defined endpoints attributed to the strength of the study results. 
Flegal, et al., 2013, indicate a serious increase of hazard risk ratios associated with 
overweight and obese adults. Among overweight adults, the hazard risk ratio was 0.94 (95 
percent CI, 0.91-0.96) and among obese adults, the hazard risk ratio was 1.18 (95 percent CI, 
1.12-1.25). When all obesity grades were combined the hazard risk ratio was, 0.95 (95 percent 
CI, 0.88-1.01). Hazard risk ratios for obesity grades 2 and 3 combined was 1.29 (95 percent CI, 
1.18-1.41). The relationship between BMI and HR was further strengthened when statistical 
analyses were repeated in studies when all categories of both self-reported BMI and measured 
BMI (i.e. clinical measures) were compared. Thus, the repeated analysis with measured BMI 
classification provided additional support across many of the HR associations to overweight and 
obesity. Repeated analysis reported overweight to be associated with reduced mortality, grade 1 
obesity not significantly associated with increased mortality, and the higher grades of obesity 
significantly associated with increased mortality. All grades of obesity and grades 2 and 3 
obesity were associated with significantly higher all-cause mortality. With respect to how 
weight can affect the quality and length of life, this meta-analysis found that overweight was 
associated with significantly lower all-cause mortality. The results from this study reinforce the 
endless amount of research studies that report even small, sustained decreases in weight can have 
an over-all positive long-term impact on quality and length of life. 
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 To address the reliability of results and the validity of using standard BMI classifications 
across multiple studies, the NIH-based alliance of the American Association for Retired Persons 
(AARP) sought to determine if BMI and the hazard risk ratio risk (HR) associated with all-cause 
mortality could be statistically validated in older adults (age 50 to 71 years) (Adams, et al., 
2006). The relationship between BMI between 24.9 to 29.9 (overweight) and the attributable 
causes of death has been questioned within this age group, as it is often difficult to separate and 
identify causes of mortality as a person ages. The significance of investigating BMI and its 
relationship to all-cause mortality HRs within this age group could provide a plethora of relevant 
information that could improve clinical, policy, intervention, and treatment proposals aimed to 
identify and adequately combat the current obesity epidemic. 
The AARP Diet and Health Study survey questionnaire collected data on food frequency 
habits, demographics, and various health status variables of 567,169 U.S. adults (n = 340,148 
men and (n = 227,021 women) between the years of 1995 and 1996 (Schatzkin, et al., 2001). 
Ten years later, Adams et al. (2006) used the AARP data to determine if BMI, at both baseline 
and follow-up, altered the relative risk ratio of death. Statistical analyses were implemented to 
control for potential biases related to pre-existing chronic disease and smoking status, and 
relative risk ratios (RR) were adjusted for age, race or ethnic group, level of education, smoking 
status, physical activity, and alcohol intake. 
Across gender, age, race, and ethnicity, the RR of death among both men and women 
increased linearly at baseline and follow-up as BMI increased, in all racial or ethnic groups, and 
at all ages. At baseline, among healthy people who had never smoked, the risk of death was 
associated with overweight and obesity in both men and women (Table 6). 
Table 5.  .BMI at 50 years of Age and multivariate relative risk ratio (RR) for men and women. 
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 BMI 
≥25.0- 
26.4 
BMI 
≥26.5- 
27.9 
BMI 
≥28.0- 
29.9 
BMI 
≥30.0- 
34.9 
BMI 
≥35.0- 
39.9 
All Men 1.00 1.09 1.18 1.46 1.86 
Healthy Men 
Non-Smokers 
1.05 1.31 1.49 1.96 2.46 
All Women 1.08 1.15 1.28 1.51 1.90 
Healthy 
Women Non- 
Smokers 
1.21 1.19 1.37 1.99 2.57 
Adams et al.  2006. 
 
 
The statistical associations of the relative risk of death at midlife (50 years of age) among 
those who had never smoked, increased by 20 to 40 percent among those categorized as 
overweight according to BMI. Excess weight in all cohort participants, categorized beyond 
normal BMI limits at baseline, accounted for approximately 7.7 percent of all premature deaths 
among men and 11.7 percent of all premature deaths among women. When controlling for pre- 
conditions and smoking status for all cohort participants, it accounted for 18.1 percent of all 
premature deaths among men who had never smoked and 18.7 percent of all premature deaths 
among women who had never smoked. The results of this study do not suggest a causal 
relationship between BMI and death; however, it does establish an association between BMI at 
mid-life, and the relative risk of death due to weight status. Specifically, it indicates the 
significance and potential impact a higher BMI may have after the age of fifty. 
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 Discussion 
 
Economists project that a significant decrease in research and development funds was 
appropriated to the discovery of new prescription medications that can extend and improve the 
quality of life (Adams & Brantner, 2011; CBO,1998; Kisselman, 2011). If this is the projected 
outcome for new drug discovery, it is essential that for the future generations of tomorrow, they 
have the skills and knowledge needed to stay healthy, as opposed to depending on medications to 
treat otherwise preventable conditions and diseases, such as obesity. From a health promotion 
perspective, providing those needed skills and knowledge is possible through resources already 
available. As NIH public health programs continue to mature and adapt to the needs of an ever 
growing and diverse America, predominating the difficulties that are unique to its state and 
community-based programs, there is no shortage of ideas, methods, and interventions to combat 
the current obesity epidemic. Traditionally, NIH funded programs turn to the clinical setting, to 
investigate how general family physicians fit into reducing obesity in America. 
Pharmaceutical Prescription Medications and Weight-loss Supplements: A Summary of the 
Identification, Approval, Indication, Effectiveness and Health-related Risks for Weight-loss 
The FDA Drug Approval Process 
 
Within the scope of this study, it is imperative to have a basic understanding of the 
complex and costly process of bringing a prescription medication to the U.S.  consumer.  Having 
a basic understanding of the cost of a prescription medication, provides many links to the social 
determinants in health belief change models, and how social norms can influence decision- 
making beliefs before purchasing a medication. Contrary to popular belief, pharmaceutical 
companies  do  not  solely  determine  drug  prices.    Determinants  for  establishing  prices  for 
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 medications are a function of 11 independent cost and pricing categories, with multifarious 
influencing factors within each category (Mattingly, 2012). Similar to most consumer products, 
the basic economic principle of “supply and demand” influences drug availability and price. A 
comprehensive analysis for medicinal pricing in the Unites States is available, at no cost, by the 
Academy of Managed Care Pharmacy, and is far beyond the scope of this study (Rubenstein & 
Tag, 2013). However, understanding the basic processes of securing just one patented FDA 
approved medication to the consumer, imparts critical insight into the health-related value of the 
prescription medications that afford U.S.  citizens improved health status. 
In the United States, the government is responsible for ensuring that prescription 
medications are safe for consumption by the general population. The Food and Drug 
Administration (FDA) is the U.S. government-based organization that regulates prescription 
(Rx) medications for human consumption. Revered as a global leader in public health, the 
FDA’s mission is to develop new tools, standards, and approaches that enhance the ability to 
assess the safety, efficacy, quality, and performance of all products the organization regulates 
(FDA, 2013). As seen in Table 7, prescription medications for human consumption, regardless 
of indication for use, arguably have the most rigorous FDA approval process worldwide 
(PhRMA, 2013). The process of FDA drug approval is rigorous, methodical, prolonged, and 
exorbitantly expensive. The total projected cost of just one FDA approved pharmaceutical 
medication averages 12-15 years between the pre-clinical trial phase of compound discovery to 
market launch and ranges from $800 million to 2.0 billion dollars (Adams, et al., 2006; Adams & 
Brantner, 2011; DiMasi, 2003; Paul, 2010). 
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 Table 6: Application Approval Process of a New Drug in the U.S 
 
 FDA DRUG APPROVAL PROCESS 
~12-15 Total Years to Market 
 
  
Pre-clinical 
Testing 
↓ 
FI
LE
 
IN
D
* 
W
IT
H
 
FD
A
 
↓ 
 
Phase 
I 
 
Phase 
II 
 
Phase 
III 
↓ 
FI
LE
 
N
D
A
* 
W
IT
H
 
FD
A
 
↓ 
 
 
FDA 
 
Phase 
IV 
Years ~3.5 ~1 ~2 ~3 ~2.5 
A
D
D
IT
IO
N
A
L 
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FD
A
 
 
 
Sample 
 
 
Animal 
 
~20-80 
Healthy 
Volunteers 
~100-300 
Patient 
Volun- 
teers 
 
~1000-3000 
Patient Volun- 
teers 
 
 
 
 
Review 
Process 
and Ap- 
proval 
 
 
Purpose 
 
Assess 
Safety And 
Biological 
Activity 
 
Establish 
Safety and 
Dosage 
Evaluate 
Efficacy 
and Iden- 
tify Side 
Effects 
Verify Effi- 
cacy and Audit 
Adverse Reac- 
tions During 
Long-Term 
Use 
 
 
 
Success 
Rate 
 
 
~5,000 
Compounds 
Evaluated 
 
 
 
~5 Drugs Enter Trials 
 
 
 
~1 Drug 
Approved 
 
 
.Adapted from PhRMA Spring 2013 Version 3.0. 
*IND: investigational new drug application. Provides outlined proposal for human testing in clinical trials. 
*NDA: new drug application. 
*FDA drug approval process chart reflects approximations in all categories, it is important to note that drugs such as 
orphan drugs typically take longer to develop, research, gain FDA approval and become available for human 
consumption. 
 
 
 
The U.S.  market is a free market, designed to allow its citizens to make profit, based on 
products sold to the consumer. Modestly stated, the laws regulating a free market protect 
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 individuals and businesses from excess of government tax, which protects business owners from 
profit loss. As compared to general retail good prices, there are many more costs associated with 
the development of medicinal prescription drugs. Compared to typical retail products (i.e. 
cosmetics, electronics, and food) purchased in the general public sales free-market, a new 
prescription medication is subject to more governing laws and drug approval costs in research 
and development (R&D), than the average retail good (DiMasi, 2003). The future of 
prescription drug manufacturing, availability, and cost in America, are solely dependent on the 
qualified medical professional writing the prescription i.e. physician, nurse practitioner, 
whereas, the regulation of general retails items are not. In other words, despite the amount of 
medications available to the consumer, if the physician is not willing to write a prescription for a 
certain drug, there is often minimal to no profit made on that drug, dependent on drug class and 
category (CBO, 1998; DiMasi, Feldman, Seckler, & Wilson, 2010; Morgan, Grootendorst, 
Lexchi, Cunningham, & Greyso, 2011). 
In the US, consumers need a physicians’ prescription to obtain a prescription medication 
from a pharmacy. They do not need such a prescription to purchase an OTC medication. 
Therefore, when it comes to using/consuming a prescription medication, physicians’ decisions 
also play a key role in medications that consumers can have access. For weight-loss 
medications, if obtaining a prescription and/or visiting a physician is considered to be a barrier, 
the consumer may lean toward purchasing an OTC medication or may ask other healthcare 
professionals, e.g., a personal trainer, for advice on such medications. 
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 History of Prescription Weight-loss Medications 
 
An alternative strategy to diet, exercise and surgery interventions for weight-loss, is the 
use of pharmaceutical medicines. Pharmacological and behavioral interventions for obesity have 
had limited success in physician-based clinical settings and have generated little satisfaction 
among physicians (Ashworth, 2002; Stafford and Radley, 2003; Wooley & Garner, 1994; 
Yanoversuski, 2002). The current recommendation for the treatment of obesity is increased 
physical activity and reduced caloric intake. However, when the behavioral approach is not 
sufficient, a pharmacologic treatment is recommended by physicians (Stafford and  Radley, 
2003). Currently, pharmaceutical medications for obesity are considered “lifestyle drugs” that 
have experienced both positive and negative consumer and physician popularity (Moldrup, 
2004). The term “lifestyle” medication has had several definitions over the years, but currently 
reflects a method of weight-loss therapy that is primarily patient selected. Because of this view, 
the FDA and health insurance formularies currently list treatments for obesity that are grouped 
with other patient-selected therapies, i.e. medications for baldness. Unfortunately, anti-obesity 
weight-loss prescription medications are commonly not covered by insurance companies (WIN, 
2009). This suggests a potential gap in the importance of treatments for obesity (Anderson, 
2008; Moldrup, 2004). This has led to diminished importance and emphasis placed on 
prescription medications for reduction of weight, despite the current weight of our nation 
(PhRMA, 2013). Reimbursement of health care services associated with weight management 
has gradually improved in the past decade, however, is often limited to those who have a BMI 
higher than 35, with additional co-morbidity risk factors (Bardia, Holtan, Slezak, & Thompson, 
2007). Effective therapy for overweight and obese patients is no longer as simple as receiving a 
medical recommendation from a doctor, advice on a healthy diet and increased physical activity. 
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 Integrated interventions that encompass all aspects of health, across  multiple  environments 
where individuals spend time, have produced the most successful long-term weight-loss and 
optimal health status. Primary care setting interventions have reported limited sustainability. 
Again, doctors continue to cite that programs that are not integrated within the financial system 
of an organization often fail and have a very limited impact without additional support within the 
worksite and/or the community. To determine the most efficient and effective physician-based 
weight-loss intervention programs, it is imperative that a complete demographic, socioeconomic, 
cultural, evaluation of the population be performed. Table 8 provides examples of currently 
available FDA approved prescription weight-loss medications. 
There are current streams of scientific literature that have identified various prescription 
medications for their potential to enhance both short-term and long-term weight-loss. The 
pharmaceutical industry has developed new, promising FDA approved prescription anti-obesity 
medications and these new drugs are effective, based on an improved understanding of the 
multiple mechanisms and complex physiological systems targeting appetite (Aronne, Powell, & 
Apovian, 2011). However, it is important to understand that FDA approved medications 
specifically indicated for weight-loss, are not comparable to other medications indicated for off- 
label use to augment weight-loss. Off-label use of prescription medications is the use of any 
OTC or Rx medications to treat a condition other than what the drug is indicated to treat. 
Examples of off-label drug use of prescription medications are depression and Type-II diabetes 
drugs, which are used to treat obesity and enhance weight-loss, not necessarily to treat 
depression and diabetes (THA, 2013; WIN, 2013). 
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Table 7.  FDA Approved Prescription Drugs Indicated for Weight-loss. 
 
Clinical Drug Name Brand Name 
Diethylpropion Tenuate® 
Tenuate Dospan® 
Benzphetamine Didrex® 
Lorcaserin Belviq® 
Methamphetamine Hydrochloride Desoxyn® 
Orlistat Xenical® 
Phendimetrazine Tartrate Adipost® 
Bontril SR and PDM® 
Melfiat® 
Phentermine-Topiramate Qysmia® 
Phentermine Hydrochloride Adipex-P® 
Fastin® 
Oby-Cap® 
Suprenza® 
T-Diet® 
Zantryl® 
Sibutramine Meridia® 
Source: NIH 2013; WIN 2013 
 
There is a vast amount of scientific literature detailing the mechanisms and effects of past 
and present therapeutic medications, specifically indicated for weight-loss in the treatment of 
obesity (Li, Cheung, & Ming-Fang, 2011). The two primary functions of weight-loss 
medications in the human body, are through the suppression of appetite and the reduction of the 
absorption of fatty foods (Cooke and Bloom, 2006; Sargent and Moore, 2009). In past years, 
there have been numerous FDA approved brand name and generic prescription drugs for the 
treatment of obesity; however, several have been withdrawn from the market because of their 
adverse effects (Glazer, 2001; Jick, et al., 1998; NTF-OT; 1996). In 1995-1997, the FDA 
voluntarily withdrew fenfluramine and dexfenfluramine from the U.S.  market, due to increased 
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 reports of heart valve damage and heart attack of patients who took these medications over a 
prolonged period. In 1999, the Sibutramine Cardiovascular Outcomes Trial explored the 
prevalence of patients who experienced major adverse cardiovascular events while taking 
sibutramine. This appetite suppressant was highly associated with increased heart rate and blood 
pressure, and the findings of this trial ultimately led to its withdrawal in both Europe and the 
United States (Fanghanel, et al., 2000). Rimonabant was also found to have similar adverse 
effects, and although rimonabant was not associated with major cardiovascular risk factors, it 
was associated adverse psychiatric side effects, leading to its withdrawal by the FDA in the U.S. 
market. 
Other prescription drugs doctors prescribe “off label” to promote weight-loss include 
bupropion, a drug used to treat depression, and metformin, a drug used to treat type II diabetes 
(Kang, 2012). In fact, amphetamine, rimonabant, and sibutramine licenses were withdrawn, due 
to the increased risk of psychiatric disorders and non-fatal myocardial infarction or stroke. As a 
result, pharmaceutical companies lost great amounts of net-profit, due to the litigation for 
damages and deaths that occurred from persons taking these medications. With the recent 
emphasis on government based initiatives to reduce overweight and obesity in the general U.S. 
population, there has been a new urgency to discover improved treatments that are both better 
tolerated and more efficacious (Halford et al., 2010; Kennett and Clifton, 2010; Rodgers et al., 
2010; Vickers et al., 2011). In this context, major recent advances in our understanding of the 
basic neurobiology of appetite and energy homeostasis have identified numerous targets for 
potential anti-obesity drug development (Halford et al., 2010; Heal et al., 2009; Wilding, 2007). 
The drugs presented in this review were referenced in a myriad of sources, with available 
retail pharmacy information to determine an accurate list of drugs currently approved by the 
30  
 Food and Drug Administration (FDA) as appetite suppressants (Aronne, Powell, & Apovian, 
2011; Chawla & Kochar, 2006; WebMD, 2013; WIN, 2009). Arguably, the largest selection by 
mechanism, and most prescribed prescription anti-obesity medications are the appetite 
suppressants. Appetite suppressants trigger certain brain chemicals that help decrease an 
individual’s desire to eat. Arguably, the largest class of anti-obesity drug is the phentermine’s 
class. Phentermine’s are available as both brand and generic drugs. Examples of brand names 
include Adipex-P®; Anoxine-AM®; Fastin®, and Ionamin®. As previously mentioned, two very 
controversial appetite suppressant drugs, fenfluramine and dexfenfluramine, were pulled off the 
market in 1997. These two drugs had sizeable prescription sales in the nineties, and represent 
some of the dangers associated with obesity treatment. 
Perhaps in response to two of the popular appetite suppressant drugs being pulled from 
the, a new anti-obesity class of drug became available to the public in 1999 (Bray, 2000). 
Approved by the FDA, and marketed to the public as Xenical®, the lipase inhibiting drug orlistat 
began to gain physician drug mentions to patients as the safer alternative to stimulant and 
appetite-based prescription weight loss medications. At the time of product launch, the 
mechanism of action for orlistat was novel to both physicians and patients. Working by blocking 
fat absorption and digestion of food in the intestines, the drug blocks the body from delivering an 
overall percentage of the food substances ingested. For this drug to be utilized in the body, it is 
dependent upon the consumption of foods with higher concentration of fat content. The 
mechanism of action for orlistat is it that it blocks enzymes in the stomach and small intestine 
from hydrolyzing dietary fat in the form of triglycerides into absorbable free fatty acids. The 
result is fewer absorbed fats. The resulting caloric deficit may have a positive effect on weight 
control, in that orlistat inhibits dietary fat absorption by approximately 30 percent.  Thus, when 
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 compared to other types of weight-loss medications, orlistat aids in the reduction of caloric 
uptake within the body itself, which can result in weight loss (Bray, 1999). 
Generally, physician and pharmaceutical-based medication guidelines recommend that 
prescription weight-loss medications are indicated for use by patients who have a BMI of greater 
than or equal to 30, or a BMI of 27 with additional adverse risk factors such as high blood 
pressure, high cholesterol, and diabetes (Bray and Ryan, 2012, FDA, 2013; Yanoversuski, 2002). 
Because the mechanism of action for appetite suppressants is via stimulation of the 
hypothalamus, they subsequently increase metabolic response by way of neural brain receptors. 
This pathway results in an increased “feeling” of energy, as well as repressed appetite. Because 
appetite suppressants have been correlated to critical cardiovascular risk factors (CV), caution is 
advised for the use of suppressants for those within higher BMI categories, (i.e. Obesity Grades 
II and III), (AHFS, 2006; Jick, et al., 1998; Khan, et al., 1998). Conclusively,  accepted 
guidelines recommend that for most patients, initial weight-loss attempts should be attempted 
through healthy lifestyle and behavioral changes for a period of six months, prior to the use of 
prescription weight-loss medications, (CDC, 2013). 
Flegal, et al., reported in 1996 that the effectiveness of anti-obesity prescription 
medications, in combination with diet and exercise behavior therapies, could produce as much as 
5-15 % decrease in body weight as well as noticeable improvements in comorbidities associated 
with obesity (Flegal, 1996). One of the most thorough studies investigating physician mentions 
of prescribed weight-loss medications to date sought to identify incidence of physicians who 
mentioned and/or prescribes a weight-loss medication (Stafford and Radley, et al., 2003). Using 
data from Intercontinental Marketing Services (IMS) Health and National Disease and 
Therapeutic Index (NDTI), from 1991-2001, Stafford and Radley, et al., developed a serial cross 
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 sectional study to analyze only office-based physician visits of clinically obese patients (N = 
13,452) patients (Stafford and Radley, 2003). Outcome measures were the number of drug 
mentions, including non-brand name drugs. The mean numbers of anti-obesity medications 
prescribed were examined along with other factors, to develop an estimate reflective of national 
physician practice methods. The approximate examination of over 55 million patient visits over 
an eleven year time period, yielded interesting results, especially when considering the fact that 
during this period both fenfluramine (the “fen” of “fen-phen”) and dexafluramine (Redux) were 
pulled off of the U.S. market by the Food and Drug Administration. 
The most dramatic finding from Stafford and Radley et al. was that substantially more 
prescriptions were written for Fen-Phen and Redux between 1995 and 1997. Specifically, in 
1996 there were 10.6 million drug mentions for anti-obesity prescriptions and 9.4 million 
mentions in 1997. Also reported in these findings was the number of patients who physicians 
reported as being obese. In 1991, the number of physician reported obese patients was 2.6 
million; peaking at 7.8 million in 1996, and then decreasing to 4.2 million in the late 1990’s. An 
overwhelming majority of obese patients, 79 percent of those patients reported to be obese as of 
2002, were female between the ages of 20 and 59 years of age. These characteristics did not 
change within the timeframe examined (1991-2001). Overall physician mentions and patient use 
of phentermine has remained constant over time. In 2002, the data for phentermine’s show 
300,000 quarterly mentions by physicians, and appears to be the most common medication of 
choice for anti-obesity therapy. The results from this analysis suggest that between the years of 
1991-2001, physicians were mentioning and prescribing weight-loss medications for their obese 
patients.  However, analysis was only exploratory and included only physician drug mentions. 
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 This study was not able to report on the safety, efficacy, or weight-loss outcomes associated with 
the medications. 
Equally important, is evaluating the efficacy issues that are related to the use of anti- 
obesity medications. HealthyPeople predicted that by the year 2000, over 40 percent of 
Americans would be obese, and based this predication on data from the U.S. National Health 
and Nutrition Examination Survey (NHANES III). As of 2010, several reliable resources for 
weight classification data report that Americans are close to the HealthyPeople predication 
(Flegal, et al., 2010). However, in terms of health risk factors associated with the use of drug 
treatments, it is not recommended that all of those who are overweight or obese turn to drug 
therapy for a cure. In knowing the guidelines set forth for prescribing anti-obesity medications, 
it is equally important to be aware of the risk factors that have been scientifically reported to be 
associated with the afore mentioned medications. Risk factors thought to be associated with the 
use of these medications are cardiac abnormalities, such as increased blood pressure, valve 
disorders, and even stroke (Flegal, 2010; 2013). It has already been established that obesity is an 
indicator of other health risk factors such as diabetes and high cholesterol, scientists seek to 
know whether the use of these anti-obesity medications will contribute to the development of 
these risk and sequentially lead to a CV event (i.e.  stroke) factors (Derby, Myers, & Jick, 1999). 
To uncover the association of anti-obesity medication with adverse risk factors, Derby et 
al, 1999, performed a cohort study in the United Kingdom involving over eight thousand subjects 
(n = 8243), less than 69 years of age. The majority of the subjects were female, and were 
exposed to dexfenfluramine (n = 60910, fenfluramine (n = 2355), phentermine (n = 887), and 
unexposed obese subjects (n = 17225). Specifically, the study sought to determine if anti-obesity 
medications factored in the incidence and prevalence of cardiovascular abnormalities such as 
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 cardiac valve abnormalities (CVA) and stroke. The patients in this study were exposed to three 
appetite suppressant drugs, of which subjects (n = 1,000) had no prior use of any of the drugs 
used in this study. Case-control analysis was performed using age, sex, and general physician 
practice as controls, with additional variables added such as body mass index, diabetes, 
hypertension, hypercholesterolemia, and smoking status to establish reliability and validity of 
outcome measures. 
The results of the study found that among non-users (n = 42), there were 27 cases of 
CVA, only one case among recent users, and 13 cases among past users. In the case-control 
analysis, types of stroke were divided into thrombotic (n = 38) and hemorrhagic (n = 7). Three 
in the thrombotic group and one in the hemorrhagic group had been exposed to a weight-loss 
drug. The incidence rate (IR) for each of the weight-loss drugs were calculated separately. The 
IR for fenfluramine use was 2.6/1000 person-years (95% CI 0.7, 9.6), dexfenfluramine yielded 
a1.1/1000 person-years (95% CI 0.3, 3.8), and phentermine was 0/1000 person-years (95% upper 
confidence limit of 12.9). When the nested case-control analysis, the odds ratio (OR) for stroke 
after modifying for BMI, diabetes, hypertension, hyper-cholesterolaemia, and smoking yielded 
an OR of 2.4 (95% CI 0.6, 9.1 Despite significant odds ratio results, overall incidence of stroke 
was not significant in the use of anti-obesity medications and risk of stroke. However, despite a 
weak association between first incidence of stoke ad medication use, the sheer volume of 
identifiable weight-loss drug use among women in this study was alarming. A limitation of this 
study cited the average age (X = 59 [41-71] as a factor not being highly correlated to first 
incidence of stroke. The study did collect basic demographic and a selection of health-related 
variables (i.e.  smoking, BMI), for all subjects (N = 8243), however, perhaps an added limitation 
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 was having access to medical records with diet and exercise related variables and not including 
those variables in the analysis. 
Other studies on cardiac valve abnormalities have reported different findings associated 
with appetite suppressant drugs. The prevalence of cardiac valve regurgitation, a condition that 
causes insufficient closure of the valves thus causing blood to backflow through the heart, were 
identified among users of prescribed appetite suppressant medications. This population-based 
study included a five-year nested case-control analysis and involved subjects who had been 
given a prescription for appetite suppressants (N = 9,765) (Jick, et al., A population based study 
of the appetite-suppressant drugs and risk of cardiac-valve regurgitation, 1998). Of the total 
sample, 1,001 of those had taken at least one type of a weight-loss medication. Eleven of the 
subjects had a new incident of cardiac-valve disorder within the first use of the weight-loss 
medication, confirmed with a thorough clinical evaluation and echocardiography. Specifically, 
six were fenfluramine users, and five within the dexfenfluramine group, with none reported 
among the phentermine group. The prevalence for risk of acquiring cardiac abnormalities was 
even higher in those subjects who received fenfluramine and dexfenfluramine for more than four 
months, as determined in the five-year case control analysis. Over the five-year period of this 
study, 35 per 10,000 were at a greater risk of developing cardiac regurgitation with continued use 
of weight-loss drugs, however, no risks associated with cardiac abnormalities were found in the 
use of phentermine (Jick, et al., 1998). 
The FDA approved Orlistat as a prescription weight-loss medication in 1998. This drug 
works by inhibiting gastric and pancreatic enzymes from binding with fatty molecules in the 
gastrointestinal tract, resulting in a reduction of fat absorption in the blood stream by up 30% 
(Borgstrom,  1988).    Weight-loss  is  relatively  modest  but  of  sufficient  magnitude  to  have 
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 beneficial effects on cardiovascular risk, as reflected by a lowering of low-density-lipoprotein 
(LDL) cholesterol, blood pressure and glycaemia (Li, et al., 2005; Broom, Wilding, Stott, & 
Myers, 2002,). Compared with other agents, adverse effects are limited, and the most common 
health-related risks are the decrease of the absorption of fat-soluble vitamins and water. When 
used properly, clinical studies of Xenical have also found it to be a cholesterol-lowering drug, 
favorable for the treatment of diabetic patients, and has shown the capability of improving two 
known risk factors associated with premature death (i.e. weight and cholesterol) (Broom, 
Wilding, Stott, & Myers, 2002; Hauptman,et al..,2000). 
To date, many anti-obesity clinical drug trials have been limited by high attrition rates 
and lack of long-term morbidity and mortality data (Rodgers, Tschop, & Wilding, 2012). Other 
promising anti-obesity prescription medications are in development, but are years away from 
clinical use. When considering the lack of successful behavioral weight-loss treatments, and 
coupled with the public-health implications of the obesity epidemic, the development of safe and 
effective drugs should be a priority. A recent review of prescription weight-loss medications 
pessimistically concluded that “the history of anti-obesity drug development is far from glorious, 
with transient magic bullets and only a handful of agents currently licensed for clinical use” 
(Rodgers, Tschop, & Wilding, 2012, pg.  622). 
Over-the-Counter Weight-loss Supplements 
 
The FDA does not mandate scientific-based research of over-the-counter weight-loss 
supplements (OTC) for the analysis of efficacy or accuracy of claims (Glazer, 2001; Moldrup, 
2004; Motycka, 2004; Stafford and Radley, 2003). The FDA does provide extensive guidelines 
for the approval of any new OTC weight-loss aid to enter the market; however, once approved, 
they are immediately available for purchase and consumption by the general adult population 
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 (FDA, 2013). Because OTC medications do not require a prescription from a physician, all OTC 
medications that were approved for human consumption, do not generally exclude consumption 
based on health status, race, ethnicity, gender. 
The country that manufactures the largest amount of weight-related products is the 
United States, and financial experts expected its over-all worth to be approximately $310 billion 
by 2014 (M&M, 2009). This industry is driven by the availability of products and services, as 
well as greater consumer awareness and demand. The weight-loss diet pill industry (anti-obesity 
OTC medications) alone, is estimated to be worth approximately 139.5 billion dollars by 2017 
(Mayes, 2014). In the United States, OTC weight-loss aids began to gain huge popularity among 
consumers, as the fitness industry boomed in the early 1980s. 
After two popular prescription weight-loss medications were pulled from the market 
between 1995 and 1997, the medical community urged the FDA to investigate safety concerns 
related to the use of OTC weight-loss supplements. The concerns of the medical community 
were not erroneous. The deaths that resulted from ephedrine, the primary ingredient in 
Metabolife®, provided ample confirmation that OTC weight-loss aids needed to be more strictly 
overseen by the FDA (AHFS, 2006; Enders JM; USHCOGR, 2002). Thus, in order to assure the 
safety of the consumer, the FDA implemented additional checks and balances on OTC products, 
prior to the product entering the market. 
These additional FDA checks and balances on OTC weight-loss products occur in The 
Center for Drug Evaluation and Research (CDER) (FDA(a), 2013). The CDER regulates both 
over-the-counter and prescription drugs, including biological therapeutics and generic drugs. 
Within the CDER, there are four Offices of Drug Evaluation, each of which is responsible for 
specific drug types.  The task of making sure that safe and effective OTC drugs are available to 
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 U.S. consumers is the responsibility of the Office of Drug Evaluation IV (ODE-IV). ODE-IV 
appoints the Non-Prescription Drug Evaluation Committee (NPDE) to oversee the labelling, 
safety, and effectiveness of OTC medications. However, OTC medications are not required to 
provide scientific research to support their claims and are not required by the FDA to engage in 
the rigorous testing of the level used for approval of prescription medications. Once CDER has 
approved an OTC product, application of the products’ review is then sent to The Office of 
Medical Products and Tobacco (OMPT). Once the OMPT approves the product, the product is 
ready for immediate placement in the market. Comprehensive reviews of OTC and prescription 
treatments are available from several sources (Campbell, 2001; Glazer, 2001; Motycka, 2004). 
In the past decade, manufacturers of OTC weight-loss supplements have provided a 
sizable increase OTC weight-loss supplements. Consumers can select an OTC weight-loss 
medication that type, access, and selection of OTC weight-loss supplements.Consumers are 
bombarded with an overabundance of over-the-counter weight-loss aids to choose from, with a 
majority of those products claiming safe, fast, and effective weight-loss results. Unfortunately, 
the exaggerated weight-loss claims associated with many of the direct-to-consumer OTC weight- 
loss advertisements can be very misleading to consumers. The Federal Trade Commission 
(FTC) and FDA work together to regulate advertisement and claims of OTC weight-loss 
supplements and have specific requirements that products provide accurate information of their 
claims, so that the consumer can make an informed decision about the product before purchasing 
the product (FTC, 2001). The FDA and FTC requirements mandate that all OTC medications, 
regardless of type or indication for use, must clearly list all ingredients, indication for use, 
dosage, and age-approved usage recommendations. Due to the FDA’s previous findings on the 
health risks associated with these products, all OTC weight-loss aids must disclose that the 
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 product does not have an FDA evaluation and approval of its safety and effectiveness (FDA(a), 
2013). Also included in the fine print, The FDA mandates that all weight-loss products must 
have a clear statement that all consumers can understand, declaring that diet and exercise are an 
important part of any successful weight-loss program. The FDA also provides an open access 
list of current and past OTC weight-loss supplements that are banned and considered dangerous 
for human consumption (FDA (b), 2013). The FDA depends on the general public to notify the 
FDA of these products, and to date, the previously prescription medication orlistat (OTC brand 
name Alli®) is the only FDA approved OTC weight-loss drug currently available to the 
consumer. 
In current scientific research streams, compared to the popularity of US adults using OTC 
weight-loss medications (Blanck, et al., 2007; Saper, Eisenberg, & Phillips, 2004), existing 
clinical studies do not provide statistical support for the effectiveness of OTC weight-loss 
supplements in reducing body weight (Morelli & Chang, 2013). Pittler & Ernst performed a 
systematic meta-analyses review, including only randomized double blind studies of OTC 
products of dietary supplements, with no prior pre-market testing of their independent weight- 
loss claims (Pittler & Ernst, 2004). A comprehensive search using multiple scientific databases 
resulted in the inclusion of systematic reviews and meta-analyses using only randomized, 
double-blind trials, and 25 additional trials that included data on dietary supplements. The 
supplements included in the study all cited weight claims as part of their direct-to-consumer 
advertising, and the analysis included chitosan, chromium picolinate, ephedra sinica, garcinia 
cambogia, glucomannan, guar gum, hydroxy-methylbutyrate, plantago psyllium, pyruvate, yerba 
mate, and yohimbe. Unfortunately, the analysis uncovered no significant results for weight-loss 
claims, however, there were minimal findings thought to be encouraging.   Significant adverse 
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events were found in this analysis for E. sinica- and ephedrine-containing supplements, which 
discovered an associated higher risk for CV events. The authors concluded that evidence for 
most dietary supplements as aids in reducing body weight is not convincing, and none of the 
reviewed dietary supplements should be recommended for use to produce weight-loss. 
The clinical effects and tolerability of the OTC product, comprising the two natural 
extracts of Sphaeranthus indicus and Garcinia Mangostana, were also scientifically tested for its 
effectiveness in enhancing weight-loss (Stern, Peerson, Mishra, Mathukumali, & Konda, 2013). 
Stern, et al., designed two separate, random assignment, double blind, placebo-controlled, 
clinical trials to coincide simultaneously, testing the claims of the OTC herbal product (Stern, et 
al., 2013). Subjects (n = 200) with a BMI between 30 and 40 kg/m2 , were randomized into two 
separate trial groups(n = 100; n = 100) for eight weeks, receiving either 400 mg of herbal blend 
twice daily, or two identical placebo capsules. Caloric intake was restricted to three, 2000 
kcal/day meals, coupled with 30 minutes per day, 5 days per week, of low-impact walking for all 
subjects, for the duration of the 8-week study. Additional blood work was collected for serum 
glycemic, lipid, and adiponectin levels at baseline and compared to day 5 samples for any 
significant improvements. At study conclusion (n = 95 due to attrition), statistically significant 
reductions in body weight (5.2 kg; p < .0001), BMI (2.2 kg/m2; p < .0001), as well as waist 
(11.9 cm; p < .0001) and hip circumferences (6.3 cm; p = .0001) were observed in the herbal 
group compared with placebo. An increase in serum adiponectin concentration was also found 
in the herbal group versus placebo (p = .0008), as well as reductions in fasting blood glucose 
(12.2 percent, p = .01), cholesterol (13.8 percent, p = .002), and triglyceride (41.6 percent, p < 
.0001) concentrations. No adverse changes were reported across organ function panels, multiple 
vital signs, and no additional major adverse events (i.e.  CV) were reported.  Notably, 2 weeks 
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 into the study, incremental weight-loss elicited by the herbal blend was statistically significant as 
well as reductions in waist and hip circumferences. The results of the study suggest that the 
herbal blend appears to be a well-tolerated and effective ingredient for weight-loss and weight 
management, and is effective when combined with a standard diet, and daily exercise, compared 
with the control group diet management and exercise alone. Garcinia Mangostana is similar to 
the Garcinia Cambogia extract and is currently a trending OTC weight-loss aid to be used alone. 
The active ingredient of both garcinias, are said to enhance weight-loss mechanisms in the 
human body via the hydroxycitric acid found in them. Research has shown that hydroxycitric 
acid inhibits adipocyte differentiation, reduces fatty acid synthesis, lipogenesis, and apididymal 
fat accumulation through reducing ATP-citrate lypase activity, and suppresses appetite 
(Cherniack, 2008; Kim et al., 2004; Saito et al., 2005). In simpler terms, it reduces the free- 
floating sugars and fats in the blood stream, thus preventing increased fat storage by these 
substances. Garcinia extracts have been available to the consumer for 10 years, with no adverse 
side effects officially reported to the FDA, and no statistical significance reported in clinical 
weight-loss research studies (Ohia et al., 2002 Saito, et al., 2005). 
An examination of dietary supplement use for weight-loss and perceptions about safety, 
efficacy, and regulatory oversight of these products was conducted via random digit-dialed 
telephone survey in 2005-2006 of US adults (Pillitteri, et al., 2008). The survey assessed the 
beliefs and practices related to weight control in which the outcome measures included the 
prevalence of dietary supplement use for weight reduction, a demographic profile of supplement 
users, and the knowledge about safety, efficacy, and regulation of dietary supplements. Of the 
adults who made a serious weight-loss attempt within the past year prior to the participation in 
study, (n = 1,444), 33.9% reported ever using a dietary supplement for weight-loss.   When 
42  
 gender was included in the analysis, supplement use was more prevalent among women (44.9%) 
than men (19.8%). Higher use of supplements was seen for respondents between the ages of 25 
and 34 years as well as being African Americans (48.7%) and Hispanics (41.6%). Significant 
use also occurred in Whites: 31.2%, less educated, 38.4 % high school degree or less; and 31.1% 
some college or more. Respondents from lower income households more commonly used 
supplements (41.8% < $40K, 30.3% ≥ = $40K). Across the total sample, those reported being 
overweight was (29.1%) and obese (40.7%). 
Many users and non-users of dietary supplements had misperceptions about these 
products, in fact, many believed the Food and Drug Administration (FDA) did perform clinical 
testing and/or evaluation for safety and efficacy before marketing. It was alarming that in using 
the term “dietary”, the majority of subjects believed that they are safer than over-the-counter or 
prescription weight-related medications. Rayalam et al. (2008) suggests implementing more 
scientific studies in which multiple natural resources are evaluated for their effectiveness in 
weight-loss. Examples of combing two products Raylam, et al. identifies for their potential 
effects on weight reduction are green tea and Garcinia Cambogia. 
There is some scientific evidence in non-weight-loss based studies that green tea leaves 
are high in anti-oxidants, and report that the catechins in green tea, show a combination of 
actions.  Green tea studies report in-direct, but small significant changes in suppressing appetite , 
a reduction in free floating triglycerides, increases in energy expenditure, as well as a decrease in 
lipogenic activity and adipocyte variation (Boschmann & Thielecke, 2007; Chantre & Lairon, 
2002; Dulloo et al.; 1999, Hsu & Yen, 2006; Kao et al., 2000; Lin & Lin-Shiau, 2006; Moon et 
al., 2007, Nagao et al., 2005; Thielecke & Boschmann, 2009; Wolfram et al., 2006). 
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 Research for the identification of natural weight-loss remedies continues to gain 
popularity. Other notable natural weight-loss aids showing promise in anti-obesity metabolic 
effects in both animal and human studies include, but are not limited to: pomegranate extract 
((Lei et al., 2007); pinellia ternate (Kim et al., 2006); peanut shell extract (Arachis hypogaea) 
(Moreno et al., 2006); nelumbo nucifera (Ono et al., 2006); raspberry ketone (Morimoto et al., 
2005); and salacia (indian herb); (Li et al., 2008). Where these are very promising findings, the 
human studies were small, and have not been validated with repeated study results. However, 
the possibility of these natural products combined in more precise dosages, might shed more 
light on that how they may be able to target different obesity genes and/or different stages of the 
adipocyte life cycle. Such findings could lead to the scientific breakthroughs in obesogens and 
their mechanisms leading to the exploration and identification of safer and more effective 
pharmacological treatment for obesity. 
U.S.  Physicians: Licensure, Best Practices, Role in the Obesity Epidemic 
 
Finding a solution in how to implement successful weight-loss interventions in  the 
general practitioner’s office is of critical importance to the health of the United States. 
Understanding the importance of the role medical doctors (M.D.’s) have in helping patients 
diagnose and treat obesity is critical to the long-term health and quality of life for the patient. 
Medical doctors, who are licensed to practice general family medicine, seek to promote optimal 
health, examine and diagnose health status, recommend necessary treatment and track progress 
for their patients. Equally important is the role doctors have in promoting preventive actions and 
encouraging positive lifestyle behaviors. The AMA has recently identified obesity as a disease, 
thus in addition to identifying and treating obesity and its secondary conditions and related 
comorbidities, counseling patients about safe and effective weight-loss and weight maintenance 
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 programs is now considered standard best practice (AMA, 2013; Kushner, 2003; Lyznicki JM, 
2001). 
Educational requirements for physicians in the US are rigorous compared to the 
requirements of other health professionals, and practicing family physicians enter the job force 
after completing an average of 8 years of higher education and training (Table 11). The 
American Medical Association (AMA) is the certifying professional organization through which 
medical doctors obtain a medical license to practice medicine in the United States (Kushner, 
2003; Lyznicki, 2001). The primary care provider (PCP) or general family physician (GFP) is 
considered a critical team member for an overweight or obese person (USDHHS, 2013). On 
average, most American citizens, with either private or government sponsored medical coverage, 
complete three health care visits annually, mostly to their primary care physician (PhRMA, 
2013). Due to the recent improvement in healthcare resources, policies, and programs in the 
United States, children, adolescents and adults now have affordable and accessible healthcare 
options available to them (CDC(c), 2005; PPACA, 2010). Commonly, it is the general family 
physician who is often, the first licensed medical professional that a patient will have the 
opportunity to discuss health status, weight status, and weight related issues with (PhRMA, 
2013). General practitioners (G.P.’s/family physicians) see a wide range of health issues that 
commonly affect the general population. More often than not, they are the first health 
professionals that have the opportunity to provide patients with a medical diagnosis of obesity, 
classify their weight status as related to accepted BMI categories, and recommend appropriate 
treatment modalities to improve over-all health of their patients. 
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Table 8.  Adapted from the 2013 Bureau of Labor Statistics: Family and General Practitioners. 
 
 
Bureau of Labor Statistics: Family and General Practitioners 
Median Annual Wage $164,400 
Employment 2010 691,100 
Projected Employment 2020 859,300 
Projected 2020 Job Openings Based on Need 305,000 
Percent Change Projected between 2010 and 2020 24.0% 
Entry-Level Education Minimum Requirements 
4 years of University – Undergraduate Degree in 
Health-related Accredited University Program 
4 Years of Medical School – Medical Degree 
 
Doctoral or 
Professional Degree 
* Does not include surgeons, based on non-specialized areas of continued residency for additional training 
 
Physicians: Best Practice in the Clinical Setting 
 
With physicians hesitant to diagnose obesity in the early 2000’s, interest in physician- 
based interventions became part of mainstream literature publications.  Galuska, et al., conducted 
a systematic review of physician-based weight-loss intervention studies (Galuska, et al.,, 1999). 
Basing study inclusion criteria on standard methods developed by the Cochrane Effective 
Practice and Organization of Care (EPOC), the primary objectives were: (1) “to determine the 
existence and effectiveness of interventions to improve health professionals' management of 
obesity or the organization of care for overweight and obese people; and (2) to update a previous 
systematic review on this topic with new or additional studies” (Galuska, et al.,, 1999, pg. 
1566). The objective measurements included clinical practice, clinical behaviors, and patient 
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 outcomes. Patient outcomes measurements were then categorized into disease status, and factors 
related to patient satisfaction, behavior, and psychological and associated weight related risk 
factors. Weight status was verified using statistical analysis to verify the measures that provided 
actual body weight, height, adiposity, and/or BMI. Six of the 18 studies were randomized 
controlled trials of health professional-oriented interventions (such as the use of reminders and 
training) and one was a controlled before-and-after study to improve collaboration between a 
hospital clinic and general practitioners (GPs). Ten randomized controlled trials and two 
controlled clinical trials of interventions comparing either the deliverer of weight-loss 
interventions or the setting of the delivery of the intervention were identified. The heterogeneity 
and generally limited quality of identified studies made it difficult to provide recommendations 
for improving health professionals' obesity management. To conclude, there were few solid 
leads about improving obesity management, although reminder systems, brief training 
interventions, shared care, inpatient care, and dietitian-led treatments may all be worth further 
investigation. Therefore, what was reported back in the early millennia has not changed much 
from present day findings (Appel, Clark, & Yeh, 2011), as decisions for the improvement of 
provision of services must be based on the existing evidence on interventions with patients and 
good clinical judgment. Conclusively, further research is needed to identify cost-effective 
strategies for improving the management of obesity. 
Physicians do understand that obesity-related behavioral treatments have low to moderate 
success, and often report frustration in that behavioral treatments are often less effective than 
treatment combined with prescription weight-loss aids (Lyznicki, 2001; Galuska, et al.., 1999; 
Garrow, 1994; Grizzard, 2002; Rose, SA; Gokun, Y; Talbert, J; Conigliaro, J., 2013; Weisburg, 
2002).  Health professionals, including family physicians practicing in general medicine, have a 
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 role in counseling patients about safe and effective weight-loss maintenance programs that 
include both behavioral as well as medical treatments. The United States Preventive Services 
Task Force (USPSTF) and the American Medical Association (AMA) both developed 
recommendations on an expansive variety of preventive health care services and policies for 
primary care physicians (PCP’s) (AMA, 2013; USPSTF, 2003). Both the AMA and USPSTF 
have listed specific recommendations that assert guidelines for physicians. These guidelines 
clearly state that physicians should screen patients for obesity, offer counseling, and explain 
behavioral interventions to promote sustained weight-loss (USPSTF, 2003; AMA, 2013). The 
recommendations from both of these organizations focus predominantly on behavioral therapies, 
such as changing an individual’s diet and exercise habits to reflect healthy eating and regular 
physical activity and/or exercise routines. Based on scientific studies that go back as far as 100 
years, the safety, reliability, efficacy, and validity of behavioral-based therapies consistently 
achieve both short term and long-term results (Blaike, 1879; Caballero, 2007). 
Although the AMA considers counseling at-risk overweight and obese patient’s essential, 
it is not a professional requirement, and often physicians do not address obesity, or they provide 
patients with referrals to other health care professionals for weight-loss solutions. The 
ubiquitous factor physicians cite for not providing best practice to patients who are at-risk, 
overweight, or obese, is time (Grizzard, 2002; NCHS, 2013; Tsai, Abbo, & Ogden, 2011). With 
the steady rise of overweight and obesity in the United States, there are thought-provoking 
streams of literature that evaluate factors related to time, such as the attitudes and perceptions 
physicians have towards obesity that suggest time is not spent counseling the patient(Tham & 
Young, 2008; Bleich, Pickett-Blakely, & Cooper, 2011; Carvajal, Wadden, Tsai, Peck, & Moran, 
2013; Foster, Wadden, Makris, & Swain, 2003; Grizzard, 2002; Haire-Joshue & Klein, 2012). 
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 This stream of literature has identified that negative biases towards corpulent people do exist, 
and physicians’ biases are no different from the general population, despite the fact that there is a 
decent statistical chance that those physicians surveyed, fall into the overweight category. 
Harvey, et al., sought to determine the frequency in which primary care physicians’ 
document (1) obesity as a diagnosis (2) weight-loss management plan (Harvey, Glenny, Kirk, & 
Summerbell, 2002). At the time of this study, obesity was not recognized as a medical disease, 
thus physicians did not have the ability to code for obesity in patient medical records, which 
complicated identifying results to be included in this review. Physician-patient visits between 
November 1, 2004, and October 31, 2005 were included for review, and the inclusion criteria 
was PCP-based visits for general medical examinations of patients with a BMI of 30 or 
greater(obese). Initially, close to ten-thousand general medical examinations (N = 9,827) were 
identified. Meeting the inclusion criteria was difficult, as physicians typically coded for 
demographic variables, BMI, and comorbidities, however, documentation of obesity and obesity 
management strategy was not always coded. For some physicians, codes for obesity and obesity- 
related management counseling was not available in those using electronic-based coding 
software. The sample population identified 21.3% of patients as obese, (n = 2,543), however, 
only 19.9 % had a diagnosis of obesity documented (n = 505). Within the same sample of obese 
patients, only 22.6 % had an obesity management plan documented (n = 574). As age increased 
in patients, physicians were less likely to document a diagnosis of obesity, (OR = 0.97, 95 % CI 
[0.96, 0.98], with similar results if the patient was male (OR = 0.60, 95 % CI [0.47, 0.76]. 
Interestingly, despite obesity being defined as a BMI of greater than 30, physicians were 
significantly more likely to diagnosis obesity in those with a BMI greater than 35 (OR = 2.54, 
95% CI [2.10, 3.16]; diabetes mellitus (OR = 1.40, 95% CI [1.09, 1.78] and obstructive sleep 
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 apnea (OR = 2.34, 95% CI [1.79, 3.07]. Physicians were less likely than physician-residents to 
document obesity as a diagnosis (OR = 0.55, 95% CI [0.44 to 0.69]. Diagnosis of obesity was 
the strongest predictor of a physician documenting a weight management plan (OR = 2.39, 95% 
CI [1.90 to 3.02], however, diagnosis was more likely to occur if multiple health problems were 
also present. Within this review, even though most obese patients did not have a prior diagnosis 
of obesity or an obesity management plan, physicians who diagnosed obesity within in this 
review, were more likely to also document a weight-loss management plan. 
Historically, the most prevalent moderating factor MD’s struggle with has been allotting 
enough time to provide counseling during office visits with their at-risk patients (Grizzard, 2002; 
Ashley, et al., 2001; Hsai & Tabas, 2009 ; Kraschnewski, 2013; Kushner, 1995; Tsai, Abbo, & 
Ogden, 2011; Yarnall, et al., 2003). However, current streams of literature report this is not the 
main challenge being cited. Currently, the reoccurring main factor reported in the mainstream 
scientific literature is adequate training (Bleich, Pickett-Blakely, & Cooper, 2011; Puhl, 
Peterson, & Luedicke, 2012; Rose, et al., 2013; Yoong, Carey, Sanson-Fisher, & Grady, 2012). 
Adequate training includes continuing education courses that provide models for physicians to 
approach and provide evidence based weight management counseling for their patients. In the 
U.S., it has become socially and politically incorrect to ask a person their weight (Hilbert A, 
2013; Puhl, Peterson, & Luedicke, 2012). The prevalence of this social stigma compounds the 
challenge for doctors to discuss weight and weight-related issues, despite adiposity level 
(Hilbert, 2013; Kushner, 2003; Moore, 2010; Weisburg, 2002). Interestingly, it is an equally 
challenging factor for physicians to discuss weight with at-risk patients with abnormally low 
BMI (less than 18.0), as these patients have reported discomfort discussing weight status with 
their physicians (Haire-Joshu, 2011; Moore, 2010; Puhl, Peterson, & Luedicke, 2012). 
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 Research literature streams that examine in-office physician-patient communication 
topics, report that patients do not turn to their family physician to discuss unhealthy weight status 
or BMI, and physicians do not feel comfortable addressing a patient’s’ weight status (Flocke, 
Clark, Schlessman, & Pomiecko, 2005). Routinely, it is the secondary medical issues associated 
with elevated weight status and BMI which motivate a patient to seek medical attention 
(Caballero, 2007; Danaei, et al., 2009; Finucane, 2011; Flegal, et al., 2002; Flegal, 2004; Hilbert, 
et,al, 2013; , 1999; Lyznicki, et al., 2001; Ángyán et al.,, 2002). Therefore, it is critical that 
physicians, upon first appointment, address unhealthy weight status with their patients, establish 
baseline measures of weight, identify secondary risk factors, provide counseling, and establish a 
plan of action to reach a healthy weight (Haire-Joshu, 2011). 
Unfortunately, studies have shown that physicians do not conduct weight counseling for 
the majority of their affected patients (Foster, et al., 2003; Galuska, et al., 1999; Kraschnewski, 
2013; Grizzard, 2002; Lyznicki, et al., 2001; NIH, 1998; Rose, Gokun, Talbert, & Conigliaro, 
2013). Physician-based barriers to conducting weight counseling and intervention include, but 
are not limited to, pessimism that patients can change, time limitations, and inadequate 
physicians training in behavioral lifestyle management (Bleich, Pickett-Blakely, &  Cooper, 
2011; Bray & Ryan, 2012; Carvajal, Wadden, Tsai, Peck, & Moran, 2013; Foster, Wadden, 
Makris, & Swain, 2003; Haire-Joshue & Klein, 2012). Further, PCP’s report having insufficient 
behavioral lifestyle tools to aid in weight-counseling efforts, and report existing interventions are 
relatively ineffective for U.S. adults (LeBlanc, et al.., 2011; Tsai & Wadden, 2009; Wadden, 
Volger, & Sarwer, 2011; Yoong, et al.,2012). 
Foster, et al, designed a study to assess physicians’ attitudes toward: (1) obese patients, 
 
(2) underlying causes of obesity, and (3) treatment of obesity. (Foster, Wadden, Makris, & 
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 Swain, 2003). A national random sample of 5,000 primary care doctors (PCP’s) were assessed 
for their attitudes about obesity via a questionnaire. The sample was randomly assigned to group 
one (n=2,500) or group two (n=2,500), and questionnaires were randomly assigned within each 
sample. The only differences in the questionnaires were BMI definitions: (1) BMI of 30 to 40 
and (2) BMI of 40 or greater. The aim of the Foster, et al, study was to compare physicians 
attitudinal responses based on patients’ weight status. Results were based on six hundred twenty 
physicians (n = 620) completed questionnaires, with adequate representation of both male (n = 
388) and female (n= 232) doctors. Across the total sample physicians (n = 620), 12% were 
obese, the mean BMI was 25.5 (± 4.3), the mean age was 44.0, the mean year since completing 
medical school was 1982, and 81.0% were Caucasian. 
Results of the Foster, et al., study found that independent variables (characteristics) of the 
physicians sampled, had no significant effect on any of the results pertaining to obesity, causes 
of obesity, and perceptions of obese patients.Physicians in this study perceived obese patients as 
awkward (61.7%), unattractive (53.2%), ugly (49.5%), noncompliant (50.8%), weak-willed 
(44.0%), and lazy (29.7%). That is, more than half of physicians completing the questionnaires 
in this study had perceptions of their obese patients that are representative of negative attitudes. 
When evaluating questions related to the causes of obesity, physicians generally reported 
behavioral changes, as opposed to genetic reasons, main causes of obesity. 84.3 % (p 0.0009) of 
the physicians cited physical inactivity as the most important cause of obesity, more so than any 
other cause of obesity. Related behavioral causes physicians cited as secondary and tertiary to 
physical activity were overeating (69.0%) and a high-fat diet (67.8%). At the bottom of the list 
for causes of obesity, only two genetic causes were reported, with 19.5% and 11.6% of the 
physicians citing metabolic defect and endocrine disorder.  Obesity treatments were compared to 
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 the treatments of 10 other chronic disease treatments for their effectiveness in the clinical setting. 
Physicians were asked to rank each treatment in comparison to treatments for obesity, (1 = least 
effective to 3= most effective. Over-all, obesity treatment was rated as significantly less and 
least effective compared to 9 of the 10 other chronic conditions listed for comparison. 
Interestingly, past and current treatment options for chronic conditions (i.e. asthma, blood 
pressure, cholesterol, diabetes, depression, osteoarthritis) as well as obesity, are behavioral, 
medical (Rx), or a combination of both.The top 7 of the 10 chronic diseases listed in this study, 
historically call for the use of prescription medication(s), in which physicians report as primary 
and necessary treatments (Higashi, et al., 2007; Karlsson, Taft, Ryden, Sjostrom, & Sullivan, 
2013; Redelmeier, Tan, & Booth, 1998). In the context of the importance of obesity medication 
use, 91.4% of the physicians reported that obesity is associated with serious medical conditions, 
92% believed obesity is a chronic disease, however, 43.4% reported that medications to treat 
obesity should be limited to less than three months. When asked if reimbursement for more time 
spent counseling obese patients were provided, more than one-half (53.9%) reported they would 
spend more time working on weight management issues with their patients. Foster et al, 
summarize that PCP’s view obesity as mostly a behavioral problem and share the negative bias, 
attitudes and perceptions of the general population. 
Recently, Kraschnewski, et al., (2013) assessed physicians’ role in the treatment of 
overweight and obese patients. Three principal variables were tested as outcomes of interest, 
which were either identified as physician ordered and/or delivered health education counseling 
for (1) weight, (2) diet, or (3) exercise. Interestingly, an additional composite variable labelled, 
“weight-related counseling” was included. The purpose of the inclusion of this variable was to 
specify if  one  of  the  three  counseling  variables  (weight,  diet,  or  exercise)  were  provided. 
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 Primary care physician (PCP) weight-related counseling rates were compared using data from 
the 1995–1996 and 2007–2008 National Ambulatory Medical Care Survey (NAMC). The total 
sample of physician surveys regarding adult patient visits were collected (n = 32,519). The 
percentage of adults who were overweight and obese increased from 52.1% in 1995 to 63.3% in 
2008 (BRFSS, 2013). When considering this increase, patients with a PCP diagnosis of being 
overweight or obese during 2007–2008, had 36 percent lower odds of receiving weight-related 
counseling. PCP rates of office-based weight-counseling visits declined from 7.8 percent of 
visits in 1995–1996 to 6.2 2007–2008. Results also concluded that PCP’s were not providing 
adequate weight-related lifestyle counseling. Differences in weight-related counseling for obese 
patients were significant: there was a decrease in the odds of receiving weight-loss counseling in 
1995-1996 and continued to decline in 2007-2008. When calculated to percent of obese patients 
actually receiving counseling, 39.9 percent were counselled in 1995-1996 whereas only 29.9 
percent were counselled in 2007-2008. The rates of patients receiving individual diet, exercise, 
and weight-related counseling similarly declined. Large declines in the odds of a patient with 
multiple obesity-related risk factors who actually received weight counseling were among those 
with hypertension (47%) and diabetes (59%). This is an important finding, as hypertension, 
diabetes, and obesity are all factors correlated to premature death. More importantly, those 
patients with significant co-morbidity risk factors, who did not receive the counseling, could 
have benefited from weight-related PCP counseling. To summarize the significance of these 
findings, an estimated 1.1 billion outpatient visits occurred for both 1995-1996 and 2007-2008. 
Of these 1.1 billion visits, 840 million PCP visits occurred without counseling for weight, 
exercise, and/or diet, despite physicians being aware of the high prevalence of overweight and 
obese patients during the time of this study 
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 Rose, et al. (2013) published a meta-analysis on physician weight-loss advice and patient 
weight-loss behavior change that lent insight into the physician-patient relationship among 
overweight and obese adults (Rose, Gokun, Talbert; Conigliaro, 2013). Criteria for study 
inclusion were (1) primary care physician (PCP) weight screening and counseling, (2) patient 
weight perception, and (3) patient weight-loss attempts. The final meta-analysis included 12 
large studies published between 1999 and 2011 and more than two-hundred thousand patient- 
physician visits were included for analysis (N = 207, 226).  Accounting for the large sample size, 
8 of the 12 studies used national U.S. survey data from either BRFSS, NHANES, or NIH funded 
research studies. Combined demographics across studies, reported that 60% of the patients were 
female and 37% were Caucasian.  Nineteen percent of patients from the total sample (n = 39, 
310) reported receiving advice to lose weight or being told that they were overweight. When 
investigating for between-study moderators that could impact the association of physician advice 
and patient weight-loss efforts, random effects analysis found no statistically signiﬁcant 
difference in the effectiveness of advice in studies using obese patients alone versus mixed 
samples(normal and overweight) (OR = 3.44, 95%; [CI 2.37, 5.00] versus mixed sample (OR = 
3.98, 95%; [CI 2.53, 6.26; (P 0.63)]. Studies using national versus local survey data also had no 
statistical signiﬁcant differences in the effectiveness of physician advice when crossed against 
obese patients versus mixed samples (OR = 4.19, 95%; [CI 2.75, 6.38] versus (OR = 3.33, 95% 
[CI 1.36, 8.15, p 0.65)]. Survey method (telephone; in-person survey) also reported no statistical 
differences (OR = 5.50, 95% [CI 3.46, 8.72 versus 3.00], 95% [CI 2.15, 4.17], P 0.04). 
Conclusively, the Rose, et al. meta-analysis summated that patients who did receive counseling 
had positive perceptions of physician weight-loss counseling, and subsequent patient-based 
weight-loss attempts were attempted by the patient, regardless of weight-losses or gains between 
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 doctor visits. Furthermore, regardless of study size, positive associations were demonstrated 
across all patients, regardless of patient variables, who received both advanced counseling and 
simple PCP recognition, or a diagnosis of overweight and obese weight status. Importantly, 
results of this meta-analysis provide support for and encouragement of patients and physicians to 
establish an open dialogue concerning weight and weight-related topics. 
Interestingly, from a social perspective, it could be hypothesized that the patient-based 
misconceptions about body weight found in the Rose, et al. (2013) meta-analysis are 
representative of the basic constructs within the Theory of Planned Behavior (Ajzen, 1988). 
Considering the social norm constructs, current attitudes and acceptance of heavier body types 
are generally accepted due to the increased prevalence of the exposure to more obese and super- 
obese people within the environment. This study did not report on the weight-loss effectiveness 
and outcomes in terms of actual weight-loss, however, it does provide support for physicians, in 
that physicians can make a positive impact through weight-loss counseling. 
To assess the effectiveness and weight-loss outcomes associated with physician-based 
weight-loss counseling, Bardia, et al. (2007) implemented a meta-analysis of available research 
studies in scientifically reviewed journals. Data from systematic abstracts (n = 648)  and 
literature reviews (n = 6,498) between 2005 and 2010 were screened to assess the effectiveness, 
as well as the detriments, associated with PCP weight-loss interventions for overweight and 
obese adults. Due to the high number of clinical trials conducted in PCP settings, studies were 
excluded based on strength of clinical intervention. A simple and direct rating scale was used to 
establish strength of study as good, fair, or poor. Behaviorally based interventions resulted in an 
average of 6.6 more pounds lost at 12 to 18 months than the control studies that offered no 
behavioral  PCP  interventions.    Additionally,  over  time,  patients  receiving  more  behavioral 
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 treatment sessions were associated with greater weight-loss. Pharmaceutical-based interventions 
coupled with behavioral counseling had varied results. For example, orlistat plus behavioral 
intervention resulted in a loss of 6.6 pounds more than did placebo, after 12 months, however, 
metformin (indicated for the treatment of diabetes, not weight-loss) resulted in less weight-loss 
than orlistat. Despite the limitations of this meta-analysis, Bardia, et al. (2007), concluded that 
behaviorally based PCP interventions are both safe and effective for weight-loss and continued 
weight-loss maintenance. 
Literature streams also attempt to uncover the time barrier physicians report as 
problematic. Gulbrandsen, et al. (2012) sought to answer what patients perceive during their 
doctor visits. Perceptions of time and the extent to which they perceive the physician being 
rushed during encounters were evaluated. The study examined characteristics of both the patient 
and physician, physician communication, physicians’ influence with the patients, patient 
perceptions of time spent, and patient perception of the physician rushing. There were 461 audio 
recorded encounters of overweight or obese patients with 40 primary care physicians. 
Time spent with physician and all communication about weight was calculated using the 
Motivational Interview Treatment Integrity scale (MITI). Surprisingly, there were 320 
encounters in which weight was discussed, which are contradictive of other research findings 
(Grizzard, 2002; Kraschnewski, 2013; Rose, SA; Gokun, Y; Talbert, J; Conigliaro, J., 2013). 
Post-visit questionnaires were completed by both the patient and physician, in which they 
estimated the amount of time spent and perception of being rushed. When compared to 
physicians, patients (n = 461) estimated visits to be longer than they actually were by an average 
of 2.6 minutes. Patients estimated visits to be an average of 1.17 minutes shorter  when 
physicians used weight-based statements, and 4.56 minutes longer when weight-based statements 
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 were not mentioned. When race was evaluated, Caucasian patients perceived time as shorter 
than African Americans, 1.45 versus 4.28 minutes more than actual duration. Although patients, 
on average, did not perceive their physician to be rushed, physicians felt rushed in 66% of visits. 
Although variations were reported in patients' ability to estimate the length of time spent, family 
physicians were able to conceal feeling rushed. 
Another approach used to determine how physicians communicate with their patients is 
through focus groups. Focus groups are commonly more intimate settings, in which a trained 
professional moderates subjects through a series of topics in which each participant’s opinions, 
experiences and recommendations are documented and then coded for statistical analysis 
(Tabachnick and Fidell, 2006). In 2010, Gudzune et al., used focus groups to explore how PCPs 
communicate with patients about weight management (Gudzune, Clark, Appel, &  Bennett, 
2010). Community-based PCPs (n = 26) in Maryland, who had patients enrolled in a practice- 
based, randomized, controlled weight-loss trial, participated in the study. Data was collected via 
audio-recorded sessions for each focus group; transcribed verbatim and coded transcripts were 
then used for content. Three communication-based themes about weight-loss counseling were 
reported: (1) motivating patients to lose weight, (2) partnering with the patient to achieve weight- 
loss, and (3) handling challenges that arise during weight counseling. The primary finding 
suggested that the use of patient-centered approaches to communicate with their patients about 
weight-loss were most successful. 
The United States Preventative Task Force (USPSTF) developed a simple framework 
known as the “5A's” (Ask, Advise, Assess, Assist, and Arrange) for the delivery of preventive 
counseling in primary care (USPSTF, 2003). The “5A” approach in weight counseling 
interventions are designed for the individual patient, in contrast to pre-determined larger scale 
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 health promotion models, and this approach has been validated for efficacy, efficiency, and 
reliability in the PCP clinical setting (Glasgow, Emont, & Miller, 2006; Glasgow, Bull, Piette, & 
Steiner, 2004; Glasgow, Eakin, Fisher, & Bacak, 2011; Glasgow, Goldstein, Ockene, & Pronk, 
2004). A nationally representative survey of U.S. physicians was conducted in order to 
determine the information physicians are actually communicating with their patients concerning 
diet, exercise and weight-loss (Smith, et al., 2011). Using the AMA’s physician database, 1,211 
PCPs participated in the survey. Outcome measures on physician-based assessment included 
counseling, referral, follow-up of diet, physical activity, and weight control in adult patients with 
and without chronic disease were considered. Measures of the recommendation and/or use of 
pharmacologic treatments and surgical referrals for overweight and obesity were also included in 
the survey. PCP’s included in the survey were either internists (n=403), family physicians/PCP 
(n=388), and obstetrician/gynecologists (Ob/Gyn) (n=420). Selected survey response results are 
provided in Table 9. 
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 Table 9.  Survey of U.S. physicians’ communication with patients on behavioral aspects 
 
of healthy lifestyle habits. 
 
 
 
 
Survey Question 
Total 
n=1211 
n=% 
Internal 
Medicine 
n=403 
n=% 
PCP 
n=388 
n=% 
OB/Gyn 
n=420 
n=% 
 
 
P value 
I do assess diet using 
general questions 1020 (84.2) 362 (89.8) 
349 
(71.5) 
309 
(73.4) <0.001 
I do not assess diet 134 (11.1) 27 (6.7) 27 (5.5) 80 (19.0) <0.001 
I do assess physical 
activity using general 
questions 
 
1142 (94.3) 
 
389 (96.5) 373 (76.4) 
380 
(90.3) 
 
0.087 
I do not assess physical 
activity 57 (4.7) 10 (2.5) 11 (2.3) 36 (8.6) <0.001 
I do assess sedentary 
behavior using general 
questions 
 
697 (64.4) 
 
245 (63.2) 270 (72.2) 
182 
(47.8) 
 
<0.001 
I do assess weight 
regularly 1156 (95.2) 378 (94.0) 
369 
(95.1) 
409 
(97.4) 0.19 
I do assess height 
regularly 908 (77.0) 299 (74.5) 
316 
(81.9) 
293 
(70.9) <0.001 
I do assess BMI 
regularly 554 (48.7) 186 (46.4) 
209 
(55.1) 
159 
(38.7) <0.001 
Adapted from Smith, et al. 2011 
 
Smith et al. (2011) reported additional findings worthy of concern. Findings from this 
study provide additional support for the need of improved physician-patient communication. 
Disconcertingly, less than 50% of PCPs reported providing specific guidance on diet, physical 
activity, or weight control 100% of the time to patients, regardless of weight classification 
(Smith, et.  al 2011).  Results also indicated that regardless of patients' chronic disease status, 
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 less than 10% of PCPs always referred patients for further evaluation, and less than 22% reported 
always systematically tracking behavioral risk factors for their at-risk patients for overweight 
and/or obesity. Overall, statistical analysis showed that family practice physicians had a better 
odds ratio (OR) of providing general counseling (OR = 0.82) general diet counseling (OR = 
0.99) general physical activity counseling (OR = 0.85) general guidance for weight control (OR 
= 0.79), referrals (OR = 0.85), and systematically tracking patients progress (OR = 0.57). The 
percentage of physicians who did provide weight-loss guidance, 70 percent of the PCPs reported 
prescribing pharmaceutical weight-loss agents, and of those, 86 percent had referred their patient 
for obesity-related surgery. Results concluded that the majority of PCPs' do assess weight status; 
however, the vast majority in this study did not report providing patients with additional 
behavioral change strategies, tools, or interventions to achieve weight-loss. Although the 
underlying causes for the gap in PCP counseling are not known, evidence exists for 
implementing better strategies for physicians to counsel their at-risk patients. Thus, taking a 
closer look at clinically based PCP weight-loss interventions in primary care settings is where we 
can begin to understand the barriers physicians face in providing patients with successful advice, 
tools, and interventions. 
An extensive review of physician-only based weight-loss interventions were examined 
for success (Tsai & Wadden, 2009). Initial on-line scientific journal searches yielded 1,672 
published abstracts and titles, which specifically used PCP-based behavioral and/or 
pharmacotherapy interventions from 1950 to 2009. The three main inclusion criteria for studies 
were (1) randomization of trial, (2) obesity based intervention in US adults, and (3) primary care 
physician office or explicitly intended to model a primary care setting. Inclusion criteria was 
also based on, treatment modality, provider, setting, weight change, and attrition.  Studies were 
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 classified as (1) PCP counseling alone, (2) PCP counseling + pharmacotherapy, and (3) 
“collaborative” obesity care (treatment delivered by a non-physician provider). Statistical results 
only allowed for the summarization of studies and not pooled data due to the small number of 
studies that shared heterogeneity. Based on the stringent inclusion criteria, only ten (n=10) trials 
met the inclusion criteria for analysis. In studies (n = 4) in which PCPs provided the USTPTF 
recommended behavioral counseling, none reported any clinically significant weight-loss 
(Christian, et al., 2008; Cohen, D’Amico, & Merenstein, 1991; Martin, et al., 2008; Ockene, et 
al., 1999). In reviewing the studies for actual weight-loss (n = 10), the most weight-loss was 
reported in an all-female adult study (n = 116) and results were minimal, with not more than 16.0 
pounds lost over a 1 year period of time (Ashley, St. Jeor, Schrage, & al., 2001). The longest (2 
years) and largest study of sample size (n = 665) reported the least amount of weight-loss, (mean 
= 0.5 pounds). (Logue, et al., 2005). It is evident that further research is needed to determine 
what models and interventions of managing obesity in primary care practice was effective. 
Lifestyle modification counseling for overweight and obese patients is another type of 
intervention physicians can provide their patients. Unfortunately, there is limited and often 
partial knowledge about lifestyle modification shared by physicians with their patients. To better 
understand the role of physicians in lifestyle intervention, The Dallas Heart Study (DHS) 
surveyed 2,097 obese subjects aged 16-65 years (n = 2097), for the duration of a year. The study 
documented patient utilization of health care and lifestyle counseling prior to and during 
participation in the DHS study (Powell-Wiley, et al. 2012). Obese participants were categorized 
based on the presence and number of the following cardiovascular (CV) risk factors: 
hypertension, hypercholesterolemia, or diabetes. Based on CV risk factor category, health-care 
utilization and counseling were compared.   CV risk factors were then stratified by race, and 
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 adjusted for age, sex, insurance status, and education. Results concluded that obese patients who 
sought medical care, were less likely to report counseling about losing weight. When regressed 
based on CV risk factor, likelihood of seeking weight-loss counseling was not encouraging: 41% 
with zero CV risk factors, 67% with one CV risk factor, and 87% with 2 or more CV risk factors. 
Similar results for counseling and CV risk factors were found in counseling for lifestyle dietary 
changes: 44% with zero, 71% in one and 85% in the 2 or more CV categories. Counseling for 
lifestyle physical activity changes in the zero, one and two or more CV categories were 46%, 
71%, and 86%, respectively. When regressed for race, African-Americans and  Hispanics 
without CV risk factors had lower odds of receiving counseling than Caucasians without risk 
factors on weight-loss. What the DHS study revealed was that in the absence of CV risk factors, 
lifestyle-counseling rates by physicians are suboptimal among obese patients. Physicians may 
advise obese patients with one or more CV risk factors to lose weight, but may not be providing 
enough advice and education on how to achieve lifestyle modification success. 
The many barriers physicians face with providing treatment for overweight and obese 
patients will more than likely become increasingly harder, as the prevalence of overweight and 
obesity continues to rise in the general population. A possible solution to sharing some of the 
responsibility of health care for patients is to identify other resources for care.Investigating who 
physicians can turn to, as a resource for weight-based interventions, is becoming more and more 
important in managing the obese patient. Bleiach, et al. (2011), investigated this area of 
concern. A national internet-based survey of five hundred US PCPs was administered  to 
evaluate physician perspectives related to obesity with the intent to assess: (1) causes, (2) 
physician competence, (3) perspectives on the health professional most qualified to help obese 
patients lose or maintain weight and (4) solutions for improving care (Bleich, Pickett-Blakely, & 
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 Cooper, 2011). Physicians were divided into two categories: those with greater than 20 years’ 
experience, (n = 223) and those with less than 20 years of experience (n = 277) with the mean 
year of medical school completed in 1993. This allowed the statistical analysis to test the 
relationship of years since completion of medical school, with primary measures. Using the 
Institute of Medicine (IOM) as the guideline for identifying the causes of obesity, the three main 
causal obesity categories were: 1) biological, 2) individual behaviors and 3) physical/social 
environmental factors. No interaction effects were seen for years since completing medical 
school (n = 500), and results indicated that 75% of PCPs recognized genetics or family history as 
an important cause of obesity, 47% recognized metabolic effect and 25% recognized endocrine 
disorders. The majority of physicians cited behavioral factors as the most commonly reported 
causes of obesity. When reviewing other important factors causing obesity, an astounding 99% 
of PCPs cited insufficient physical activity, 99% cited overconsumption of food, 95% cited 
restaurant or fast-food eating, 94% cited consumption of sugar based drinks, and 89% cited lack 
of will power. PCPs also identified environmental factors as important causes of obesity. 
Eighty-five percent of PCPs cited cultural factors, 75% cited lack of information on good eating 
habits, and 59% cited lack of access to healthy foods. Results from this study conclude that a 
majority of physicians cite behavioral factors as the most important causes of obesity, however, 
this information only supports previous studies of physician beliefs, and does not provide a 
solution to intervention and treatment modalities. The authors did, however, identify resources 
in which they believe the most able to aid in treatment (Table 10). 
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 Table 10: PCP Identifying Most Qualified Health Professional to Help Obese Patients. 
 
 
Health 
Professional 
 
Total 
PCP 
n=500 
 
 
Percent 
PCP 
Less than 
20 Years 
n=227 
 
 
Percent 
PCP 
Greater than 
20 Years 
n=223 
 
 
Percent 
 
P 
Value 
 
Nutritionist/ 
Dietitian 
 
223 
 
45 
 
166 
 
48 
 
67 
 
41 
 
0.21 
 
Primary Care 
Physician 
 
199 
 
39 
 
135 
 
41 
 
64 
 
37 
 
0.40 
 
Behavioral 
Psychologist 
 
57 
 
14 
 
30 
 
9 
 
27 
 
20 
 
0.01 
 
Endo- 
crinologist 
 
6 
 
1.0 
 
3.0 
 
0.7 
 
3 
 
1.5 
 
0.45 
 
Nurse 
 
3 
 
0.5 
 
2.0 
 
0.7 
 
1 
 
0.5 
 
0.81 
Adapted from (Bleich, Pickett-Blakely, & Cooper, 2011). 
 
Notes: p-values reflect t-tests in the differences in proportions 
 
The overall sample of PCPs indicated that there was not one health professional who 
emerged as prominent. Interesting to note, only five health professionals were listed as choices 
on the survey, with nutritionist and dietician listed together. Perhaps this is a limitation and 
should have been listed in the study. The limitation being that there are various other health 
professionals that are qualified to help people who are overweight or obese. For example, 
physicians could refer a patient to a physical or occupational therapist. Such therapists often 
possess  undergraduate  degrees  in  an  exercise  related  field;  have  achieved  higher  levels  of 
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 graduate education, as well as certifications related to diet, exercise, and exercise prescription 
(Oprescu, 2012). 
Additional findings from Oprescu, et al., suggest that PCP perspectives on additional 
training and practice-based changes for improving obesity treatment interventions are optimistic. 
Three hundred and thirteen PCPs reported having received some training in obesity-related care 
that was helpful. In terms of practice-based solutions, using BMI as a fifth vital sign would be 
helpful, as it was reflected in 93 percent of the total sample. Across all physicians, helpful 
practice-based solutions also included: 1). diet/exercise tips in patients’ charts (89%), 2.) having 
scales report BMI (85%), and 3). BMI should be written into patients charts (69%). PCPs 
reported competence in treating obese patients, with almost all PCPs feeling competent giving 
diet-related counselling (90%) and exercise-related counselling (92%) to obese patients. 
However, less than half (n = 218/44%) reported that they were usually successful in helping 
obese patients lose weight (Bleich, Pickett-Blakely, & Cooper, 2011). To summarize, although 
PCPs report adequate training concerning obesity-related issues, this study suggests that PCPs 
should be responsible for administering the medical education skills they are most qualified to 
deliver, but enhance a patient’s weight-loss success by being able to refer patients to more 
diversified healthcare teams and practice resources. 
Thorough obesity screening policy and management to prevent integrated weight-loss 
interventions from failure are a central focus of the American Medical Association (AMA, 
2013). The AMA, CDC, WHO and other reputable organizations advocate and promote the 
adoption and application of theoretical based models that provide unique management of chronic 
diseases (LeBlanc, et al.., 2011; Bray & Ryan, 2012; Wadden, Volger, & Sarwer, 2011; 
Kumanyika, Fassbender, & Sarwer, 2012).  Many studies provide survey research on physician 
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 based weight-loss perspectives and programs; however, there is a need for more scientific studies 
from within the clinical practice that are founded in theory (Appel, Clark, & Yeh, 2011). There 
are many advantages to using theoretical based models to develop weight-loss programs, 
whether for private practice or larger scale community-based health programs. Theory-based 
models provide the avenue for weight-loss interventions within a clinical setting to address a 
myriad of physician-reported challenges in a systematic and organized manner. Additively, the 
use of theoretical models can also aid in the development of clinical/physician based weight-loss 
intervention programs to include multilevel strategies unique to the targeted population or 
community in which it is being offered (Appel, Clark, & Yeh, 2011; Logue, et al, 2005; 
Ackermann & Marrero, 2007). 
To explore the effectiveness of theory based weight-loss models, researchers at Johns 
Hopkins University implemented the Practice-Based Opportunity for Promotion of Weight 
Reduction Trials (POWER) in three randomized control trials (RCT), across 4 years ( 2006- 
2011) (Appel, Clark, and Yeh, 2011; Bennett, et al., 2012; Wadden, Volger, & Sarwer, 2011; 
Wells, 2009). The purpose of the POWER program was to examine the effects of clinical 
practice weight-loss interventions based on various interventions for each trial. Each  trial 
included only obese participants with 1 or more CV risk factor, and investigated the 
effectiveness of the unique interventions offered in each trial.Due to the length of each trial, in- 
person follow-up visits at 6, 12, and 24 months were required by all participants to avoid 
attrition.  Results from each of the randomized control trials were not remarkable. 
The first RCT was implemented across 6 primary care practices and included obese 
patients (N = 390), with two or more metabolic syndrome components. Intervention in this trial 
were (1) minimal care, (2) brief lifestyle counseling, and (3) enhanced lifestyle counseling with 
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 either meal replacements or weight-loss medication. Statistical analysis on the effectiveness of 
each intervention was tested across many physician and patient-based variables.  Primary 
patient- based data was collected at pre-determined 6, 12, and 24 month time periods. Examples 
of physical data collected for each obese patient were weight change, BMI, metabolic syndrome 
prevalence, lipid levels, blood pressure, and waist circumference. Additional data was collected 
on mood, quality of life, sexual functioning, psychological, and behavioral variables.At the 
completion of the first trial, interventions with enhanced lifestyle counseling that incorporated 
meal replacements or orlistat, produced an average loss of 4.3 kg. Only one third of these 
participants lost approximately 5% of their initial weight, however, small changes in weight-loss 
was also associated with improvements in CVD risk factors. 
The second RCT was implemented in three community health centers and included obese 
patients (N = 360), low income, predominantly racial/ethnic minority patients, with a diagnosis 
of hypertension. Interventions in this trial compared usual care to lifestyle modification with 
electronic supports, plus interpersonal and socio-environmental support provided by community 
health workers and community resource connections. Primary patient based data was collected 
at pre-determined 6, 12, and 24 month time periods.Examples of physical data collected for each 
obese patient were weight change, BMI, metabolic syndrome prevalence, lipid levels, blood 
pressure, and waist circumference. Additional data was collected on mood, quality of life, sexual 
functioning, psychological, and behavioral variables.Results from interventions in the 
intervention group compared to usual care group for changes in weight was less than 1 pound, 
and no significant results were noted for mean changes in systolic blood pressure in the 
intervention groups compared to the control. 
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 The third RCT trial obese patients in two primary care practices with hypertension, 
hypercholesterolemia, and/or diabetes. Interventions in this trial were more complex than the 
first two trials and included (1) behavioral intervention via telephone, internet, and  email; 
without in-person counseling visits, (2) behavioral intervention via telephone, internet and email; 
with in-person (group sessions), (3) control intervention via usual medical care with self-directed 
weight methods. Baseline control measures included blood pressure, hypertension, lipid levels, 
HOMA-IR index, and Framingham Risk Score. Results after conclusion of the 24 month trial 
were disappointing. The mean change in weight from baseline reported an average loss of less 
than 2 pounds in the group receiving remote support only and less than 2 pounds in the group 
receiving in-person support. The change in weight from baseline did not differ significantly 
between the two intervention groups in this trial. 
Despite disappointing results in all three POWER trials, results reported that no subjects 
any group had an increase in either weight or BMI. The authors suggest that even in the absence 
of in-person contact via PCP or weight-loss coach, weight-loss success can be achieved through 
systematic internet, or telephone-based interventions. The implications of this study further 
suggest that in the primary care setting, PCPs should consider the implementation of behavioral 
weight-loss interventions that do not necessarily have to be in-person. 
Patients report to their physicians that cost is a major barrier to achieving weight-loss 
goals (Anderson, 2008). The literature on cost and its association to weight status, point to 
evidence that individualized directed advice can reduce overweight and obesity or its risk; 
however, the discrepancy lies within the program intervention policies and strategies themselves 
(Patrick, et al., 2009; Svetkey, et. al, 2008; Tate, Wing, & Winett, 2001). There are many 
schools of thought on the best strategies and policies, based on public health promoters, which 
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 prove effective in the primary care setting. However, many factors can easily become obstacles 
in public-based initiatives provided in the private care setting of a physicians’ office/clinic. The 
gap in the research that needs attention, in obesity-related research, is the cost-effectiveness of 
such physician-based programs. 
Solutions to Barriers 
 
The patient barrier of cost may be resolved for some Americans who enroll in the new 
government-funded health insurance program. The concern of our Nation’s health has attracted 
the attention of current U.S. President, Barack Obama. In 2010, The Patient Protection and 
Affordable Care Act (PPACA; “Obamacare”) include obesity-related recommendations, similar 
those of the AMA and USPSTF, for both children and adults covered under Medicaid and/or 
Medicare services (PPACA, 2010). Simply stated, the PPACA mandate(s) require that health 
insurance companies cover physician counseling to help obese patients try to lose weight. The 
physician is now required to screen for and counsel at-risk patients with a BMI equal to or 
greater than 30. Additionally, there is no cost to the patient, such as a deductible, co-payment, or 
co-insurance fee. Since PPACA went into effect, there has been an increase in physicians 
referring obese patients to other professional services for specialty care. This may be due to the 
decreases in reimbursement physicians receive from state and government- based health 
coverage (Kisselman, 2011; Rubenstein & Tag, 2013). Specialty care/referral services are not 
limited to but may include telephone counseling, health coach visits, or placement into 
behavioral lifestyle programs. For example, when a physician writes a patient referral 
prescription, if the specialty service is covered by the patient’s insurance, a behavioral lifestyle 
service such as Weight Watchers™ might be prescribed. Subsequently, Weight Watchers™ 
might offer additional discounts or reimbursements to the client.  Physicians, who treat patients 
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 with private or no insurance, are neither required nor mandated to provide weight-related 
counseling by any professional organizing body. However, they can refer to the AMA, CDC, 
and WHO guidelines for treating overweight and obese patients. With the adoption of the 
newest HealthyPeople2020 physician-based guidelines, along with the current AMA’s stand on 
actively improving the amount of diet, exercise and prevention based health counseling 
physicians consistently deliver to all patients, hope for a healthier nation is ever renascent 
(USDHHS, 2013; AMA, 2013). 
In an attempt to improve and strengthen the role of physician in the primary care setting, 
public policy and health goals were re-evaluated. Thus, reducing the prevalence of overweight 
and obesity became a global effort. At the recent WHO global conference on obesity, the role of 
primary care physician was re-evaluated and re-defined, based on evidence that public health 
directives can positively impact and influence physicians willingness to become more 
participatory in the fight against the obesity epidemic. Due to the re-evaluation of public health 
policy framework(s) from across the globe, development of specific physician-based 
recommendations have been accepted and adopted by many countries, due to their 
generalizability across populations. Physicians are now provided with a universally accepted 
definition of overweight and obesity. Universal educational tools are also available so that 
physicians can effectively communicate with their patients about the major damaging health 
impacts that are associated with overweight or obese classification. 
Certified Personal Trainers 
 
The foundations of fitness began in the 19th century and were offered more as a social 
program, with focus on prevention of disease, injury, and sedentary lifestyle (Green, 1986; 
Wharton, 1982).  In an effort to combat poor health status of the working class and to improve 
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 work performance, physical activity was separated in two facets: (1) health is a matter of 
personal responsibility and (2) the body was a marker of social status (Bordo, 1993; Bordieu, 
1988; Featherstone, 1982; Schwartz, 1986). Societal beliefs stereotyped people of poor health as 
low social status, low economic status, weak moral character, and as over-all failures (Falk, 
1994; Mrzorek, 1989). The industrialization of the U.S. in the 20th century, coupled with 
advances in medicine and health science, re-invented physical activity through marketing and 
advertisement strategies. Physical activity and exercise were now viewed in society  as  a 
personal choice to improve personal health (Falk, 1994; Mrozek, 1989). This resulted in an 
industry that produced increasing pressure on society to place more importance on physical 
appearance, resulting in popular trends of physical activity in society, such as trends such as 
jogging, aerobics and tennis. As these trends grew, the consumer demands also grew, leading to 
the development of private and public fitness facilities, health foods, and athletic shoes (Kaye, 
1977; Taylor, 1969; Taylor, 1972; Wharton, 1982; Vanderbilt, 1998). The increase in the fitness 
industry throughout the 1970’s and 1980 has helped to reshape public health advocacy, disease, 
and physical activity society now has access to today. Thus, public health programs and policies 
adjusted to meet the current needs of the public. Nineteenth century health problems such as 
tuberculosis, cholera, and clean air were replaced with health prevention and programs providing 
initiatives associated with behavioral health factors, such as smoking and physical activity (CDC, 
2013). 
Today, fitness is a multi-billion dollar industry, commercialized and not necessarily 
focused on important health issues such as disease prevention and control (MaGuire, 2009). 
Maguire (2001) outlines the fitness industry from a social marketing perspective, and concludes 
that personal training has become essential in the marketing of the fitness industry in general. 
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 Certified Personal Trainers (CPTs) are key in the connection between the fitness industry and 
consumers from a social marketing perspective. Not only do they harbor the responsibility of 
marketing a facility, or their own independent business, but also the serious responsibility of 
helping a consumer with attaining personal health. 
CPTs fall under the “service work” category and defy many of the traditional definitions 
of other professions within this category (Hochschild, 1983; Smith, 1994; Wharton, 1993; 
Wharton, 1999). This responsibility of aiding the consumer has been termed “emotional” 
responsibility by Maguire (Smith-Maguire, 2001). Although CPTs hold many responsibilities in 
the service industry, scholarly awareness of their importance has been far underestimated (Rapp, 
et al., 1999). CPTs are responsible for far more than the guidelines set forth by their organizing 
bodies and consumer reports. It is clear that education and intervention are necessary to reduce 
the incidence and prevalence of obesity and because such efforts have historically been rooted 
within the fitness industry, focusing on CPTs is a logical place to start 
This shift in focus has led traditional medical establishments to place more importance on 
how the fitness industry can influence the health of a society in general. Equally important is the 
rising cost of health care insurance, and because of this problem, the fitness industry was able to 
redirect its message and market exercise and physical activity as a preventative measure, in order 
to reduce consumer related health insurance costs, simply by being “fit” (Drury, 1988; Sage, 
1998). Beginning in the early 1970’s, the adoption of corporate wellness programs and facilities 
was on the rise. Initially, work-site related research indicated that such programs lacked 
effectiveness due to the consumer’s willingness and level of comfort associated with a work- 
based physical activity program/facility (Aldana, 2001; CDC, 2005). In response, to combat this 
problem,  industry  began  marketing  the  importance  of  gym  memberships,  emphasized  the 
73  
 importance of personal trainers, and how individualized exercise programs could provide 
additional benefits to the consumer based on factors such as cost and time. For the purpose of 
this research, the fitness industry is defined as a corporate business, and like any business, the 
bottom line is profit. Therefore, beginning in the 1970’s up until the new millennia,  the 
consumer did not receive a marketing message from the fitness industry to spend money for 
intrinsic health factors, but rather for extrinsic health factors. The Health of the Nation Report 
provides current data on weight and health-related issues, and clearly reports a steady decline in 
the health of our nation since 1962 (NCHS, 2013). Direct-to-consumer marketers working for 
the fitness industry know that consumers respond to advertising that targets their needs, wants, 
and desires in terms of buying a “quick fix,” a “magic pill”, and “easy exercise” to combat 
obesity. Overall, marketing strategies in the fitness industry have not been based on the idea that 
there is a serious health-related epidemic in this nation, and that consumers have this new disease 
called obesity. 
Certification of Trainers 
A simple www.google.com Internet search of “certified personal trainers” yields over 4.1 
million results, and when searching the term “personal trainers” it increases to an astonishing 
29.9 billion results (Google, 2013). Certified personal trainers have been described as “the 
catalyst in the dynamic of learning” (Stott, 2001). There are currently an estimated 251,400 
fitness trainers in the United States, with over 300 organizations that provide certification (BLS, 
2012; 2013; Munson, 2003). Expectations that clients may have of a certified personal trainer 
are very broad. Generally, a certified personal trainer is required to provide the client with an 
extensive exercise prescription based on the client’s current health status, exercise history, 
exercise capability, and personal goals (ACSM, 2013).   Clients are also encouraged to assess 
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 their needs, evaluate the trainer’s certification and experience, and observe the certified personal 
trainers exercise session standards prior to hiring a certified personal trainer (Green, 2010). 
According to the Bureau of Labor Statistics, in 2010, there were an estimated 251, 400 employed 
fitness trainers and instructors in the United Sates, employed across 300 independent business 
establishments (BLS, 2012; Munson, 2003; BLS-EFT, 2012). As defined by the United States 
Department of Labor (USDL) (BLS, 2012): 
“Fitness trainers and instructors lead, instruct, and motivate individuals or groups in 
exercise activities, including cardiovascular exercise (exercises for the heart and blood system), 
strength training, and stretching. Instruct or coach groups or individuals in exercise activities. 
Demonstrate techniques and form, observe participants, and explain to them measures necessary 
to improve their skills.” 
Common job titles synonymous to fitness trainers inlcude, but are not limited to: personal 
trainer, certified personal trainer, aerobics instructor, fitness instructor, group fitness instructor, 
group exercise instructor, fitness coordinator, fitness director, fitness technician, fitness trainer, 
certified fitness trainer, and private trainer. Although many certified personal trainers have at 
least a Bachelors Degree in an Applied Sciences related field, not one certifying organization 
requires a degree (BLS-EFT, 2012). When considering fitness trainers and instuctors as a 
collective profession, personal training has not been acknowledged as a true profession, because 
of the lack of one universal governing body, which is responsible for rules, guidelines, education, 
and testing (BLS-OOH, 2012; Brooks, 1998). This does not insinuate the general implication 
that fitness trainers, CPTs or other exercise related occupations are not professional in terms of 
their knowledge, skills, abilities, contributions and values related to their occupation. 
Compounding the argument that certified personal trainers are not validated as professionals in 
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 Fitness Trainers and Instructors: Wages, Employment and Education 
Requirement 
health and medical-related industry is the absence of federal laws and/or regulations of personal 
training as a profession. Currently, the State of Louisiana is the only state in the Union that has 
passed and adopted legislation for attaining training certifications; however, there are still no 
federal licensing laws (Munson, 2003 (BLS-OOH, 2012.). Within the U.S. industry, 
recreational and sports facilities accounted for sixty point seven percent of fitness 
trainer/instructor occupational employment, with jobs in the arts, entertainment and recreation 
sixty-two point one percent, however, many other non-exercise or sport based jobs were verified. 
A percentage of occupational employment for fitness trainers and instructors in 2010 also 
included positions in, but were not limited to: (1) educational services at the local, state, and 
private levels (4.6 percent); (2) healthcare and social assistance (3.8 percent); and (3) religious, 
civic, political, professional, and grant based organizations (14.8 percent) (BLS-EFT, 2012). 
Table 11.  Summary of Wages, Employment, and Education Requirement of Fitness Trainers. 
 
 
 
 
 
Median Annual Wage  $31,090 per year 
 
Employment 2010  251, 400 
 
Projected Employment 2020  311, 800 
 
Projected 2020 Job Openings Based on Need  100,000 
 
Percent Change Projected between 2010 and 2020  24.0 % 
 
Education Requirement for Entry Level 
Certification 
 High school diploma or 
equivalent 
Adapted from the Bureau of Labor Statistics, 2013 
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 Businesses, associations, and organizations are independently responsible for providing 
adequate education, training, and examinations for certifications in health, exercise training, and 
other fitness related disciplines. Although many establishments aim to provide well-rounded 
exams, not all exams are equal. Most CPT certification exams access a candidate’s knowledge 
of basic health education, human physiology, understanding of proper exercise techniques, 
assessment of clients' fitness levels, and the development of exercise prescription. However, 
there is not a universal standard of requirements shared across all certifying organizations; 
therefore, each independent organization is accountable for exam content and  trainer 
requirements necessary to become a certified personal trainer (BLS (b), 2013). Prior to hiring a 
fitness trainer, it is highly recommended that clients verify the level of expertise, education, 
certification, and experience procured by the prospective trainer. Not all fitness certifications are 
equivalent. 
The Institute for Credentialing Excellence (ICE) was established in 1977, and has been 
the leading international membership organization since its inception. Formerly known as the 
National Commission for Certifying Agencies-Accredited Certification Programs (NCCA-ACP), 
ICE provides the delivery of educational and training programs, establishes quality standards for 
credentialing, and provides accreditation services to a variety of organizations. Within the ICE 
mission statement, it declares, “to help ensure the health, welfare, and safety of the public 
through the accreditation of a variety of certification programs/organizations that assess 
professional competence (ICE, 2013).” Because it is considered best practice to require 
employees of fitness facilities to possess a valid and current certification, it is highly 
recommended that potential personal trainers receive certification with an NCCA accredited 
program.  In addition to CPT certification, NCCA accredited organizations require a valid and 
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 current certification in cardiopulmonary resuscitation (CPR) prior to taking an exam (ICE, 2013). 
Therefore, it is important that clients choose a trainer who has received a certification from an 
organization that is accredited through the Institute for Credentialing Excellence (ICE) and meets 
or exceeds the criteria set forth by The NCCA (ICE, 2013) (NCCA Approved Fitness 
Organizations Source: Adapted from ICE 2013). While it could be argued that the “gold 
standard” for certification in fitness training is through the American College of Sports Medicine 
(ACSM), other significant and reputable organizations offer certification comparable to ACSM 
(BLS, 2012-13; NFPT, 2013 (ICE, 2013).(Table 12) 
Table 12: NCCA Approved Fitness Organizations. 
 
ACRONYM ORGANIZATION 
ACE American Council on Exercise 
ACSM American College of Sports Medicine 
AFAA Aerobics and Fitness Association of America 
AFTA American Fitness Training of Athletics 
CI The Cooper Institute 
ISSA International Sports Sciences Association 
NASM National Academy of Sports Medicine 
NATA National Athletic Trainers' Association 
NBFE National Board of Fitness Examiners 
NFPT National Federation of Professional Trainers 
NFTA National Fitness Therapy Association 
NPTI The National Personal Training Institute 
NSCA National Strength and Conditioning Association 
Adapted from ICE 2013 NCCA Accredited Organizations Offering Certification in Personal 
Training Adapted from ICE and Listed Organization 
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Table 13.  Educational Requirements and Costs of Various Certifications 
 
 
ORGANIZATION NAME 
 
DEGREE 
REQUIRED 
APPROXIMATE* 
COST IN U.S. 
DOLLARS: 
NCCA- 
ACCREDITED 
CERTIFICATIONS* 
Academy of Applied Personal 
Training Education (AAPTE) 
HS Diploma 
or Equvalent 
 
$900.00 
Certified Personal 
Fitness Trainer 
(CPFT) 
American College of Sports 
Medicine (ACSM) 
HS Diploma 
or Equvalent $414.00 
Certified Personal 
Trainer (CPTC) 
American Council on 
Exercise (ACE) None $399.00 
Personal Trainer 
(ACE-CPT) 
National Academy of Sports 
Medicine (NASM) 
 $599.00 Certified Personal Trainer (CPT) 
National Council for Certified 
Personal Trainers (NCCPT) 
HS Diploma 
or Equvalent $699.00 
Certified Personal 
Trainer (CPT) 
National Council on Strength 
and Fitness (NCSF) 
HS Diploma 
or Equvalent 
 
$675.00 
National Certified 
Personal Trainer 
(NCSF-CPT) 
National Exercise and Sports 
Trainers Association 
(NESTA) 
HS Diploma 
or Equvalent 
 
$449.00 Certified Personal Fitness Trainer (PFT) 
National Exercise Trainers 
Association (NETA) None $449.00 
Certified Personal 
Trainer (NETA-CPT) 
National Federation of 
Professional Trainers (NFPT) 
HS Diploma 
or Equvalent $479.00 
Certified Personal 
Fitness Trainer (CPT) 
National Strength and 
Conditioning Association 
(NSCA) 
HS Diploma 
or Equvalent 
 
$420.00 Certified Personal Trainer (NSCA-CPT) 
The Cooper Institute (CI) None $289.00 Personal Trainer Certification (CPT) 
Note: Approximate cost reflects standard prices including materials and exam feebut does not include 
premier packages, additional course resources, and taxes.  Table does not include specialty certifications, 
which may require an advanced degree and additional prerequisites. 
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The steady increase of CPTs employed by both the public and private sector may be a 
direct response to the U.S. Government HealthyPeople 2010 and Healthy People 2020 initiatives 
(USDHHS, 2013). HealthyPeople has been providing the scientific evidence needed to research, 
identify, and develop nationwide objectives in order to improve the current health status of the 
American people since its inception in 1979 (USDHHS, 2013). Healthy People 2020 has one (1) 
mission; four (4) primary goals; four (4) primary health foundation measures; forty one (41) 
focus areas; six hundred (600) specific objectives dispersed within the focus areas; and over 
thirteen-hundred measures to establish quantifiable data within each objective. The framework 
for HealthyPeople was based on the social determinants of health (Wilkinson & Marmot, 2003). 
The Nutrition and Weight Status objectives (NWS) in Healthy People 2020 focus on promoting a 
healthy diet and maintaining acceptable body weight, with objectives that emphasize strategies to 
change detrimental individual behaviors and the policies and environments that incite these 
behaviors. The mission, goals, measures, focus areas, and objectives are non-discriminatory, and 
aim to improve the health of all peoples in the United States. 
Specifically, the NWS health outline objectives promote health in settings such as 
schools, worksites, health care organizations, and communities. One specific initiative  of 
Healthy People 2020, could eventually lead to an increase in job opportunities in both the public 
and private sector, utilizing CPTs as an important member of health care teams. The Nutrition 
and Weight Status objective number seven (NWS-7) is a developmental initiative that could be 
interpreted by the fitness industry as a foundation for developing programs in which CPTs are 
utilized as a resource in the medical industry. Such CPT-based health promotion programs could 
have the potential to evolve into a valid resource for primary care physicians and bridge the 
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 previously mentioned gaps physicians face with their overweight and obese patients (USDHHS, 
2013). As written in Healthy People 2020, NWS-7 is a developmental objective with the future 
goal to implement, measure and validate policies, programs, and interventions that propose to 
“increase the proportion of worksites that offer nutrition and weight management classes or 
counseling” (USDHHS, 2013). It has been demonstrated that CPTs have an important role in 
guiding patients to eat healthy, establish exercise routines, and adopt positive behavioral changes 
(Brooks, 1998; Claps, 2005; Davis, et al., 2009; Fox, Rejeski, & Gauvin, 2000; Gavin, 1996; 
Holcomb, 2010; Maguire, 2001; McClaran, 2003; Seguin, et al., 2008, Ángyán., 2002). 
Therefore, if the fitness industry, and/or accredited fitness organizations that certify fitness 
trainers, can establish the importance of the roles CPTs play in the attitudes, beliefs, perceptions, 
and actions clients/patients have related to diet, exercise and weight-loss products, this could 
lead to resource that has not been previously established and utilized both inside and outside of 
medical health care settings. 
 Demonstrate how to carry out various exercises and routines 
 
 Watch  clients  do  exercises  and  show  or  tell  them  correct  techniques  to 
minimize injury and improve fitness 
 Give alternative exercises during workouts or classes for different levels of 
fitness and skill 
 Monitor clients’ progress and adapt programs as needed 
 
 Explain  and  enforce  safety  rules  and  regulations  on  sports,  recreational 
activities, and the use of exercise equipment 
 Give clients information or resources about nutrition, weight control, and 
lifestyle issues 
 Give emergency first aid if needed 
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 Certified personal fitness trainers (certified personal trainer) are important partners in 
health care and are key players in the battle against obesity. Often overlooked, certified personal 
trainers usually have a wealth of knowledge in the areas of physical fitness and weight 
management. Many organizations offer fitness professionals certifications to train the general 
public. Previous research examined the current state of certification criteria among organizations 
that certify personal trainers (Lobb, Lobb, Hallam, 2008). Information about the certification 
exams for multiple agencies was retrieved from associated Web sites and reviewed for questions 
or components related to anti-obesity medications. All organizations required knowledge in the 
areas of nutrition, fitness, anatomy, and physiology and none evaluated included a testing 
component concerning pharmacotherapy for the purpose of weight-loss. 
Roles of Certified Personal Trainers 
 
In the United States, the areas of health, fitness, exercise, and recreational physical 
activity has turned into a multi-billion dollar industry (Maguire 2002). Beginning in the early 
1970s, with the introduction of aerobic fitness by John Cooper, the fitness industry has morphed 
into a complex system of innovators, consumers, products, and practices. A poignant content 
analysis explores the development of the U.S. fitness industry, based on popular exercise 
manuals, between the 1970s to late 1990s (Maguire, 2008). Maguire outlined the trends of the 
fitness industry in a manner that explains the trends, preferences, and attitudes of fitness 
professionals as well as fitness consumers. This analysis provides the context in which personal 
training developed into the career choice it is today. 
Maguire begins with an explanation of the basic concepts in which academic and lay- 
press literature first pursued as sources of key interest to the consumer. Research studies, texts, 
and magazines between the early 1970s and late 1990s shared three common themes in relation 
82  
 to the fitness consumer: (1) attitude towards the body, (2) the body as a source of quantifiable 
rewards, and (3) outward appearance as a source of motivation (Bordo, 1993; Bordieu, 1988; 
Braverman, 1974; Brooks, 1998; Cohen J.   D., 1988; Falk, 1994; Featherstone, 1982; Fuller, 
1995; Fuller and Harding, 1994; Hochschild, 1983 McInnis, 1997; Mrozek, 1989; Nguyen, 1997; 
 
Rupp,  1999;  Schwartz,  1986;  Sheppard,  1998;  Smith,  1994;  Taylor,  1972;  Taylor,  1999; 
 
Vanderbilt, 1998 Wharton, 1993; Wharton, 1982 Wharton, 1999). Overall, when deciphering the 
messages across sources, texts focused primarily on health education whereas research focused 
on testing the constructs of health education. Lay press editorials, such as lifestyle magazines, 
presented extrinsically motivational pieces with basic summaries of exercise programs, tips, and 
techniques. Although there were ride ranges of textual differences, common themes that were 
identified across the sources of information, as previously mentioned. One of the strongest 
themes that appeared amongst all of the fitness publications was the promotion of attitudes 
towards the body. Thus, as the fitness industry consistently immersed the consumer with 
positive reinforcement of attitudes related to health and the body, consumers became more 
knowledgeable, driven, and claimed a more active role in their personal health. 
Bordieu’s work assessed what he termed as “elective affinity” between the fitness 
industry and consumers (Bordieu, 1988). During the 1980’s, the fitness industry was primarily 
geared towards Caucasian, middle class men and women with higher levels of education and 
income (Bordieu, 1984). This particular faction of consumers were more likely to adopt attitudes 
and beliefs that regarded the body: (1) as a project to be managed and improved (2) 
improvements are made through education and self-improvement, and (3) the body is as an 
integral component of self-identity and social mobility (Bordieu, 1984, Crawford, 1984; 
Featherstone, 1982; Featherstone, 1987).  This attitude towards the body has also been correlated 
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 to social standing, where appearance could result in increased social acceptance, status, and 
rewards (McGuire, 2002; Sassatelli, 2003). The knowledge provided to consumers on how to 
make lifestyle decisions represent health and exercise as rational outcomes, more so than health 
decisions (Maguire, 2001; Maguire, 2008). The presumption that behavioral changes related to 
physical activity is a product of receiving sufficient knowledge, education, tools and training. 
However, physical activity behavior and weight status are less the outcomes of rational or 
irrational actions, but the customary responses to other barriers (Crister, 2001; Farley & Cohen, 
2001). Despite the availability of information, for a significant portion of the population, 
individual medical self-awareness does little to address the structural constructs that facilitate 
physical inactivity. Therefore, as the fitness industry continues to grow, consumers have a 
myriad of fitness sources for education, advice, products, and services. The enigma to solve is 
how can the fitness industry make a significant contribution to the obesity epidemic as rates of 
physical activity continues to decline, and overweight and obesity continue to rise on a global 
level (BLS(b), 2013; CDC(c), 2001; CDC(a), 2013)? Perhaps the answer lies within the fitness 
industry itself, as personal trainers are often a neglected resource (Oprescu, 2012). Rupp et al 
(1999) reports that a client can be assured that a certified personal trainer has  completed 
adequate exercise education and training courses if the certified personal trainer does hold a valid 
certification (Rupp, 1999). Further studies show contradictions to Rupp et al’s study, and report 
that education, degree held (i.e. Bachelor of Science in Exercise Science), and certifying 
organization are significant predictors of a certified personal trainers knowledge. 
Two hundred twenty eight experienced personal trainers responded to a survey of 
perceived role responsibilities, conflicts, and boundary issues in this emerging profession. Sex, 
age, and trainers’ levels of experience was analyzed from a 53-item questionnaire.   Findings 
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 provide information about why clients are believed to hire personal trainers, degrees of 
responsibility trainers feel for different aspects of the relationship, common conflicts experienced 
in this profession, and relationship behaviors considered acceptable or unacceptable. From a 
number of perspectives, the results suggest that trainers may engage in and take responsibility for 
behaviors that fall beyond their legitimate domains of competence and influence. These include 
such activities as giving advice to clients about nutrition, lifestyle, and psychological agendas. 
Significant differences were observed when results were analyzed by sex, age, and experience 
level. (Fuller, et al., 1995). 
Malek, et al 2002, assessed certified personal trainers (n=115) training and experience 
compared to their actual knowledge of nutrition, health screening, testing protocols, exercise 
prescription and general knowledge required for training special populations (Malek, Malek, 
MH, & Coburn, 2002). Using a questionnaire developed for the current study, the Fitness 
Instructors Knowledge Assessment (FIKA (R)), we examined relations between commonly used 
indicators of knowledge (training and experience) and actual knowledge in the five areas of (a) 
nutrition, (b) health screening, (c) testing protocols, (d) exercise prescription, and (e) general 
training knowledge regarding special populations. FIKA provided reliable measures of 
knowledge in these areas, which are of critical importance in developing an optimal fitness 
program for the client and for avoiding unnecessary injuries. A survey of 115 health fitness 
professionals revealed that a bachelor's degree in the field of exercise science and possession of 
American College of Sports Medicine or the National Strength and Conditioning Association 
certifications as opposed to other certifications were strong predictors of a personal trainer's 
knowledge, whereas years of experience was not related to knowledge. These findings suggest 
that personal fitness trainers should have licensing requirements, such as a bachelor's degree in 
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 exercise science and certification by an organization whose criteria are extensive and widely 
accepted, before being allowed to practice their craft. What this study revealed were that levels 
of education as well as organization from which certification were obtained were strong 
predictors of knowledge, whereas years of experience were not. 
McInnis et al, found that of 82 exercise facilities surveyed, only 74 percent of clubs 
required a physician’s consent form, and 36 percent had an entire staff who held a bachelor’s 
degree (McInnis, 1997). Fuller and Harding (1994) identified a set of academic collegiate 
courses in the field of exercise science that were deemed necessary for a certified personal 
trainer. Results reported that 60 percent of those surveyed had not completed any of the courses, 
and 38 percent had not completed any of the key courses listed on the survey. A follow-up study 
by Fuller, et al., (1995), investigated the relationship between formal education, type of 
certifying organization and level of knowledge. Similar results were found as compared to the 
previous Fuller et al study; however, when identifying the certifying organization of the certified 
personal trainer, 74 percent of those certified by The American College of Sports Medicine 
(ACSM) or the National Strength and Conditioning Association (NSCA) had completed at least 
nine of the 13 courses listed as necessary. 
Researchers at the University of California did a recent survey of fitness professionals 
(n=115), and concluded that certifying organization was a significant predictor of several 
knowledge areas of personal training (Malek 2002). Similar to previous findings, those who held 
an ACSM or NSCA certification averaged a knowledge score of 70-85 percent while all other 
subjects scored below 40 percent. Collectively, these findings indicate the need for a national 
standard of knowledge, training, and skills for certified personal trainers. It has been 
demonstrated in the past that personal trainers rely on personality and appearance far more than 
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 level of education and certification to demonstrate soundness of skills to potential clients 
(Solomon, et al., 1997). Years of experience was not found to be predictive of personal trainer 
knowledge. 
Discussion 
 
The AMA now recognizes obesity as a disease. This is very likely due to both the 
increase in the prevalence of overweight/obese persons globally and the preponderance of 
evidence that excess weight and elevated BMI result in significant increases in morbidity and 
mortality. Initiatives such as those included in HealthyPeople and the PPACA also reflect the 
migration from considering excess weight as a lifestyle condition to a disease requiring 
intervention. Interventions for weight-loss include diet and exercise (lifestyle), pharmacotherapy 
and surgery, the latter have both been shown to benefit patients who are unresponsive to lifestyle 
counseling alone. For many patients with a life long history of overweight/obesity complicated 
by several co-morbid conditions (e.g., hypertension, diabetes, heart disease) appetite 
suppressants have allowed them to gain control of their dietary intake and body weight for the 
first time in their lives. If overweight/obesity were like any other disease, such as diabetes or 
hypertension, physicians would prescribe a medication only to their own patients, taking into 
account the potential risks and benefits as they pertain to that specific individual. Moreover, the 
patient would be reluctant to take a prescription from another clinician, one who may not be 
aware of his/her personal background and medical problems. If this were the case, diet drug 
usage would be well controlled and monitored. The drive to thinness is fueling the weight-loss 
industry. Out of desperation, some may turn to any “quick-fix” weight reduction product. Many 
physicians established overnight diet-pill clinics, and attracted a vulnerable public into their 
offices with advertisements exclaiming medical breakthroughs with quick, safe and permanent 
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 results. In addition, commercial weight-loss programs entered into the medical prescriptive 
market. Through medical consultant employees, the programs prescribed diet drugs in the 
program center. 
There remains the potential for social bias against overweight individuals and this has 
been shown to potentially translate into the physician’s office and the CPT session. In addition, 
while there is ample support that consumers generally trust their physician as a source for health 
care information, there is also evidence that physicians lack both the time and the information 
necessary to appropriately intervene in the weight-loss treatment plans of their patients. 
Similarly, while CPTs may be trusted sources of information regarding exercise, the variability 
in education and certification may lead to variability in the trust put into CPTs as sources for 
information and in fact, some CPTs may lack the appropriate information for valid intervention. 
Beyond diet and exercise and before surgery, there is a role for pharmacotherapy, both 
OTC and prescription in the treatment of patients with obesity; however, without appropriate 
counseling and education the vulnerable public is easy prey to opportunists who make 
unsubstantiated claims.  This leads to several research questions: 
1. Determine if positive or negative source-based statements either influence or change 
consumer beliefs and intentions to use a weight-loss medication. 
2. Determine differences  in  the effect  of recommendations, either positive or negative, 
based on source between physicians and certified personal trainers. 
3. Determine consumers’ attitudes about or intent to use a weight-loss medication differs by 
type of product. 
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 Health Behavior Change Theories 
 
The origins and foundations of present day health behavior-change theories are founded 
in early psychology-based theories of learning, expectancy-value, and consistency, such as 
Hider’s Balance Theory, Osgood and Tannenbaum’s Congruity Theory, Festinger’s Dissonance 
Theory, and Weiner’s Attribution Theory (Festinger, 1957; Heider, 1958; Fishbein, 2001; 
Fishbein & Ajzen, 1975; Osgood & Tannenbaum, 1955; Weiner, 1974; Weiner, 1980). 
Historically, within the context of public health programs and interventions, factors such as the 
growth of industry, environment, and population all contributed to the way in which health-based 
theories were viewed and utilized for the development of programs and evidence-based 
practices. The ecological approach to health behavior change assesses health behavior as a 
product of the social systems and social influencers surrounding an individual (Bronfenbrenner, 
1977; McLeroy, Steckler, Bibeau, & Glanz, 1988). In other fields using ecological theories, 
health-based behavior change theories are unique in their inclusion of a broader evaluation of 
social systems, in terms of how community, organizational, and policy may inﬂuence health 
behavior. Based on the ecological approach to health behavior change, social influencers are 
categorized into five pre-determined categories: intrapersonal, interpersonal, institutional, 
community and public policy (McLeroy, Steckler, Bibeau, & Glanz, 1988).. Examples of 
intrapersonal influencers are an individual’s decisions, attitudes, self-esteem, self-concept or 
self-regulation. Commonly used intrapersonal theories that are used to examine health behavior 
change, are the Health Belief Model, Theory of Planned Behavior, and the Transtheoretical 
Model of Change. 
When entering the basic search term “Theory of Planned Behavior” into the National 
Center for Biotechnology Information  (NCBI)  all-database search option, results  yield over 
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 12,000 full text articles (NCBI, 2013). The Theory of Reasoned Action (TRA) preceded the 
Theory of Planned Behavior (TPB) and posited, that prior to an executable action; intentions to 
act precede decisions to execute an action (Ajzen, 1985). The primary assumption of TRA is 
that positive attitude and subjective norm (influence); result in increased motivation (intention) 
to execute a behavior (action). Figure 2 illustrates the basic constructs of the  Theory of 
Reasoned Action. In TRA, attitudes develop based on an individual’s summation beliefs that are 
associated with the behavior itself, as well as the strength of each belief. Therefore, an attitude 
toward a behavior is a summation of: (1) products of the belief (2) strengths of the belief and (3) 
attitudes toward the behavior. Intentions generate from attitudes at the personal level, based on 
societal norms. Four decades of research in health behavior change, provide statistical validation 
for the high correlations that attitudes and subjective norms influence behavioral intentions 
(Sheppard, Hartwick, & Warshaw, 1998). 
In addition to the constructs of attitudes and subjective norms, the additional concept of 
perceived behavioral control, emerged as a new possible construct to include in TRA. The 
perceived behavioral control construct originated from Self Efficacy Theory (SET) (Bandura 
1977). Bandura first proposed self-efficacy in 1977, which was conceived from his original 
Social Learning Theory, known today as Social Cognitive Theory (Bandura, 1977; 1998, 2001). 
By definition, self-efficacy is "the belief in one’s capabilities to organize and execute the courses 
of action required to manage prospective situations" (Bandura, 1977). It is in the conviction that 
one can successfully execute a behavior, in order to achieve an outcome, which affects self- 
efficacy in an individual. 
In Social Cognitive Theory, self-efficacy is the most important pre-condition for 
behavioral change, as it often determines the initiation of coping related behavior(s).   Self- 
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 efficacy has consistently contributed to explaining various relationships between beliefs, 
attitudes, intentions, and behavior. As the theory of social learning and cognition (SCT) 
continued to be developed, tested, and validated in the field of psychology, it is commonly used 
today in many health-related fields (Anderson-Bill, Winett, & Wojcik, 2011; Annesi, 2005; 
Bandura, 1998). While other theoretical models base source of influence within an individual’s 
conceptualized cognitive space, the Theory of Planned Behavior considers social influence, 
based on collectivistic culture-related variables. The inclusion of culture-related variables allows 
for the identification of the strength of cultural-related variables as well as the influence on 
decision-making. It is through the inclusion of cultural-related variables that provide a better 
understanding of perceptions that are capable of being influenced by social norms and normative 
beliefs. Therefore, an individual’s health-related behavior (i.e., diet, exercise, smoking, 
drinking), might very well be located in, and dependent on the more predominate social networks 
and organizations of an individual (i.e., peer group, family, school and workplace). 
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 Figure 2. Theory of Reasoned Action. 
 
 
Ajzen & Fishbein 1977,  Ajzen & Fishbein 1985 
As Ajzen (1991) states in the Theory of Planned Behavior, knowledge of the role of 
perceived behavioral control was founded on Bandura’s concept of self-efficacy (Bandura 1977). 
The Theory of Planned Behavior is an extension of the Theory of Reasoned Action, to theorize 
that attitudes toward a behavior are the function of three metrics: (1) beliefs and the associated 
strengths of beliefs toward the behavior, (2) subjective norms around the behavior, and (3) locus 
of control for the individual (Ajzen, 1985). As TRA was adopted and applied, investigational 
studies did not show that behavioral intention always led to actual behavior, creating a counter 
argument against the high relationship between behavioral intention and actual behavior, citing 
the concept of circumstantial limitations (Bagozzi, 1981). Specifically, the argument was based 
on the idea that behavioral intention cannot be the exclusive determinant of behavior, where an 
individual’s control over the behavior is restricted or incomplete (Bagozzi, 1981). In response, 
Ajzen  and  Fishbein  acknowledged  and  explored  this  counter  argument,  and  added  the 
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 component, “perceived behavioral control “to the TRA theoretical framework. With the 
inclusion of perception, the Theory of Reasoned Action could then include and account for 
volitional behaviors, therefore, providing an approach to identify and enhance the prediction of 
behavioral intention and actual behavior. It is through this addition, that the Theory of Planned 
Behavior was conceived (Ajzen, 1985; Ajzen , 1987; Ajzen, 1991). 
 
Figure 3: An Illustration of the Theory of Reasoned Action and Planned Behavior. 
 
 
 
Adapted from Azjen 
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The Theory of Planned Behavior also posits that behavior originates from intentions. 
Intentions in turn, originate from attitude about the behavior, the subjective norms concerning 
the behavior and an individual’s locus of control. In essence, before a person can behave in a 
certain manner, he, or she must first intend to do so. As such, altering a person’s intention 
toward a certain behavior is likely to lead in an alteration of behavior. It is possible to alter an 
individual’s intentions to act, by manipulating their unique attitudes about the behavior. 
Subjective norms represent how the person believe others will desire him or her to behave and 
are less correlated with behavior than attitudes. 
Theory of Reasoned Action (TRA) and Theory of Planned Behavior (TRB) each provide 
for the ability to measure the concept of social influence. Social norms and normative beliefs, 
are the direct measures used establish the foundation to identify and measure social influence in 
TRA. Simply stated, elaborative thoughts on subjective norms and beliefs, serve as the 
foundation that determine a person’s unique perceptions related to intent to act or performing the 
act itself.. The perceptions of social expectations to perform a specific behavior are influenced 
by numerous sources (i.e. friends, family, and society) Establishing the degree to which social 
influence affects decision-making is extremely important. The identification, measurement, and 
establishment of social sources of influence, provide a clearer understanding of perceptions. 
Recently, Fishbein and Cappella (2006) stated that self-efficacy is the same as perceived 
behavioral control in his integrative model, which was also measured by items of self-efficacy in 
a previous study (Ajzen, 2002a). In previous studies, the construction and the number of item 
inventory of perceived behavioral control have depended on each particular health topic. For 
example, for smoking topics, it is usually measured by items such as “I don’t think I am addicted 
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 because I can really just not smoke and don’t feel crave for it,” and “It would be really easy for 
me to quit.” Thus, simply stated, the concept perceived behavioral control is the perception of 
the ease or difficulty of a particular behavior. It is linked to control beliefs, which refers to 
beliefs about the presence of factors that may facilitate or impede performance of the behavior. 
It is usually measured with items which begins with the stem, “I am sure I can (i.e., exercise, quit 
smoking, etc.)”. Generally, a self-report instrument (i.e. questionnaire) is designed to measure 
the confidence toward the probability, feasibility, or likelihood of executing given behavior. 
For example, consider how an individual would decide whether to take a prescription 
and/or OTC weight-loss aid. Table 14 provides hypothetical examples of both positive and 
negative subjective normative beliefs (thoughts), when presented with the decision of whether 
take a weight-loss aid. These (hypothetical) thoughts on weight-loss aids then influence 
subjective norms, which lead to the intention to act and decision to act upon the final behavior 
(decision take or not take the weight-loss aid). 
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 Table 14.  Examples Of Hypothetical Positive and Negative Attitudes That May Influence The 
Decision To Take a Weight-loss Aid 
 
 From Peer Groups 
Positive: Most of my friends really believe that weight-loss aids are 
good. Negative:  Most of my friends really believe that weight-loss aids 
   From Family 
Positive: Since my spouse takes a weight-loss aid, and believes it is working, he says I 
should start taking a weight-loss aid too. 
Negative:  My spouse tried one weight-loss aid and he did not see big results, so he 
believes it won’t work for me either. 
 From Society Or Culture 
Positive: My doctor believes that prescription weight-loss aids really work. 
Negative:  My doctor just assumes I do not need to take a prescription weight-loss aid, he 
thinks it just won’t help me lose more weight. 
Source: (Original) Statements are Based on the Theory of Planned Behavior (Ajzen & Fishbein,1987) 
 
To summarize, the Theory of Planned Behavior posits that human behavior is guided by 
three constructs. "behavioral beliefs," "normative beliefs," and "control beliefs.” In their 
respective categories, “behavioral beliefs” produce a favorable or unfavorable “attitude toward 
the behavior”; “normative beliefs” result in “subjective norm”; and “control beliefs” give rise to 
“perceived behavioral control.” In combination, “attitude toward the behavior,” “subjective 
norm,” and “perceived behavioral control” lead to the formation of a “behavioral intention” 
(Ajzen, 2002b). In particular, "perceived behavioral control" is presumed to not only affect 
actual behavior directly, but also affect it indirectly through behavioral intention (Zimmerman et 
al., 2005). 
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 Theory of Planned Behavior 
 
The Theory of Planned Behavior (TPB) is a well-established, widely adopted, and 
applicable model for health-based behavior change research. In many areas of public health 
research, such as health awareness, promotion, prevention, communication, education, and 
policy, the simplicity of the TPB theoretical framework (see Figure 3), behavior change the 
model generalizable for its use within and across, (Ajzen, 1991; Ajzen, Joyce, Sheikh, & Gilbert- 
Cote, 2011;Taylor, et al., 2006),also, when compared to other health behavior change theoretical 
models, TRB is less theoretical framework complex by design with fewer constructs, thus, 
facilitating the improvement in the predictability of achieving changes in intended behavior(s) 
(Baban & Craciun, 2007). In these areas of research, the primary goal of TPB-based 
interventions is to increase the likelihood of positive behavior change (action/outcome), which is 
a direct result of an individual’s decision-making process. Remembering that the TBP’s main 
hypothesis is that a belief is the basic determinant of any given behavior, if an intervention can 
change or modify an underlying belief, then the probability of changing the behavior is higher. 
Specific areas of priority in public health research, have reported positive results in behavior 
change interventions by implementing the TPB theory as the foundation for their research 
design. Examples include, but are not limited to, condom use, (Albarracin, 2001; Beadnell, et 
al., 2008; Taylor., 1999); diet and exercise, and obesity (Courneya, et al., 2000; Gratton, et al.). 
The implementation of the Theory of Planned Behavior is also a relevant and useful 
framework for research studies that seek to investigate how source of credibility may be 
correlated to normative beliefs of weight-loss medication. In the United States, the patient/client 
decision to adhere to prescription and/or over the-counter medications is an area of special 
concern, given recent declines in the economic and health status’ of many Americans (DeNavas- 
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 Walt, Proctor, & Smith, 2012; Flegal, et al., 2010; Wang, 2008). The proposed research in this 
study will use the Theory of Planned Behavior as its theoretical framework. The primary goal is 
to expand upon what is known concerning consumer preference, pertaining to source of 
knowledge concerning weight-loss prescription and over-the counter weight-loss aids (Carr, et 
al., 2011; Fox et al., 2005). Thus, as it stands, the area of subjective norms towards obesity is 
unclear, medications for obesity treatment are dismissed as unimportant, and the majority of 
Americans are overweight or obese (Adlofsson, 2005; CDC, 2010; 2013). The “thin is in” 
concept is supportive of a global subjective norm against overweightness; however, with a 
sizeable proportion of the population living with overweightness or obesity, it is unclear what the 
true subjective norm is, especially at the individual level. As such, this research will focus on 
changes in belief, following a source credibility intervention and will assess if interaction effects 
will potentially confound the results. 
Establishing if a consumer is more likely to determine a behavioral decision, based on 
source of knowledge, is important in understanding the acceptance of information about a 
weight-loss aid. An individual's behavioral intention cannot be the exclusive determinant of 
behavior, where an individual’s control over the behavior is incomplete. In investigating 
perceived behavioral control, the Theory of Planned Behavior can uncover relationships between 
behavioral intention and actual behavior. Several studies found that the theory of planned 
behavior would help better predict health-related behavioral intention than the Theory of 
Reasoned Action (Ajzen, 1988). Nair used the theory of reasoned action as a framework for an 
assessment of attitudes effects on medication discontinuation following the introduction of 
change in cost sharing in the form of copayments for prescriptions within an insurance plan. 
Nair evaluated several constructs and their relationship to discontinuation intentions.   These 
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 included attitudes toward prescription insurance, generic medication perceptions, formulary 
attitudes, and willingness to switch and how they related to prescription discontinuation (Nair, 
2003). 
It is in the context of the decision to obtain knowledge of a weight-loss aid, either OTC or 
prescription, that patients will engage an information source. Patients/clients process 
information from several sources, develop beliefs about the purchasing of the product such as 
efficacy expectations, develop an intention to purchase and purchase the medication. Assuming 
that the prescription represents appropriate medical care, failure to comply with a written 
prescription represents an opportunity for therapeutic failure and patient harm. 
Both physician and CPT knowledge and attitudes related to the use of weight-loss 
prescription medications and supplements is reported in the literature streams. However, when 
comparing CPTs to physicians, the amount of literature on the knowledge and attitudes about 
weight-loss aids is extremely disproportionate, highly favoring physician literature streams. This 
lack of a drug education requirement highlights a key issue facing the increasing involvement of 
both pharmacotherapy and personal trainers in the fight against obesity. As a common and 
trusted touch point for patients working to lose weight, personal trainers have the ability to 
support patients engaging in diet, exercise, and pharmacotherapies to reduce weight. However, 
with a lack of focus on pharmacotherapy in the certification process and with thousands of 
certified personal trainers in the United States, it is important to understand personal trainers' 
views and knowledge of pharmacotherapy for weight-loss. Because patients/clients often discuss 
potential alternative diets and treatments with their trainers, and because of all information 
sources,  are  seen  more  frequently than  other  providers,  as  OTC  and  prescription  therapies 
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 increase in availability, personal trainers may have an increased potential to identify potentially 
life threatening issues. 
In previous research, beliefs were found to be strongly negative toward pharmaceuticals 
amongst personal trainers, specifically; personal trainers were biased against pharmaceutical 
obesity interventions in weight-loss plans (Lobb, Lobb, Hallam 2008). This bias represents an 
attitude toward pharmaceutical anti-obesity therapies that is probably best assessed using an 
evaluation of belief formation and assessing the ability of information provided to alter 
preconceived beliefs about anti-obesity treatments. This begs the question, if trainers did speak 
positively to clients about pharmaceuticals how would that affect their clients behavioral 
intentions?  Several theoretical frameworks exist to scientifically evaluate such effects. 
However, this theoretical framework is not without limitations, the theory of planned 
behavior is based on cognitive processing and level of behavior change. Compared to affective 
processing models, the theory of planned behavior overlooks emotion variables such as threat, 
fear, mood and negative or positive feeling and assessed them in a limited fashion. In particular, 
in the health-related behavior situation, given that most individuals’ health behaviors are 
influenced by their personal emotion and affect-laden nature, this is a decisive drawback for 
predicting health-related behaviors (Dutta-Bergman, 2005). Poor predictability for health-related 
behavior in previous health research may be attributed to the exclusion of this variable. 
Discussion 
 
The perceptions, roles, conflicts and boundaries that challenge both physicians and 
certified personal trainers in the delivery of effective weight-related counseling and treatment, 
modalities to their clients/patients was presented in Chapter 2.   Based on scientific self-report 
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 qualitative survey research, it has also been established that certified personal trainers actually 
engage in and accept responsibility for giving opinions, advice, and recommendations in areas of 
training considered outside of their area of expertise and/or certification(s) (Gavin, 1996; 
Holcomb, 2010; Malek, Malek, MH, & Coburn, 2002; Malek, et al., 2002; Smith-Maguire, 2002; 
Smith-Maguire, 2008). This does not imply that CPTs are not qualified or should not 
communicate, teach and foster their clients to learn about health and medical-related topics 
outside of their areas of expertise and certification. In fact, based on the “gold standard” in 
acquiring CPT certification, it gives a plausible reason for organization(s)  (i.e.  American 
College of Sports Medicine) to develop additional specialized certifications with emphasis in 
areas that do not exist (i.e. knowledge of key pharmaceutical and over-the-counter medications 
that may have adverse effects during exercise). Considering that, a general family physician is 
often the first person with the opportunity to clinically intervene and provide weight-loss 
treatment(s), the multifarious mêlées physicians face only compound their ability to provide 
effective and successful long-term treatment(s) for weight-loss (Yoong, et al.., 2012). Thus, the 
initiatives of both the U.S. The Patient Protection and Affordable Care Act and Healthy People 
2020 to improve the health of Americans, through reducing the prevalence of overweight and 
obesity in both children and adults, lead to the development of the primary aim of this study. 
The weight-related initiatives in both the PPACA and Healthly People 2020, provide a myriad 
supportive statements that call for the identification of new external professional resources that 
can work in conjunction with physicians. As written, in addition to the physicians, nutritionists, 
and bariatric surgeons already utilized in weight-related medical treatments, the statements 
outlining the call for additional viable professional resources are stated simplistically, and 
without specific limitations (PPACA, 2010 USDHHS, 2013;). 
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 Therefore, the primary interest of this research study is to investigate consumer beliefs 
about prescription (Rx) and over-the-counter (OTC) weight-loss medications.Specifically, this 
study will investigate the degree to which a physician (MD) and certified personal trainer (CPT) 
influence consumer beliefs associated with weight-loss aids. According to current literature 
streams, both MD’s and CPTs are traditional sources of information that consumers have relied 
upon for obtaining health and medical-based information. Research indicates that consumers 
trust physicians to provide them with reliable and valid clinically based medical information 
concerning their health (Bleich, Pickett-Blakely, & Cooper, 2011). The research literature also 
indicates that consumers trust certified personal trainers to provide them with reliable and valid 
exercise and diet based information (Holcomb, 2010). However, as compared to MD’s, CPTs 
have not been utilized by consumers as a source of information for clinically based medical 
information concerning their health, yet have the potential to become an extremely valuable 
resource for the U.S. initiatives to reduce the prevalence of overweight and obesity in the United 
States (Flegal, et al., 2010; Harris, Holden, & Chen, 2010; Oprescu, 2012; USDHHS, 2013). 
Understanding the perceived beliefs consumers have towards both of the sources of 
knowledge and weight-loss medications will help to discern the process in which they form their 
belief systems. There are many obstacles that physicians and certified personal trainers can be 
challenged with their ability to provide effective intervention to overweight and/or obese 
patients.Using a survey to gather information concerning why clients hire a certified personal 
trainer, the relationship between the client and certified personal trainer, responsibility of 
certified personal trainer, level of conflict, and the extent to which a certified personal trainer 
disapprove of client interaction that extends beyond what is considered appropriate professional 
behavior.   Two hundred and twenty-eight trainers responded with completed surveys.   The 
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 results indicated that the two primary reasons a client hired a trainer was for body shaping (82 
percent) and weight management (78 percent). Notably, exercise adherence (72 percent) was 
also a contributing factor to hiring a trainer. Trainers also reported the following: 
1. 85 % would definitely give exercise advice outside a session 
 
2. 80 %would definitely give health and lifestyle advice 
 
3. 61 % would definitely give nutrition advice 
 
Thus, communication during medical encounters can improve patients' abilities to 
exercise appropriate control over their health. A major factor in enabling patients to increase 
control over their health involves developing their competencies for making decisions and 
enacting behaviors that can lead to desired and attainable, health outcomes. Key in education on 
this factor is communication around and support in decision-making about prescription 
medications, because whether and how to use medications are among the most common and 
important decisions in which patients can participate. With respect to communication about 
prescription medications, physicians most frequently mentioned product name (78.2 percent of 
consultations) and instructions for use (86.7 percent of consultations). Patients were extremely 
passive, rarely offering their opinion or initiating discussion about any aspect of the treatment. It 
was suggested that improving patients' decision-making competencies may require more 
discussion of benefits and risks, as well as discussion of patients' opinions about the prescribed 
medications and their abilities to follow through with the treatment plans. Physicians tended to 
overestimate the extent to which they discussed patients' ability to follow the treatment plan, 
elicited patients' opinion about the prescribed medication and discussed risks of the medication. 
Moreover, 24.3 percent of the patients left the consultation with an 'illusion of competence', a 
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 belief that important topics had been discussed when, in fact, they had not been mentioned at all. 
The pattern of results illustrates the complexity of health promotion in primary care, and 
underscores the importance of attending to both perceived and actual communication in medical 
encounters. 
It is evident from the literature, that there exists a clear demand for pharmaceutical anti- 
obesity medications, the ability to treat obesity with those agents, as well as scientific research 
supporting the safety and effectiveness of the agents available. The recurring problem within the 
literature is clear, no matter which pharmaceutical therapy is chosen, there continues to not only 
be a need and demand for these medications, but information about these medications and the 
need and demand for both is growing. Weight-loss as reported in these studies, is short term, and 
as cited in Wooley’s and Garner article on the behavioral aspects of weight-loss, 90-95 percent 
of all patients reported regaining weight lost. A harsh, but yet reasonable approach is to treat the 
patient, not the condition.  As quoted from Garner and Wooley (1994, page 309): 
“The failure of fat people to achieve a goal they seem to want- and to want 
almost above all else-must now be admitted for what it is: a failure not of 
those people but of the methods of treatment that are used.” 
Perhaps if this attitude toward obesity were accepted not only by the physician, but also 
by the patient, weight-loss goals would be more achievable and sustainable without the need for 
drug therapy. Attitudes among others in fields related to health also play a role in the 
psychology of treating patients. Recently, the Cooper Institute in Dallas Texas looked at bias 
toward obesity among exercise science students. Using the Implicit Association Test (IAT) and 
the Antifat Attitudes Test (AFAT), among 136 undergraduate students and 110 graduate 
students, the results showed a strong bias in good and bad attitude, coupled with motivated and 
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 lazy stereotype associated with persons who are obese (p < .0001). The implications of these 
results suggest a negative bias to those who are obese, thus, when coupled with the responsibility 
of health promotion to all persons, those attitudes may contribute to the continuing 
discrimination against the obese. Education may be appropriate to overcome these biases; 
however, it is perhaps more important to understand that if the biases were overcome, how that 
could affect trainer/client communications and client behavior. 
Treating the underlying causes of obesity, such as diet exercise and lifestyle behavior 
modifications should clearly be the first step in treatment. These changes in lifestyle should help 
attribute to long-term weight-loss. If treating the underlying causes of obesity do not improve 
weight-loss results, then drug therapy should be an option as a method of treatment used 
simultaneously with the lifestyle modifications already in place. Taking a more holistic 
approach towards the treatment of obesity, accelerated with pharmaceutical intervention can be 
an acceptable answer in the battle of fighting this epidemic. In that light, this work seeks to 
understand if information provided by personal trainers regarding weight-loss medications can 
alter consumer beliefs about those medications. When degrees of change in beliefs are present, 
to what extent are they comparable, or different, to beliefs if a physician were to provide the 
same information? This project includes eight research hypotheses that pose to evaluate the role 
of source of credibility (information providers) and the belief formation process of the consumer. 
This research explores the role of physicians and personal trainers and their influence on 
consumer perceptions of over-the counter and prescription pharmaceutical weight-loss 
medications. Scenarios will explain medications that was used to model the intervention, with 
two primary sources of information: physician (MD) and certified personal trainer (CPT). This 
results in the following testable null hypotheses: 
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 H10: There is no significant three way interaction between the variables medication type, 
physician communication and trainer communication for either attitudes or intentions to 
try a weight-loss medication. 
H20: There is no significant two way interaction between medication type and physician 
communication, medication type and trainer communication, or physician 
communication and trainer communication for either attitudes or intentions to try a 
weight-loss medication. 
H30: There is no significant difference in attitudes formed about weight-loss medication 
use based on the medication type, prescription vs.  over-the-counter. 
H40: There is no significant difference in attitudes formed about weight-loss medication 
use based on the level of communication provided by the physician, positive vs. 
negative, about the medication. 
H50: There is no significant difference in attitudes formed about weight-loss medication 
use based on the level of communication provided by the trainer, positive vs. negative, 
about the medication. 
H60: There is no significant difference in intentions to try a weight-loss medication 
consumption based on the medication type, prescription vs.  over-the-counter. 
H70: There is no significant difference in intentions to try a weight-loss medication use 
based on the level of communication provided by the physician, positive vs. negative, 
about the medication. 
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 H80: There is no significant difference in intentions to try a weight-loss medication 
consumption based on the level of communication provided by the trainer, positive vs. 
negative, about the medication. 
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CHAPTER 3 
 
RESEARCH METHODS AND DESIGN 
 
This section describes the operationalization of the variables, selection of the sample 
frame and sampling methods, the design of the scenarios as stimuli, and the statistical method for 
modeling the results. 
Study Design 
 
The objective of this study was to evaluate the attitudes held by, and intentions of, 
consumers and their intent to use a weight-loss medication based on source of information 
(Ajzen, 1988, 1990). The study was a 2x2x2 experimental research design, which used analysis 
of variance (ANOVA) to test the statistical significance of differences between groups 
(Tabachnick & Fidell, 2006). Data was collected using a self-administered on-line survey 
questionnaire. Survey questionnaire items were designed to collect information about: (1) the 
respondents demographics, (2) treatment scenarios to test the hypotheses, and (3) the 
respondents’ attitudes and intentions. 
Sampling 
 
Data was collected using an online panel of respondents. Research Now® was used to 
recruit participants and administer the research survey questionnaire and instrument. Research 
Now® is a global digital data collection company that specializes in providing a myriad of high 
quality research-based services. Specializing in survey-based research projects, Research Now 
provides an extensive panel of survey participants that span across 38 countries, with over 6.5 
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 million active members (Research Now, 2014).  Recruitment for study participants was initiated 
by the primary researcher, in conjunction with Research Now®, and was based on the 
proposed study inclusion criteria (Appendix A). After excluding potential subjects using 
those criteria, Research Now® then developed a usable list of adult participants. Adolescents 
and children were not included in the study. Those who were under the age of eighteen were 
not recruited for participation, due to several factors, i.e. securing valid (on-line) parental 
approval, and levels of experience and or knowledge with physicians, diet, exercise, 
weight-loss medications, and the over-all complexity of the treatment scenario content. For 
those over the age of eighteen, the proposed inclusion criteria did not discriminate against 
factors such as age, gender, race, geographic location, socioeconomic status, or health status. 
Each study participant who met the proposed research inclusion criteria was offered equal 
opportunity to participate. The sample population for this study consisted of participants 
who were overweight or obese. Respondents who read and accepted the study description, 
purpose, and confidentiality pages by pressing the agreement option, were eligible to participate 
in the study (Appendix A). 
Exclusion from the study was determined if the respondent answers yes to any of the 
following main exclusion criteria (Appendix A): (1) current use of weight-loss medication (Rx or 
OTC), (2) current weight-loss counseling (MD or CPT), and (3) valid professional license (MD 
or CPT), and (4) normal BMI. To date, there are no known scientific research articles that have 
specifically explored and tested the specific components that were proposed in this research 
study design. Therefore, key findings from the proposed study, added additional knowledge to 
existing health and medical-based weight-loss programs, and how programs can improve patient- 
centered weight-loss care by providing patients with more choices in who delivers weight-loss 
counseling and interventions. 
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 After receiving official University approval to collect data, three pre-determined days 
(Waves) of data collection occurred: (1) Wave A sent 100 surveys on day one of data collection, 
(2) Wave B sent 100 surveys two days after day one, and (3) Wave C sent 100 surveys five days 
after day one. Due to University IRB mandated policies regarding research guidelines for data 
collection and analysis, following Wave C all data collection was closed and this analysis was 
based on data collected from surveys that met all study criteria. 
A sample size of consumers was determined to test the three independent variables (IV). 
Each independent variable had two levels per IV, to the dependent variables (DV) (Hair, 1998). 
The independent variables were (1) physician communication (positive/negative 
recommendation), (2) trainer communication (positive/negative recommendation), and (3) 
medication type (Rx and CPT). The dependent variables were intention to use a weight-loss 
medication and attitudes formed about weight-loss medications, following the communication 
(treatment scenarios) by trainers and physicians. A priori power analysis (G-Power) was 
conducted to calculate an adequate sample size necessary to run a three-way ANOVA, with 
possibilities that two-way interaction terms and main effects might have been significant. In 
summary, the a priori calculations suggested that with an alpha of 0.05, a power of 0.80, and 
eight test cells, an adequate sample size for this study would be approximately 160 respondents. 
Details of this calculation are below: 
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 F tests - ANOVA: Fixed effects, special, main effects and interactions 
 
Analysis: a priori: Compute required sample size 
 
Figure 4 – Power Analysis for Three-Way ANOVA. (G*Power) 
 
 
 
 
 
 
Input: 
Effect size f=0.25 
  
α err prob = 0.05 
Power (1-β err prob) = .80 
Numerator df = 2 
Number of groups = 8 
Output: 
Noncentrality parameter λ 
 
= 
 
9.8750000 
Critical F = 3.0580504 
Denominator df = 146 
Total sample size = 158 
Actual power = 0.8016972 
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 Questionnaire Design 
 
The survey questionnaire was developed, programmed, and hosted on the Internet. 
Survey data was collected using a self-administered on-line questionnaire from an online panel 
of respondents provided by Research Now®. All respondents volunteered to participate in the 
proposed research study, and our voluntary participants of the Research Now® panel. Research 
Now® pre-screened the panel respondents, based on historical demographics and study inclusion 
criteria. The survey design called for Research Now® to pre-screen respondents for inclusion 
criteria, and an additional screen based on study inclusion criteria was administered within the 
survey questionnaire. The survey questionnaire was comprised of four main sections: (1) 
screening page for inclusion criteria, (2) scaled survey instrument to develop a baseline 
understanding of pre-existing consumer-based knowledge, attitudes and intentions around 
weight-loss medications (Rx and OTC), source of credibility and source of information (MD and 
CPT), and social norms related to weight-related topics, (3) the treatment scenarios and, (4) 
demographic questions (Appendix A ). 
The scaled survey section was measured based on pre-existing Likert-type and semantic 
differential scales using ratings from 1 – 7. Utilizing pre-validated scales provides an increased 
level of statistical reliability and validity, due to the increased level of confidence that the scale 
measures what it is supposed to measure (Alreck and Settle, 2004). The questionnaire was 
reviewed by faculty at the University of Mississippi, and then pre-tested with a sample of 10 
consumers selected based on study criteria. The questionnaire was then revised for clarity. The 
next section describes the conceptual and operational definitions of independent and dependent 
variable and the items used to measure them. 
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 Variables 
 
This study involved information variables that served as the antecedents for intentions. 
In total, there were three dichotomous independent variables (1) medication type (Rx and OTC), 
(2) physician communication (positive vs. negative) and, (3) trainer communication (positive vs. 
negative). The goal of the information provision (treatment scenarios) was to provide insight 
into consumer decision-making. The use of both positive and negative information is a logical 
choice, because little is known about consumer intentions to try a weight-loss medication, based 
solely on the source of information presented in the proposed research design (MD and CPT). 
Therefore, the proposition that intentions formed by clients can occur for both OTC and 
prescription medications for weight-loss, might be dependent upon the source of the information 
from which it is being presented. Based on information source (MD and CPT), information for 
the treatment scenarios presented about weight-loss medications, are acceptable, as this is an 
experimental design. 
Operational Definitions of Independent Variables 
 
Medication Type 
 
1) Prescription  Weight-loss  Medication  (Rx):  Medications  that  you  can  only  get  after 
 
obtaining a prescription from a doctor. 
 
2) Over-the Counter (OTC): Medications you can buy at any store, without having to go to a 
 
doctor or without a doctor’s prescription. 
 
Knowledge Source 
 
3) Medical Doctor (MD): Family/Primary Care Doctors that people visit first, for basic 
 
health care needs.   The MD is the doctor who then refers/sends a patient to see other 
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 specialists,   such   as   heart   doctors   and   surgeons. In   the   treatment   scenarios, 
 
recommendations about weight-loss medication was either positive or negative in nature. 
 
4) Certified Personal Trainer (CPT): For this study, the “gold standard” of CPT fitness 
 
professionals.   A CPT with a 4-year college degree and a CPT certification (A CPT is 
 
NOT an athletic trainer or physical therapist). In the treatment scenarios, 
 
recommendations about weight-loss medication was either positive or negative in nature. 
 
Dependent variables 
 
The dependent variables in the proposed research design are consumers’ attitudes about 
weight-loss medication and intention to try the medication type. In the study, attitudes are 
operationalized as perceptions toward the use of a weight-loss medication. The work of Petty 
and Cacioppo (1986) provided the foundation for the scale used to test for attitudes and 
intentions to use weight-loss medications. Several studies have validated the reliability of this 
scale (Lobb, 2007; Jalnawala, 2005, Jalnawala and Wilkin, 2007; Sewak 2002, Sewak, Wilkin, 
Bentley and Smith, 2005, West, Wilkin, and Bentley, 2004). 
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 Figure 5: Questions to assess attitudes about the use of a weight-loss medication 
 
 
My use of an Rx weight-loss medication to support my weight-loss program would be: 
Bad 1 2 3 4 5 6 7 Good 
Unfavorable 1 2 3 4 5 6 7 Favorable 
Harmful 1 2 3 4 5 6 7 Beneficial 
Useless 1 2 3 4 5 6 7 Useful 
Ineffective 1 2 3 4 5 6 7 Effective 
Unnecessary 1 2 3 4 5 6 7 Necessary 
Dangerous 1 2 3 4 5 6 7 Safe 
Not helpful 1 2 3 4 5 6 7 Helpful 
*Scale to measure attitudes about use of a weight-loss medication. 
 
The analysis of the attitude measure were conducted on the summated scale 8 items, 
resulting in an attitude variable with a possible range of 8 to 56. The intention variable was 
operationalized as consumers’ willingness to use a weight-loss medication and assessed using 
four semantic differential questions. The analysis for the intention DV was conducted on the 
summated scale of those four questions. Items that represent indicators of a consumers’ intent to 
use a weight-loss medication, were utilized in order to identify the unique combinations of 
influencers on a consumers’ decision-making process in any sub-group analyses (i.e. attitude, 
social norm, source credibility, source of information.) Sewak’s intention scale (2002, 2005) 
included constructs that are strong indicators of intent to try purchase a medication. These 
constructs were adapted in the proposed research to assess consumer intent to try a weight-loss 
medication (Appendix A). 
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 Figure 6: Questions to assess intent to try a weight-loss medication 
 
Based on the information available in this scenario, how likely are you to try a 
prescription weight-loss medication? 
No chance 1 2 3 4 5 6 7 8 9 Sure to try 
Unlikely 1 2 3 4 5 6 7 8 9 Likely 
Not possible 1 2 3 4 5 6 7 8 9 Very possible 
 
Intend not to try 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
Intend to try 
*Adapted from Sewak (2002, 2005) 
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 Data Collection 
 
After obtaining The University of Mississippi’s Institutional Review Board (IRB) 
approval, measures were pretested along with the rest of the instrument for clarity. For final data 
collection, the Research Now® administered the surveys. Research Now® provided full 
disclosure of their policies, terms, and use of their services. Members were required to 
acknowledge and agree to company disclosure terms, in order to participate in surveys. 
Members were free to decline or accept participation in any surveys sent to them. Guidelines for 
the survey were given to Research Now® and were rigorously executed during the subject 
selection process (Appendix A). 
Standard demographic assessments occurred at the beginning of the survey, to crosscheck 
inclusion criteria questions about BMI, medication use, and weight-loss counseling. In the final 
data collection, all scales were tested for their reliability and validity, which is discussed in the 
next section. Treatment scenarios were developed using the three variables and their associated 
levels. The messages within the treatment scenarios were kept consistent across all presentations 
of the same variable levels throughout the scenarios. Flesch-Kincaid reading level for each 
scenario was set below the tenth grade reading level (Alreck and Settle 2004). All eight- 
treatment scenarios can be found in Appendix A. 
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 Figure 7.  Example of Scenario of Information Provided to respondents 
 
Assume that you are the following patient as described. 
Your doctor has advised you start a diet and exercise program. You have 
started eating healthier and working out, and have decided to train with a certified 
personal trainer. 
While the trainer is working with you, you ask about prescription weight-loss 
medications (Rx). 
           very  little  to  help  and  can  be  harmful,  we  should  focus  on  your  
exercise program." 
The following week you have a follow up visit with your doctor.  You then ask 
your doctor about prescription weight-loss medications (Rx). 
The doctor says, "They can be helpful when used appropriately, with diet and 
exercise.   In fact, I have many patients take them and they have had 
successful weight-loss results." 
Your doctor then gives you a prescription (Rx) for a weight-loss medication. 
  
 
 
Data Analyses 
 
Analyses were conducted using the IBM Statistical Package for the Social Sciences 
(SPSS) version 22.0. A 2x2x2 design of information source crossed with weight-loss 
medication. It is important to have the ability to remove outlier responses and to have a robust 
enough sample to find statistical differences should they exist. Therefore, a sample size of 
n=160 is proposed based on the power calculation. Thus, there are eight scenarios (2x2x2). This 
provides for an analysis of both main and interaction effects. Testing for significance of 
interaction effects were tested prior to testing for the main effects. Figure 8 outlines  the 
statistical analysis approach. 
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 Figure 8: Statistical Analysis Plan for Testing Hypotheses in Proposed Design 
 
 
 
 
 
Each hypothesis was tested at the <0.05 level using univariate ANOVA. Attitude 
formed about the medication was the first dependent variable tested and intention to try was the 
second dependent variable tested. In the analysis, the second order interaction term  was 
analyzed at an <0.05 level first, then the first order interactions terms at an <0.05 level, 
then the main effects were tested at an <0.05 level. If at any stage in the analysis the 
interaction term is significant, tests were conducted of the simple effects rather than the 
main effects. 
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 Following the analysis of the interaction terms, hypotheses were tested using ANOVA at an 
 
<0.05 level. 
 
H10: There is no significant three way interaction between the variables medication type, 
physician communication and trainer communication for either attitudes or intentions to 
try a weight-loss medication. 
H20: There is no significant two way interaction between medication type and physician 
communication, medication type and trainer communication, or physician 
communication and trainer communication for either attitudes or intentions to try a 
weight-loss medication. 
H30: There is no significant difference in attitudes formed about weight-loss medication 
use based on the medication type, prescription vs.  over-the-counter. 
H40: There is no significant difference in attitudes formed about weight-loss medication 
use based on the level of communication provided by the physician, positive vs. 
negative, about the medication. 
H50: There is no significant difference in attitudes formed about weight-loss medication 
use based on the level of communication provided by the trainer, positive vs. negative, 
about the medication. 
H60: There is no significant difference in intentions to try a weight-loss medication 
consumption based on the medication type, prescription vs.  over-the-counter. 
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 H70: There is no significant difference in intentions to try a weight-loss medication use 
based on the level of communication provided by the physician, positive vs. negative, 
about the medication. 
H80: There is no significant difference in intentions to try a weight-loss medication 
consumption based on the level of communication provided by the trainer, positive vs. 
negative, about the medication. 
In addition, information was gathered from respondents to assess a priori level of: (1) 
source credibility for MDs and CPTs, (2) attitudes and beliefs about medications (Rx and OTC), 
and (3) social norms associated with various weight-loss related topics. This information was 
collected and used to determine potential sub-groups within the study. The identification of sub- 
groups allowed for statistical analyses to detect and assess for impact of both the interaction and 
main effect term significance. The results of this study reported on the final statistical analyses 
used to test for mean sub-group differences. ANOVA was used to assess and report the sub- 
group means and results were based on the validated scales. 
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CHAPTER 4 
 
RESULTS 
 
Introduction 
 
This chapter provides an analysis of results of the attitudes and intentions consumers 
have towards the use of over-the-counter (OTC) and prescription weight-loss medications (Rx). 
Using the Statistical Package for the Social Sciences (SPSS), survey data was formatted for 
analysis of variance. 
Descriptive Results: Demographics 
 
Overall, the total sample population was one hundred and sixty-eight (N = 168).  Of the 
total sample, the average age was thirty-six (X = 36.9; SD = 8.36) with 26.8 percent male (n = 
45) and 73.2 percent female respondents (n = 123). Marital status included 48.8 percent (n = 82) 
single unmarried respondents and 39.9 percent married (n = 67).  Work status, education, and 
ethnicity were: (1) full time employment (67.9%), (2) Bachelor’s degree or higher (61.4%), and 
(3) 80.4 percent Caucasian.  Geographic location was fairly evenly distributed, and consisted of 
 
17.9 percent from the south Atlantic region, 23.2 percent from East  North Central, 12.5 percent 
Middle Atlantic.  See Table 15 for complete geographic dispersion. 
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Table 15. Geographic Location per Region 
 
Region Number per Region Percent 
New England 7 4.2 
Middle Atlantic 21 12.5 
East North Central 39 23.2 
West North Central 14 8.3 
South Atlantic 30 17.9 
East South Central 11 6.5 
West South Central 15 8.9 
Mountain 14 8.3 
Pacific 15 8.9 
U.S.  Territory 1 .6 
Other 
(Foreign U.S. 
Military Base) 
1 .6 
Total 168 100.0 
 
 
Subjects reported taking an average of two prescription medications (Rx) per day (n = 94, 
X = 1.54, SD = 2.41). The average cost of those prescription medications was approximately 
twenty-nine U.S. dollars per month (n = 94; X = 27.85, SD = 37.46). No subjects (n = 0) were 
currently taking an anti-obesity weight-loss prescription medication. 
 
Scale Reliability 
 
The reliability of each of the scales (source credibility, attitude, intention) was assessed 
using Cronbach’s Alpha. All of the scales had reliability greater than 0.700, with source 
credibility at 0.731, attitude at 0.990, and intention at 0.992. With the reliability of the scales, 
the hypothesis testing proceeded as planned. 
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 Hypothesis Testing 
 
Hypothesis testing proceeded using the three-way univariate ANOVA for attitudes 
toward medication consumption and intentions to try the weight-loss medication. The first two 
hypotheses dealt with the second order and first order interaction terms and stated: 
H10 There is no significant three-way interaction between the variables 
medication type, physician communication, and trainer communication for either 
attitudes or intentions to try a weight-loss medication. 
H20: There is no significant two-way interaction between medication type and 
physician communication, medication type and trainer communication, or 
physician communication and trainer communication for either attitudes or 
intentions to try a weight-loss medication. 
As seen in the Table 16, the three-way interaction term (MD Communication (+/-) X CPT 
communication (+/-) X medication type (Rx/OTC) was non- significant in the ANOVA for 
attitudes toward medication consumption (F = 0.062, df = 1, α = 0.803). In addition, none of the 
two-way interaction terms were significant for the attitude measure ((MD x CPT F=.034, df = 1, 
α= 0.855), (MD x Rx/OTC F=0.722, df = 1, α = 0.396), (CPT x Rx/OTC F = 0.011, df = 1, α = 
0.917)).  Results of the analysis of the interaction effects are detailed in Table 16. 
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 Table 16.  Tests of Between-Subjects Effects – Three-Way ANOVA 
Dependent Variable: Attitude 
 
 
Source 
Type III Sum of 
Squares 
 
Df 
 
Mean Square 
 
F 
 
Sig. 
Corrected Model 783.276a 7 111.897 41.750 .000 
Intercept 14233.400 1 14233.400 5310.691 .000 
MDx 739.590 1 739.590 275.952 .000 
CPTx 17.021 1 17.021 6.351 .012 
Medx 24.443 1 24.443 9.120 .003 
MDx * CPTx .090 1 .090 .034 .855 
MDx * Medx 1.935 1 1.935 .722 .396 
CPTx * Medx .029 1 .029 .011 .917 
MDx * CPTx * 
Medx 
.167 1 .167 .062 .803 
Error 3580.668 1336 2.680   
Total 18597.344 1344    
Corrected Total 4363.944 1343    
a. R Squared = .179 (Adjusted R Squared = .175) 
 
 
Furthermore, the three-way interaction term (MD Communication (+/-) X CPT 
communication (+/-) X medication type (Rx/OTC)) was also non- significant in the ANOVA for 
intentions to try (F=0.184 df =1, α=.668). In addition, none of the two-way interaction terms 
were significant for the intention measure ((MD x CPT F=.084, df = 1, α= 0.772),(MD x 
Rx/OTC F=2.927, df = 1, α = 0.166),(CPT x Rx/OTC F = 0.000, df = 1, α = 0.995).  Results of 
the analysis of the interaction effects are presented in Table 17. 
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 Table 17 Tests of Between-Subjects Effects – Three-Way ANOVA 
Dependent Variable: Intention 
 
 
Source 
Type III Sum of 
Squares 
 
df 
 
Mean Square 
 
F 
 
Sig. 
Corrected Model 1414.086a 7 202.012 39.708 .000 
Intercept 17365.001 1 17365.001 3413.324 .000 
MDx 1308.241 1 1308.241 257.152 .000 
CPTx 22.527 1 22.527 4.428 .036 
Medx 72.197 1 72.197 14.191 .000 
MDx * CPTx .429 1 .429 .084 .772 
MDx * Medx 9.755 1 9.755 1.917 .166 
CPTx * Medx .000 1 .000 .000 .995 
MDx * CPTx * 
Medx 
.938 1 .938 .184 .668 
Error 6796.789 1336 5.087   
Total 25575.875 1344    
Corrected Total 8210.874 1343    
a. R Squared = .172 (Adjusted R Squared = .168) 
 
 
 
 
Given the lack of significance for all of the interaction terms, both second order and first 
order for attitudes and intentions, the hypotheses tests for the main effects proceeded as 
proposed. 
Main Effects Hypotheses Tests 
 
Hypotheses three, four and five dealt with the differences in attitudes formed based on 
the variables physician communication (MD), certified personal trainer communication (CPT), 
and  weight-loss  medication  type  (Rx  and  OTC).    Following  the  non-significance  of  the 
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 interaction terms, the mean differences were tested using ANOVA.  The results on hypotheses 
three through five: 
H30: There is no significant difference in attitudes formed about weight- 
loss medication use based on the medication type, prescription vs. over- 
the-counter. 
For hypothesis three, there was a significant difference between the mean values, and the 
null was rejected.  When medication type was Rx, the mean attitude was significantly greater (X 
= 3.39, p < 0.05) than when the medication type was OTC (X = 3.12). 
 
H40: There is no significant difference in attitudes formed about weight- 
loss medication use based on the level of communication provided by the 
physician, positive vs.  negative, about the medication. 
For hypothesis four, there was a significant difference between the mean values, and the 
null was rejected. When physician communication was positive, the mean attitude was 
significantly greater (X = 4.00, p < 0.05) than when the physician communication was negative 
(X = 2.51). 
H50: There is no significant difference in attitudes formed about weight- 
loss medication use based on the level of communication provided by the 
trainer, positive vs.  negative, about the medication. 
For hypothesis five, there was a significant difference between the mean values, and the 
null was rejected. When trainer communication was positive, the mean attitude was significantly 
greater (X = 3.37, p < 0.05) than when the trainer communication was negative (X = 3.14). 
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Hypotheses six, seven, and eight dealt with the differences in intentions formed based on 
the variables physician communication (MD), certified personal trainer communication (CPT), 
and weight-loss medication type (Rx and OTC). Following the non-significance of the 
interaction terms, the mean differences were tested using ANOVA. The results on hypotheses 
six through eight: 
H60: There is no significant difference in intentions to try a weight-loss 
medication consumption based on the medication type, prescription vs. 
over-the-counter. 
For hypothesis six, there was a significant difference between the mean values, and the 
null was rejected. When medication type was Rx, the mean intention was significantly greater 
(X = 3.83, p < 0.05) than when the medication type was OTC (X = 3.36). 
H70: There is no significant difference in intentions to try a weight-loss 
medication use based on the level of communication provided by the 
physician, positive vs.  negative, about the medication. 
For hypothesis seven, there was a significant difference between the mean values, and the 
null was rejected. When physician communication was positive, the mean intention was 
significantly greater (X = 4.39, p < 0.05) than when the physician communication was negative 
(X = 2.46). 
H80: There is no significant difference in intentions to try a weight-loss 
medication consumption based on the level of communication provided by 
the trainer, positive vs. negative, about the medication. 
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 For hypothesis eight, there was a significant difference between the mean values, and the 
null was rejected.  When trainer communication was positive, the mean attitude was 3.73 (p < 
0.05) compared to when the trainer communication was negative (X = 3.47). 
Final Summary Results 
 
All interaction terms in the ANOVAs performed were non-significant.  Overall, the 
impact of physician communication, trainer communication and medication type on both 
attitudes and intentions was significant.  Table 18 summarizes the statistical findings for each 
hypothesis. 
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Table 18 – Hypotheses Test Summary Support? Significance Results 
H10 There is no significant three-way 
interaction between the variables 
medication type, physician 
communication, and trainer 
communication for either attitudes or 
intentions to try a weight-loss  medication. 
Yes See H2 Lack of significant 
results: Analysis of 
main effects (See H2) 
H20: There is no significant two-way 
interaction between medication type 
and physician communication, 
medication type and trainer 
communication, or physician 
communication and trainer 
communication for either attitudes or 
intentions to try a weight-loss 
medication. 
Yes See H3-H8 Lack of significant 
results: Analysis of two-
way interaction terms 
(See H3-H8) 
H30: There is no significant difference 
in attitudes formed about weight-loss 
medication use based on the medication 
type, prescription vs. over-the- counter. 
No p <0.05 Medication Type and 
Attitudes: 
Rx Higher (X = 
3.39) OTC (X = 
 H40: There is no significant difference 
in attitudes formed about weight-loss 
medication use based on the level of 
communication provided by the 
physician, positive vs. negative, about 
the medication. 
No p <0.05 Communication of MD 
and Attitudes: 
Positive Higher (X = 
4.00) Negative (X = 
2.51) 
H50: There is no significant difference in 
attitudes formed about weight-loss 
medication use based on the level of 
communication provided by the trainer, 
positive vs. negative, about the 
medication. 
No p <0.05 Communication of CPT 
and Attitudes: 
Positive Higher (X = 
3.37) Negative (X = 
3.14) 
H60: There is no significant difference in 
intentions to try a weight-loss 
medication consumption based on the 
medication type, prescription vs. over-
the- counter. 
No p <0.05 Medication Type and 
Intentions: 
Rx Higher (X = 
3.83) OTC (X = 
3.36) 
H70: There is no significant difference in 
intentions  to try a weight-loss medication 
use based on the level of communication 
provided by the physician,  positive vs. 
negative, about the medication. 
No p <0.05 MD Communication   
and Intention: 
Positive Higher (X = 
4.58) Negative (X = 
2.61) 
H80: There is no significant difference in 
intentions to try a weight-loss 
medication consumption based on the 
level of communication provided by the 
trainer, positive vs. negative, about the 
medication. 
No p = 0.055 CPT Communication  
and Intention: 
Positive Higher (X = 
3.72) Negative (X = 
3.47) 
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CHAPTER 5 
 
DISCUSSION 
 
Introduction 
 
This chapter discusses the implications of this study, based on the results of the null 
research hypotheses presented. The purpose of this study was to explore the influence on the 
attitudes toward, and intent to use, a weight-loss medication among overweight and obese 
consumers. The exploratory treatment scenarios posed mock consultations by both an MD and 
CPT, and explored how attitudes and intents differed by source of information, type of 
communication, and medication type.  The theoretical foundation used to measure intent to take 
a weight-loss medication was the Theory of Planned Behavior (TPB) (Ajzen, 1991). The TPB 
constructs that were measured within this study, included attitude, and intention. 
The primary goal of this study was to explore how two different information sources 
influenced a person’s decision-making process, regarding the intention to use weight-loss 
medications. Subjects were instructed to visualize themselves in a situation in which they were 
seeking knowledge and information about anti-obesity medications. After being presented with 
the information scenarios, the survey instrument sought to discover to what extent attitudes about 
the intent to use a weight-loss medication changed, based on the advice of a general family 
physician (MD) versus a certified personal trainer (CPT). The primary contribution of this study 
provided insight into the concept of certified personal trainer’s as a reliable, valid, and 
professionally recognized resources within the clinical weight-loss setting.   To the best of the 
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 authors’ knowledge, to date, here are currently no streams of research literature that have 
explored and identified the CPT as a professional resource as such resources within the clinical 
setting. The findings of this research study have very important implications in the fight against 
obesity in the United States. The American Medical Association’s (AMA) recent re- 
classification of obesity as a disease led to the development of best practice goals, objectives, 
and initiatives for physicians to diagnose and treat their overweight and obese patients (AMA, 
2013). Review of the weight-related AMA best practice physician initiatives, guided the concept 
of utilizing certified personal trainers, working alongside physicians within their clinical settings. 
Results of this study indicated that CPTs could become valuable resources for physicians, in 
order to provide meet AMA best practice goals, objectives, and initiatives. 
As intended, the sample population was one based on weight-status [overweight and 
obese (n = 16.1%, n = 83.9 %)]. Excluding professionally licensed physicians, surgeons, nurse 
practitioners, and those holding a certification in exercise training, strengthened and controlled 
for biases that might have screwed the results. Excluding MDs or CPTs from this study, 
controlled for biases such as expert knowledge, and preference of one information source over 
the other that could have potentially yielded much different results. For example, from the TPB 
theoretical perspective, both MDs and CPTs have pre-existing beliefs and attitudes about the 
importance of diet and exercise over other weight-loss strategies, such as prescription medication 
use or surgery (Honda, 2004, Ko, 2008, et al., Kraschnewski, et al., 2013, 2008, Noel, et al., 
2012, Yoong, et al., 2013). 
The sample population (N = 168) was asked about their prior history of Rx and OTC 
weight-loss medications. Those who had past successful experiences with an Rx or OTC 
weight-loss medication were the minority for both Rx and OTC [(Rx: n = 23 (9.5 %); OTC: n = 
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 40 (8.3 %)]. Many factors can interfere with the effectiveness of any medication, regardless of 
type, however, it was not within the scope of this study to investigate reasons why a weight-loss 
medication did or did not work. In this study, considering the results for past use of Rx weight- 
loss medications not working, over-all, subjects were willing to try a weight-loss medication 
again. When subjects were asked, prior to the treatment scenarios, if diet and exercise were not 
enough, which type of weight-loss medication they would consider trying first, the responses for 
weight-loss medication type were evenly distributed [ (Rx: n = 168, f = 92 (54.8 %); OTC: n = 
168, f = 76 (45.2%); none: n = 0)]. The TPB theoretical construct of attitude was tested in this 
question. Results implied that subjects did not have pre-formed attitudes or beliefs about he 
medications, which changed their intent toward using a weight-loss medication of a particular 
type, or whether or not the type of medication would work for them. This suggests that 
regardless of medication type or prior experience, subjects’ pre-existing attitudes did not affect 
how subjects responded to the treatment scenarios as well. Conclusively, regardless of 
information source, when diet and exercise are not enough, and Rx and OTC medications were 
reported to have failed in the past, results indicated that: 
1. 54.8 % would be willing to try a Rx medication. 
 
2. 45.2 & would be willing to try an OTC supplement. 
 
3. 0% reported they would not try either. 
 
Additionally, given the results from questions related to insurance coverage and fitness- 
based topics, contributions of insurance coverage to support to weight-loss were less than 
desirable. Only 12 (out of 168) respondents reported that their insurance paid for some level of 
membership to a fitness facility.  Even more alarming, only one person reported that they were 
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 certain of their insurance policy paying for consultations or appointments with a certified, or 
non-certified, fitness or exercise personal trainer. It has already been established that obesity is 
an indicator of other health risk factors such as diabetes and high cholesterol (Flegal, 2013). 
Given current measures to prevent and treat obesity-related conditions (PPACA, 2010), it is 
common for a physician to refer a patient to cardiologists who employ certified physiologists to 
conduct appropriate tests. Under the umbrella of the cardiologist, most insurance carriers do 
cover the costs associated with seeing a certified physiologist. Perhaps, under the umbrella of 
the general family physician, it should be commonplace for insurance companies to cover further 
exercise and fitness-related consultations and appointments with the certified personal trainer. 
Hypothesis One and Two 
 
Failure to reject the first two hypotheses provided support for the idea that the subjects in 
this study had overall varying attitudes and intentions to try a weight-loss medication and that the 
interventions did not interact in a manner that necessitated an analysis of simple effects. 
Regardless of information source (CPT vs. MD), both the medication type and the type of 
communication had an effect on whether or not subjects were willing to try a weight-loss 
medication. In other words, when subjects were presented with all of the treatment scenarios, 
differences were seen across all variables and there was not an interaction effect requiring an 
independent variable to be held constant for analysis. This was true for both the three-way 
interaction term MD x CPT x Medication type as well as the two –way interaction terms (CPT x 
MD, CPT x Med, MD x Med). Thus, rejecting both hypotheses one and two means that there are 
main effects differences and to provide further explanation, main effects were analyzed to 
determine the extent to which each independent variable had an effect on attitudes and intentions 
(H3-H8). 
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 Discussion Hypothesis 3 and 6: Attitudes and Intentions Based on Medication Type 
 
H30: There is no significant difference in attitudes formed about weight- 
loss medication use based on the medication type, prescription vs. over- 
the-counter. 
H60: There is no significant difference in intentions to try a weight-loss 
medication consumption based on the medication type, prescription vs. 
over-the-counter. 
Several factors may have influenced the participants in this study towards having higher 
attitudes and intentions to try a prescription weight-loss medication (Rx). As discussed 
previously, safety and effectiveness of prescription weight-loss drugs, costs, and the higher 
number of available OTC weight-loss supplements to prescription medications were among the 
issues that could have had an impact on attitudes toward consumption. It is entirely plausible 
that either Rx or OTC medications were preferences for the respondents. Based on the Theory of 
Planned Behavior, based on over twenty years of empirical research analysis in many genres of 
social science fields of study, it is accepted that attitudes lead to intentions, and intentions to 
behaviors (Ajzen 1988). 
In this study, the attitudes toward the weight-loss medication were statistically higher for 
the prescription medication scenarios than the OTC scenarios. Statistical analyses showed 
significant support for prescription medication in both the pre-and post-measured scale, 
regardless of SC or communication type (+/-). Preference for the Rx medication over the OTC 
did not change, despite the very small percentage of subjects reporting that either of the 
medication types had actually worked for them in the past.   As discussed in Chapter 2, these 
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 results may convey greater support for pre-existing beliefs that Rx weight-loss medications are 
safer and efficacious than the OTC. Collectively, the results across all hypotheses and treatment 
scenarios support higher attitudes and intentions for prescription weight-loss medications versus 
over-the-counter. 
Hypotheses 4 and 7: Attitudes Based on MD Communication 
 
 
 
H40: There is no significant difference in attitudes formed about weight- 
loss medication use based on the level of communication provided by the 
physician, positive vs.  negative, about the medication. 
H70: There is no significant difference in intentions to try a weight-loss 
medication use based on the level of communication provided by the 
physician, positive vs.  negative, about the medication. 
Hypotheses four and seven dealt with the impact of physician communication on attitudes 
toward and intention to use weight-loss medication. Many streams of obesity-related literature, 
in the medical, social, and psychological sciences, provide statistical support for the use of 
positive communication in weight-loss intervention(s). The impact of negative communication 
has not been the predominant focus of previous research. Of all the associations between 
attitudes and intentions for weight-loss medications, physician communication had the strongest 
directional effect on both dependent variables. This is consistent with prior literature and our 
current health care system structure. 
Discussion Hypothesis 5 
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 H50: There is no significant difference in attitudes formed about weight- 
loss medication use based on the level of communication provided by the 
trainer, positive vs.  negative, about the medication. 
Similar to MD results, attitudes were also higher towards the use of a weight-loss 
medication following positive communication about the medication from a personal trainer. 
When communication about a weight-loss medication was presented in a positive manner, the 
subjects showed consistently higher attitudes about the weight-loss medication, regardless of 
type. 
Discussion Hypothesis 8: Intentions Based on Source and Communication Type 
 
 
H80: There is no significant difference in intentions to try a weight-loss 
medication consumption based on the level of communication provided by 
the trainer, positive vs.  negative, about the medication. 
Ultimately, the trainer communication did not have an impact on intention to use the 
weight-loss medication. At the very least, this is a positive finding in that trainer communication 
cannot override the strength of the MD communication. In other words, “what the doctor says 
goes,” however, sub-analysis were conducted using the source credibility of the trainer and the 
impact of trainer communication on intention.  For the sub- analysis, those that held the trainer as 
a credible source (5 or higher on a 7-point scale) were analyzed for differences from those that 
felt the trainers were less credible (4 or lower). While only 24 people felt that trainers were a 
credible source of information on medications, for those persons the intention was significantly 
different when CPT communication was evaluated using ANOVA (mean intention 4.13 vs. 
4.84, p < 0.05).   In addition, source credibility (SC) of trainers was independently associated 
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 with mean differences in intentions toward weight-loss medication use using ANOVA 
(mean difference for SC 4 or less 3.45 vs. 4.49 for SC of 5 or higher, p < 0.05). Ultimately, 
as can be seen in Table 19, the level of source credibility led to higher intentions and at 
higher levels of source credibility had greater impact of CPT communication. 
 
Table 19.  Sub-analyses for SC, CPT and Intention 
 
Trainer Source 
Credibility 
Trainer Communication Mean Intention 
Score 
 
SC less than 5 
Negative communication 3.35a 
 Positive communication 3.54b 
 
SC 5 or higher 
Negative communication 4.13a,c 
 Positive communication 4.84b,c 
a-a , b-b, c-c statistically different p < 0.05 
 
Limitations 
 
This study was exploratory and the topic was purposively selected,, because to the 
best of the author’s knowledge, this study was the first of its kind. The absence of 
previous scientific research related to the unique independent and dependent variables in 
this study, is considered a limitation. Recalling that there are many clinical and non-
clinical trainer certifications, this study was inclusive only to the non-clinically-based 
certified exercise personal trainer. The scientific literature that was available and reviewed 
at the time of this study, focused mainly on those certifications considered clinical, who 
work with at-risk, and specialized populations (i.e. exercise physiologists, physical 
therapists). In discerning and defining the CPT to the participants in this study, the goal 
was to reduce the limitations related to the lack of previous research specific to the 
purpose of this study. 
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 There were limitations related to the study implementation and design. To ensure 
an adequate sample size and inclusion of specifically required study participants, a 
professional research-based survey company (Research Now®) was used to recruit subjects. 
In doing so, this did not allow for a true randomly selected sample population. Although an 
adequate sample was collected (N = 168) that met the requirements for running the 
appropriate statistical analyses, a larger sample would have yielded more distinct results. 
Due to time and financial limitations, it was necessary to procure Research Now® to 
complete this study. 
Related to the limitation of sample size, hypotheses testing and results could have 
been improved upon, by increasing the sample size. A larger sample size would have 
allowed the study design to add to the null hypotheses testing. To explain, if the sample 
would have been eight times larger (N = 168 x 8 = 1344), random assignment of scenarios 
and extensive statistical analyses would have been possible rather than presenting all 
scenarios to each respondent. However, because of these limitations, each participant did 
receive all eight scenarios. Because each subject did receive all eight treatment scenarios, 
results were able to test all eight scenarios equally, and results reflected the collection of 
important consumer-based information unique to each scenario. Although it could be 
argued that the sample population is not generalizable outside of the sample population 
tested, an argument for generalizability does exist. Because the proposed research design 
was exploratory and adequately accounted for sample size, statistical power, and effect 
size, it is generalizable to the unique sample population it sought to test (adults with 
overweight or obese health status). 
Conclusions 
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 This study sought to determine whom consumers would identify as a plausible 
and credible source of information when considering the use of an OTC or prescription 
weight-loss supplement/medication. The majority of the research literature points to the 
physician serving as the primary source that consumers use for this type of information. 
According to the literature, by default, physicians are arguably the most logical and 
attainable health professionals that overweight or obese people do turn to for weight-
related medication inquiries. Unfortunately, the literature does not indicate whether 
certified personal trainers are also utilized as credible weight-loss medication consultants. 
In this study, results clearly indicated that the physician was perceived as the preferable 
credible source, and this held true, regardless of preconceived attitudes/beliefs related to 
source, medication type, or type of communication given about the weight-loss drugs. 
However, given the overwhelming impact of the physician, the medication type, and to a 
certain extent the trainer, each had an influence on attitudes and intentions. 
The study defined both the CPT and MD according to the standard and accepted 
descriptions in their respective fields (ACSM, AMA). Thus, it is extremely relevant to 
understand that the CPT was defined as a bachelor level degreed expert in physical activity 
and exercise, whereas the MD was defined as a licensed expert in general family 
medicine. Additionally, the treatment scenarios in this study were written in a manner that 
did not bias the subject towards favoring the recommendation of the CPT or MD, the 
type of medication, or whether or not to have certain beliefs or attitudes about either 
medication. Therefore, the treatment scenarios allowed the subjects to perceive the CPT 
alongside the physician as equal credible sources. 
The most encouraging findings in this study revealed noteworthy support for 
certified personal trainers to be credible sources of information. Considering the 
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 contribution of the other independent variables to attitude formation, subjects’ attitudes were 
impacted in a  positive manner following positive communication by the CPT and when 
subjects that regarded the CPT as having a higher credibility, intentions showed 
significant differences. It is important to recognize that the subjects did not allow any of 
the CPT-based positive communication treatment scenarios to effect the over-all results of 
the study. Unmistakably, subjects favored the advice of the physician over the CPT. 
Disconcertingly, less than 50% of primary care physicians reported providing 
specific guidance on diet, physical activity, or weight control 100% of the time to patients, 
regardless of weight classification (Smith, et al., 2011). However, within the scope of this 
study, there are a number of reasons as to why CPTs are not viewed as the more credible 
source for weight-loss related information: 
• Level of Education 
• Certifying Organization 
• Type of Certification 
• Certification Knowledge and Testing Requirements 
• Continuing Education and Training 
• Type of Employment 
• Place of Employment 
• Gym Facilities and Owners 
• Federal and State Laws Governing CPT Hiring and Praxes 
• Industry Related Litigation, Law Suits 
 
 
In turn, these factors may also affect how the CPT views how to effectively train a 
client. One universal licensing body, with requirements, rules, training, procedures, etc., 
regulates U. S. Physicians (AMA), and the majority of consumers understand how 
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 physicians obtain a license to practice medicine. Additionally, the AMA’s official stance is 
to help physicians improve on how they consult with their overweight and obese patients 
i.e. time, communication, training, etc.  It is clear that certifying CPT organizations do not 
have a universal and collaborative stance on the fight against obesity, as the AMA does for 
its physicians and other health advocates and professionals. Therefore, while trainers have 
a limited ability to influence decisions about medication today, the potential exists 
following efforts to increase trainer credibility that such an influence could exist. The 
lingering questions remain: 
Who is asking too little or too much in the fight against obesity, the AMA of its 
physicians, the physician to the AMA, pharma to the physician, pharma to the consumer, the 
consumer to their physician, the consumer to their CPT, the organizations of their CPTs, the 
CPTs of their organizations, or the consumer of oneself? 
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APPENDIX – SURVEY INSTRUMENT 
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 PROGRAMMER NOTES IN BOLD BLACK FONT 
 
 
PLEASE RECORD THE TIME IT TAKES TO COMPLETE SURVEY AND PROVIDE THIS 
INFORMATION IN DATA FILE 
 
 
SECTION: INTRODUCTION 
 
 
My name is Linda Lobb, and I am doctoral  candidate at the University of Mississippi. I am very 
interested in understanding what consumers think about weight-loss medications. The purpose of my 
study is to understand what consumers believe about the use of weight-loss medications. The title of 
my study is: 
 
 
“Certified Personal Trainers and Physicians: An Evaluation of Consumer Preference, Influence, 
and Decision Making on Intent to Use a Weight-loss Medication” 
 
 
CONFIDENTIALITY 
All personal information entered in this survey questionnaire WAS KEPT CONFIDENTIAL, and WILL 
NOT BE SHARED with any outside parties. All answers and information collected from the survey 
questions WILL ONLY BE USED FOR RESEARCH PURPOSES. The data collected will only be 
used to provide a general summary of the purpose of this study. 
 
 
This study has been reviewed by The University of Mississippi's Institutional Review Board (IRB). 
 
(Protocol #14x-172), approved as Exempt under 45 CFR 46.101(b) (#2). 
The IRB has determined that this study meets the ethical obligations required by federal  law and 
University policies. If you have any questions, concerns, or reports regarding your rights as a research 
subject, please contact the IRB office at (662) 915-7482. By clicking the box below, I understand the 
purpose of this study and I agree to take this survey. 
 
 
Yes CONTINUE WITH SURVEY 
 
 
No TERMINATE AND SHOW “THANK-YOU FOR YOUR TIME.” 
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SECTION II: SCREENING QUESTIONNAIRE (SQ) 
SQ1. What is your age? 
  years TERMINATE IF LESS THAN 18 
 
SQ2. Are you a licensed physician? 
1. Yes (Please check one): 
o DO 
o DDS/DMD 
o DPM 
o MD 
o OD ….AND THEN TERMINATE 
2. No 
 
SQ3. Are you a nurse practitioner? 
1. Yes TERMINATE 
2. No 
 
 
SQ4. Do  you  have  a  certification  in  personal  fitness  training? Please  check  organization  and 
certification. Multiple entries may be made. 
 
4. Yes (after checking, TERMINATE) 
ORGANIZATION (Check all that apply) CERTIFICATION (Check 
all that apply) ACE  CT 
ACSM CPT 
AFFA FT 
AFPA CFT 
IFPA PT 
ISSA CPT 
NASM 
NCSF 
NESTA 
NFPT 
NPTI 
NSCA 
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 Other (Please List and Write the name of specialty certification) 
5. No 
 
 
SQ5a. Please enter your HEIGHT in Feet and Inches [_|_] feet [_|_] inches 
CONVERT SQ5a TO SQ5aa (inches): 
SQ5aa = SQ5a (i) *12 + SQ5a(ii) 
SQ5b. Please enter your WEIGHT in Pounds (lbs) [_|_|_] lbs 
 
 
PROGRAMMER NOTE: 
We need to calculate the respondent’s BMI using answers in SQ5aa, SQ5b and the following formula: 
BMI = weight (lb) / [height (in)]2 x 703 (Calculate BMI by dividing weight in pounds (lbs) by 
height in inches (in) squared and multiplying by a conversion factor of 703). 
 
 
BMI = SQ5b / (SQ5aa) 2 x 703. 
SAVE BMI as a new variable in the data file. 
 
 
Example: Weight = 150 lbs, Height = 5'5" (65"). 
Calculation: [150 ÷ (65) 2] x 703 = 24.96. 
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SQ6. Have you done any of the following actions in the past 30 days? 
A. Had a doctor’s appointment specifically to get advice for weight-loss? 
Yes 
No 
 
B. Met with a certified personal trainer to start a diet and exercise program? 
Yes 
No 
 
C. Taken a prescription weight-loss medication? 
Yes TERMINATE 
No 
 
D. Taken an over-the-counter medication for weight-loss? 
Yes 
No 
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SECTION III: DEMOGRAPHICS FOR SURVEY INSTRUMENT (D) 
There may be some questions you may consider as sensitive and personal, however, they are only 
included to provide an accurate and clear report of all the data collected in this research study. 
Collectively, every completed survey will help to build a unique picture of the basic beliefs, needs, wants 
and desires of the consumers sampled in this study. 
 
 
D1. Are you…? 
6. Female 
7. Male 
 
 
D2. Are you a…? (Check one) 
1. U.S. Born Citizen 
2. Naturalized U.S. Citizen 
3. Non- U.S. Citizen 
 
D3. In what AREA of the States do you live? 
(Design as scrolled where area is entered first, then state; states was coded, for data analysis OR 
set up as you feel is appropriate) 
1. New England 
 
 
Connecticut, Maine, Massachusetts New 
Hampshire, Rhode Island, Vermont 
 
2. Middle Atlantic 
 
New Jersey, New York, Pennsylvania 
 
3. East North Central 
Illinois, Indiana, Michigan, Ohio, Wisconsin 
 
4. West North Central 
Iowa, Kansas, Minnesota, Missouri, 
Nebraska, North Dakota, South Dakota 
 
5. South Atlantic 
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 Delaware, District of Columbia, Florida, 
Georgia, Maryland, North Carolina, South 
Carolina Virginia, West Virginia 
 
6. East South Central 
Alabama, Kentucky, Mississippi, Tennessee 
 
7. West South Central 
Arkansas, Louisiana, Oklahoma, Texas 
 
8. Mountain 
Arizona, Colorado, Idaho, Montana, 
Nevada, New Mexico, Utah, Wyoming 
 
9. Pacific 
Alaska, California, Hawaii, 
Oregon, Washington 
 
10. U.S. Territory 
i.e. Puerto Rico 
 
11. U.S. Foreign Military Base 
12. Other. Please specify. 
 
 
D4. What is your current marital status? (Check one) 
8. Single/Never Married 
9. Married 
10. Not Married/Committed Living Together 
11. Separated/Divorced 
12. Widowed 
13. Decline to answer 
 
 
D5. What is the highest level of formal education you have completed? (Check one) 
A. Some high school 
B. GED 
C. High school graduate 
D. Associate’s Degree 
E. Technical School Graduate 
F. Bachelor’s Degree 
G. Master’s Degree 
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 H. Postgraduate degree 
 
 
D6. What is your race or ethnic heritage?  (Check one) 
14. African American 
15. Asian 
16. Hispanic 
17. Pacific Islander 
18. White 
19. Other (Please specify) 
 
 
D7. What is your current employment status? (Check one) 
20. Full-time (40.0 hours per week) 
21. Part-time ( Less than 20.0 hours per week) 
22. Not employed but looking for work 
23. Not employed, not looking for work 
24. Not employed, disabled 
25. Retired 
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DEMOGRAPHICS CONTINUED: DEMOGRAPHICS PART II: HEALTH INSURANCE 
INFORMATION> (DH) 
 
 
DH1. What kind of health insurance do you have? Check all that apply. 
26. NONE 
27. HMO 
28. PPO 
29. Medicare 
30. Medicaid 
31. Military (Active) - USDOF Health Care 
32. Veteran- VA Health Care 
33. Health Insurance Exchanges i.e. “Obamacare” 
34. OTHER (Please List) 
 
 
DH2. Currently, how many prescription medications do you take daily? RANGE 0-25 
 
 
SKIP DH3 IF DH2=0 
DH3. On average, how much ($) do you spend monthly on all your prescription medications? $   
per month RANGE $0-5,000 
 
 
DH4.  If diet and exercise is not enough, which type of weight-loss medication would you consider trying 
first? Check one. 
1. Prescription 
2. Over-the-counter (OTC) 
DH5.  In the past, have you taken a prescription (Rx) medication for weight-loss? 
1. Yes (if yes, go to D6) 
2. No (if no, got to D7) 
DH6. Did the prescription weight-loss medication work? 
1. Yes. 
2. No. 
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DH7. In the past, have you taken an over-the-counter medication for weight-loss? 
1. Yes (if yes, go to D8) 
2. No (SKIP D8 AND SHOW DMC1) 
DH8. Did the over-the-counter weight-loss medication work? 
1. Yes. 
2. No. 
 
 
DEMOGRAPHICS CONTINUED: DEMOGRAPHICS PART IV: CPT EXPERIENCE (DMC) 
 
 
DMC1. This question is for exercise and physical activity that IS NOT associated with physical therapy. 
Check ALL that apply: Does your insurance company provide coverage for any of the following? 
A. Membership fees associated with a fitness facility i.e. gym 
B. Monthly fees associated with using a fitness facility 
C. Yearly fees associated with using a fitness facility 
D. Exercise sessions with a fitness trainer. (NON-certified personal trainer) 
E. Exercise sessions with a certified personal trainer in a fitness facility 
F. Other (Please Enter) 
G. NONE. My insurance does NOT cover non-injury related exercise. 
CANNOT CHECK THIS OPTION WITH OTHER OPTIONS ON 
THIS LIST 
 
IF DMC1(D) CHECKED SHOW DMC1a 
 
 
DMC1a. A fitness trainer (FT) DOES NOT have a certificate in certified personal training.  Please enter 
the area of training YOUR FT helped you with: Check all that apply: 
 
 
1. Nutrition Counseling (planning personal calorie plans i.e. food journals) 
2. Weight Counseling (planning personal exercise routines i.e. exercise 
journals) 
3. Heart Health (cardiovascular) 
4. Cross-Fit (combination aerobic/anaerobic training) 
5. Aerobic Training (run, swim, treadmill, elliptical, etc.) 
6. Anaerobic (Weight Training) 
7. Yoga 
8. Pilates 
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 9. Other (Please Enter) 
10. None. Does not apply. 
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IF DMC1(E) CHECKED SHOW DMC1b 
DMC1b. A certified personal trainer (CPT) holds a certificate for the purpose of providing individual 
lessons in exercise/fitness training. Please enter the area of training YOUR CPT helped you with: Check 
all that apply: 
 
 
1. Nutrition Counseling (planning personal calorie plans i.e. food journals) 
2. Weight Counseling (planning personal exercise routines i.e. exercise 
journals) 
3. Heart Health (cardiovascular) 
4. Cross-Fit (combination aerobic/anaerobic training) 
5. Aerobic Training (run, swim, treadmill, elliptical, etc.) 
6. Anaerobic (Weight Training) 
7. Yoga 
8. Pilates 
9. Other (Please Enter) 
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SECTION IV: PRE-TEST THEORY OF PLANNED BEHAVIOR (TPB) CONSTRUCTS 
 
 
QTBP. A number of situations are described in the table below that can make it hard to stick to 
exercising regularly (i.e., exercising 3 or more times a week). 
 
 
For each of the situations listed in the table below, please rate your level of confidence on how you can 
perform exercise on a regular basis under these situations. Please rate your level of confidence using a 
number from 0 to 100, where 0 = “Cannot do at all”, 50 = “Moderately certain can do” and 100 = 
“Certain can do”. You can use any number from 0 to 100. Please enter a number in each situation or 
row in the table below. ALLOW TO ENTER ZEROS IN ALL ROWS SUCH THAT SUM OF 
ALL RESPONSES CAN BE EQUAL TO ZERO. ALLOW TO ENTER 100 IN ALL ROWS 
SUCH THAT SUM OF ALL RESPONSES CAN BE EQUAL TO 180. 
 
 Enter your rating 
below 
1.  When I am feeling tired.  
2.  When I am feeling under pressure from work.  
3. During bad weather.  
4.  After recovering from an injury that caused me to stop exercising.  
5. During or after experiencing personal problems.  
6.  When I am feeling depressed.  
7.  When I am feeling anxious.  
8. After recovering from an illness that caused me to stop exercising.  
9.  When I feel physical discomfort when I exercise.  
10.After a vacation.  
11.When I have too much work to do at home.  
12.When visitors are present.  
13.When there are other interesting things to do.  
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14.If I don’t reach my exercise goals.   
15.Without support from my family or friends.   
16.During a vacation.   
17.When I have other time commitments.   
18.After experiencing family problems.   
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SECTION V: STUDY 
DEFINITIONS 
 
Please take a moment to read this page. This section is extremely important and terms used on this 
page was referred to during the following questions in the survey. If you like, you can also print this 
page so that you can refer to the terms and definitions as you move forward. 
 
 
DEFINITIONS 
 
 
1. (Rx) Prescription Medication: Medicine ONLY from a doctor (MD). Your 
Rx medicine can come from your doctor’s office (drug sample) or from 
your pharmacist at the pharmacy (store or internet pharmacy). 
 
2. (OTC) Over-the Counter Medication: Medicine you can buy at any retail or 
internet store, without having to get a prescription (Rx) from a doctor (MD). 
 
3. (MD) Medical Doctor (MD): Physician with a Medical Degree to practice medicine. 
 
 
A physician’s assistant (PA) or nurse practitioner (NP) is NOT a physician, they 
help physicians see patients and prescribe certain medicines, such as antibiotics. 
 
 
4. (CPT) Certified Personal Trainer: A fitness trainer who has completed a 4-year 
college bachelor’s degree IN ADDITION TO having a CPT certification. 
 
 
Think of a CPT as a person you would have access to and would hire from a local gym. 
Try NOT to think of a CPT like the TV celebrities you may have seen on weight-loss 
reality shows.  This is very important. A CPT is NOT an athletic trainer (CAT) or 
physical therapist (PT). 
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SECTION V CONTINUED: CONSUMERS AND WEIGHT STATUS BELIEFS (CSB) 
QCSB.  Please tell me how you would rate your agreement with the following statements about WEIGHT 
STATUS. 
1 = You Strongly Disagree and 7 You Strongly Agree 
 
 Strongly 
disagree 
     Strongl
y 
agree 
A.  Overweight is the result of bad 
genetics 
1 2 3 4 5 6 7 
B.   Obesity is the result of bad genetics 1 2 3 4 5 6 7 
C.   Overweight is the result of bad 
behaviors 
1 2 3 4 5 6 7 
D.  Obesity is the result of bad behaviors 1 2 3 4 5 6 7 
E. Being overweight is a condition in 
which weight-loss medications are 
important treatments 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
F.   Obesity is a disease for which 
weight- loss medications are 
important treatments 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
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SECTION V CONTINUED: CONSUMERS AND WEIGHT-LOSS METHODS (CWM) 
 
 
QCWM.  Please tell me how you would rate your agreement with the following statements about HOW 
TO LOSE WEIGHT. 
1 = You Strongly Disagree and 7 You Strongly Agree 
 
 
 
 Strongly 
disagree 
     Strongl
y 
agree 
A.  I think diet is an important part of a 
weight-loss program 
1 2 3 4 5 6 7 
B.   I think exercise is an important part of 
a weight-loss program 
1 2 3 4 5 6 7 
C.   I think Rx weight-loss medication use 
is an important part of a weight-loss 
program 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
D.  I think OTC weight-loss supplement 
use is an important part of a weight-loss 
program 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
E.   People overestimate the use of Rx 
medications relative to exercise, diet 
and lifestyle changes 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
F.   People overestimate the use of OTC 
medications relative to exercise, diet 
and lifestyle changes 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
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SECTION V CONTINUED: CONSUMER MEDICATION BELIEFS 
 
 
QCMB.  Please tell me how you would rate your agreement with the strength of your beliefs about the 
following statements about WEIGHT-LOSS MEDICATIONS. 
1 Very Negative and 7 Very Positive 
 
 Very Very Negative 
Positive 
A.  Overall, what are 
your impressions 
of Rx weight-loss 
medications? 
1 2 3 4 5 6 7 
B.   Overall, what are 
your impressions 
of OTC weight-
loss drugs? 
1 2 3 4 5 6 7 
C.   Rx weight-loss 
medications are 
safe 
1 2 3 4 5 6 7 
D.  OTC weight-loss 
medications are 
safe 
1 2 3 4 5 6 7 
E.   Rx weight-
loss 
medications 
are worth 
paying for 
1 2 3 4 5 6 7 
F. OTC weight-
loss 
medications 
are worth 
  
1 2 3 4 5 6 7 
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SECTION V CONTINUED: SOCIAL NORMS (SN) 
 
QSN.  Please tell me how you would rate your agreement with the following statements about WHAT 
YOUR FAMILY AND FRIENDS THINK ABOUT WEIGHT-LOSS MEDICATIONS. 
1 Strongly Disagree and 7 Strongly Agree 
 
 Strongly 
disagree 
     Strongly 
agree 
A. Some friends/family members could not lose 
weight without OTC medications. 1 2 3 4 5 6 7 
B.  Some friends/family members could not lose 
weight without Rx medications 1 2 3 4 5 6 7 
C.  Friends/family members that use prescription 
medications are more likely to lose weight than 
those that do not 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
D.  Friends/family members that use prescription 
medications are more likely to maintain a diet and 
exercise regimen over time 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
E. Friends/family members that use prescription 
medications are more likely to maintain any 
weight-loss 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
F. My friends/family members that use 
prescription medications feel that the medications 
are very important to the success of the weight- 
loss program 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
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 SECTION V CONTINUED: SOURCE CREDIBILITY (SC OF BOTH MD AND CPT) 
 
 
QSC. Please  tell  me  how  you  would  rate  your  agreement  with  the  following  statements  about 
PHYSICIANS (MDs) AND CPTS. 
1 You Strongly Disagree and 7 You Strongly Agree 
 
 Strongly Strongly  
Agree  Disagree 
A.  CPTs should assess 
their clients for their 
potential need for Rx 
weight-loss 
medications 
1 2 3 4 5 6 7 
B.   MDs should assess 
their patients for 
their potential need 
for Rx weight-loss 
medications 
1 2 3 4 5 6 7 
C.   CPTs should 
recommend OTC 
weight-loss 
medications 
1 2 3 4 5 6 7 
D.  MDs should 
recommend OTC 
weight-loss 
medications 
1 2 3 4 5 6 7 
E.   CPTs have 
knowledge about 
ways to lose 
weight that work  
1 2 3 4 5 6 7 
F.   MDs have 
knowledge about 
ways to lose 
weight that work  
1 2 3 4 5 6 7 
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SECTION VI: SCENARIOS TO TEST HYPOTHESIS 
THERE ARE EIGHT (8) SCENARIOS TO BE SHOWN. EACH SCENARIO NEEDS TO BE 
SHOWN ON A NEW PAGE WITH THE FOLLOW UP QUESTION UNDER EACH. 
 
 
ROTATE THE ORDER OF THE SCENARIOS SUCH THAT EACH RESPONDENT SEES A 
DIFFERENT ORDER. RECORD THE ORDER SHOWN IN THE DATA FILE. 
The following section is going to ask you to imagine yourself in a situation with a physician (MD) or 
CPT (certified personal trainer). Please read the description in the scenario and answer the questions as 
if this situation had happened to you personally. 
On the following pages, we will show you eight scenarios one by one. Each scenario is unique and 
different. Please take time to read each scenario and answer the questions that follow. 
PAGE BREAK 
 
 
Scenario 1: OTC/CPT-/MD- 
Assume that you are the following patient as described.  You are starting a diet and exercise 
regimen on advice from your doctor.  You have started working out and have decided to visit 
a personal trainer. 
 
 
While the trainer is working with you, you ask about weight-loss medications that are over-the- 
counter (OTC). 
 
 
The Trainer says, "From what I know the over-the-counter medications do very little to 
help and can actually be harmful, we should focus on your exercise program." 
 
 
The following week you have a follow up visit with your doctor. You ask the doctor about 
prescription and over-the-counter medications for weight-loss. 
 
 
The doctor says, "In my opinion the over-the-counter medications do very little to help, 
the weight-loss is not lasting if the medications are stopped, and can actually be harmful, we 
should focus on your diet and exercise program." 
 
 
The doctor recommends that you do not take OTC medications for weight-loss. 
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ASK QSC FROM SECTION V HERE AND THEN 
PAGE BREAK PAGE BREAK 
Scenario 2: OTC/CPT+/MD- 
Assume that you are the following patient as described.  You are starting a diet and 
exercise regimen on advice from your doctor.  You have started working out and have 
decided to visit a personal trainer. 
 
 
While the trainer is working with you, you ask about weight-loss medications that are over-the- 
counter. 
 
 
The Trainer says, "From what I know, when taken as directed as a part of a diet and 
exercise program, they can be helpful." 
 
 
The following week you have a follow up visit with your doctor. You ask the doctor about 
prescription and over-the-counter medications for weight-loss. 
 
 
The doctor says, "In my opinion the over-the-counter medications do very little to help, 
the weight-loss is not lasting if the medications are stopped, and can actually be harmful, we 
should focus on your diet and exercise program." 
 
 
The doctor recommends that you do not take OTC medications for weight-loss. 
 
 
ASK QSC FROM SECTION V HERE AND THEN 
PAGE BREAK PAGE BREAK 
Scenario 3: OTC/CPT+/MD+ 
 
Assume that you are the following patient as described.  You are starting a diet and 
exercise regimen on advice from your doctor.  You have started working out and have 
decided to visit a personal trainer. 
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 While the trainer is working with you, you ask about weight-loss medications that are over-the- 
counter. 
 
 
The Trainer says, "From what I know, when taken as directed as a part of a diet and 
exercise program, they can be helpful." 
 
 
The following week you have a follow up visit with your doctor. You ask the doctor about 
prescription and over-the-counter medications for weight-loss. 
 
 
The doctor says, "They can be helpful when used appropriately, with diet and exercise. 
In fact I have had quite a few patients take them successfully." 
 
 
The doctor recommends you start taking the OTC medication. 
 
ASK QSC FROM SECTION V HERE AND THEN PAGE 
BREAK PAGE BREAK 
Scenario 4: OTC/CPT-/MD+ 
 
Assume that you are the following patient as described.  You are starting a diet and 
exercise regimen on advice from your doctor.  You have started working out and have 
decided to visit a personal trainer. 
 
 
While the trainer is working with you, you ask about weight-loss medications that are over-the- 
counter. 
 
 
The Trainer says, "From what I know the over-the-counter medications do very little to 
help and can actually be harmful, we should focus on your exercise program." 
 
 
The following week you have a follow up visit with your doctor. You ask the doctor about 
prescription and over-the-counter medications for weight-loss. 
 
 
The doctor says, "They can be helpful when used appropriately, with diet and exercise. 
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Scenario 5:Rx/CPT-/MD- 
 
Assume that you are the following patient as described.  You are starting a diet and 
exercise regimen on advice from your doctor.  You have started working out and have 
decided to visit a personal trainer. 
 
 
While the trainer is working with you, you ask about weight-loss medications that are 
prescription. 
 
 
The Trainer says, "From what I know the prescriptions medications do very little to 
help and can actually be harmful, we should focus on your exercise program." 
 
 
The following week you have a follow up visit with your doctor. You ask the doctor about 
prescription and over-the-counter medications for weight-loss. 
 
 
The doctor says, "In my opinion the prescriptions medications do very little to help, the 
weight-loss is not lasting if the medications are stopped, and can actually be harmful, we should 
focus on your diet and exercise program." 
 
 
The doctor recommends that you do not take prescription medications for weight-loss. 
 
 
ASK QSC FROM SECTION V HERE AND THEN PAGE 
BREAK PAGE BREAK 
In fact I have had quite a few patients take them successfully." 
 
 
The doctor recommends you start taking the OTC medication. 
 
 
ASK QSC FROM SECTION V HERE AND THEN PAGE BREAK 
PAGE BREAK 
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 Scenario 6: Rx/CPT+/MD- 
 
Assume that you are the following patient as described.  You are starting a diet and exercise 
regimen on advice from your doctor.  You have started working out and have decided to visit 
a personal trainer. 
 
 
While the trainer is working with you, you ask about weight-loss medications that are prescription. 
 
 
The Trainer says, "From what I know, when taken as directed as a part of a diet and exercise 
program, they can be helpful." 
 
 
The following week you have a follow up visit with your doctor. You ask the doctor about prescription 
and over-the-counter medications for weight-loss. 
 
 
The doctor says, "In my opinion the prescriptions medications do very little to help, the weight-
loss is not lasting if the medications are stopped, and can actually be harmful, we should focus on your 
diet and exercise program." 
 
 
The doctor recommends that you do not take prescription medications for weight-loss. 
 
ASK QSC FROM SECTION V HERE AND THEN PAGE 
BREAK PAGE BREAK 
Scenario 7: Rx/CPT+/MD+ 
 
Assume that you are the following patient as described.  You are starting a diet and exercise 
regimen on advice from your doctor.  You have started working out and have decided to visit 
a personal trainer. 
 
 
While the trainer is working with you, you ask about weight-loss medications that are prescription. 
 
 
The Trainer says, "From what I know, when taken as directed as a part of a diet and exercise 
program, they can be helpful." 
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The following week you have a follow up visit with your doctor. You ask the doctor about prescription 
and over-the-counter medications for weight-loss. 
 
 
The doctor says, "They can be helpful when used appropriately, with diet and exercise.  In fact 
I have had quite a few patients take them successfully." 
 
 
The doctor writes a prescription for a weight-loss medication. 
 
ASK QSC FROM SECTION V HERE AND THEN PAGE 
BREAK PAGE BREAK 
Scenario 8: Rx/CPT-/MD+ 
 
Assume that you are the following patient as described.  You are starting a diet and exercise 
regimen on advice from your doctor.  You have started working out and have decided to visit 
a personal trainer. 
 
 
While the trainer is working with you, you ask about weight-loss medications that are prescription. 
 
 
The Trainer says, "From what I know the prescriptions medications do very little to help and 
can actually be harmful, we should focus on your exercise program." 
 
 
The following week you have a follow up visit with your doctor. You ask the doctor about prescription 
and over-the-counter medications for weight-loss. 
 
 
The doctor says, "They can be helpful when used appropriately, with diet and exercise.  In fact 
I have had quite a few patients take them successfully." 
 
 
The doctor writes a prescription for a weight-loss medication. 
 
ASK QSC FROM SECTION V HERE AND THEN PAGE 
BREAK PAGE BREAK 
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SECTION VII - Scenario Follow-up Questionnaire 
Now we will show you the same eight scenarios again. This time we want you to read them again very 
carefully and answer the questions that follow. 
 
 
We are almost toward the end of this survey. These are the last set of questions in this survey. 
 
 
SHOW SCENARIOS IN THE SAME ORDER AS SHOWN IN SECTION VI. SHOW EACH 
SCENARIO ON A NEW PAGE. AFTER EACH SCENARIO WE NEED TO SHOW TWO SETS 
OF QUESTIONS. 
 
 
WHEN SCENARIOS 1, 2, 3 AND 4 ARE SHOWN, FOLLOW THE SCENARIO WITH THE 
FOLLOWING TWO SETS OF QUESTIONS: 
 
 
QS1. My use of an OTC weight-loss medication to support my weight-loss program would be: 
Bad 1 2 3 4 5 6 7 Good 
Unfavorable 1 2 3 4 5 6 7 Favorable 
Harmful 1 2 3 4 5 6 7 Beneficial 
Useless 1 2 3 4 5 6 7 Useful 
Ineffective 1 2 3 4 5 6 7 Effective 
Unnecessary 1 2 3 4 5 6 7 Necessary 
Dangerous 1 2 3 4 5 6 7 Safe 
Not helpful 1 2 3 4 5 6 7 Helpful 
 
 
QS2.  Based on the information available in this scenario, how likely are you to try an OTC 
weight- loss medication? 
No chance to try 1 2 3 4 5 6 7 8 9 Sure to try 
Unlikely to try 1 2 3 4 5 6 7 8 9 Likely to try 
Not possible I will try 1 2 3 4 5 6 7 8 9 Very possible I will try 
Intend not to try 1 2 3 4 5 6 7 8 9 Intend to try 
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WHEN SCENARIOS 5,6, 7 AND 8 ARE SHOWN, FOLLOW THE SCENARIO WITH THE 
FOLLOWING TWO SETS OF QUESTIONS: 
 
QS3. My use of an Rx weight-loss medication to support my weight-loss program would be: 
Bad 1 2 3 4 5 6 7 Good 
Unfavorable 1 2 3 4 5 6 7 Favorable 
Harmful 1 2 3 4 5 6 7 Beneficial 
Useless 1 2 3 4 5 6 7 Useful 
Ineffective 1 2 3 4 5 6 7 Effective 
Unnecessary 1 2 3 4 5 6 7 Necessary 
Dangerous 1 2 3 4 5 6 7 Safe 
Not helpful 1 2 3 4 5 6 7 Helpful 
 
 
QS4.  Based on the information available in this scenario, how likely are you to try a prescription 
weight-loss medication? 
No chance 1 2 3 4 5 6 7 8 9 Sure to try 
Unlikely 1 2 3 4 5 6 7 8 9 Likely to try 
Not possible 1 2 3 4 5 6 7 8 9 Very possible I will try 
Intend not to try 1 2 3 4 5 6 7 8 9 Intend to try 
 
 
SECTION VIII: LAST PAGE: END OF SURVEY 
 
 
QLAST. Would you like your BMI Classification? 
  Yes SHOW: Based on the height and weight you reported earlier in the survey, your BMI is XX 
(INSERT FROM BMI VARIABLE) 
  No   SHOW: Thank you for completing the survey. Would you like to be notified about the results of 
this study? 
YES 
NO 
END SURVEY
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VITA 
 
  
Linda R. Lobb, B.S., M.Ed., Ph.D. 
Mission 
To instill in athletes, a sense of self-worth that enables them to build character, 
appreciate achievement, cultivate confidence, and progress as both competitors and 
women. 
Philosophy 
Most things in life are a constant, a given, and do not change without outside 
influence.  Thus, “we are who we are and it is what it is.”  The beliefs, attitudes, and 
intentions held within each human spirit are what drive actions and produce change. 
Experience 
 
2012 to Present   Self-Employed        
Kingwood, TX 
Independent Gymnastics Consultant 
• Assisted in the personal development of collegiate gymnast’s success as students 
and athletes 
• Consultant for competitive collegiate routines on Balance Beam and Floor 
Exercise 
 
2009 to 2012  Rowland/Ballard Gymnastics Kingwood, TX 
Women’s Competitive Coach and Private Instructor 
• Coached and Mentored Elite Gymnasts to Compete at District, State, Regional, 
and National Championships 
• Developed competitive routines for Balance Beam and Floor Exercise 
• Assisted in placement of Elite Gymnasts at Division I and Division II NCAA 
Schools 
 
2006 to 2009  Delta Gymnastics West Memphis, AR 
Competitive Optional Girl’s Coach and Private Instructor 
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• Coached and Mentored Elite Gymnasts to compete at District, State, Regional and 
National Championships 
• Coordinated team activities and international meet attendance 
• Developed custom competitive routines for Balance Beam and Floor events 
• Assisted in placement of Elite Gymnasts at Division III NCAA Schools 
  
2003 to 2009  Ole Miss HESRM Department Oxford, MS 
Graduate Teaching Assistant and Researcher 
• Submitted final course grades 
• Lectured on topics in Exercise Science, Health, Health Promotion, Exercise 
Physiology Syllabus development 
• Course Outline development 
• Lecture and Lab development 
• Researcher on topics in Exercise Science, Biomechanics, Health Promotion, and 
Pharmacy Administration  
 
2002 - 2006  Medical Marketing Economics, LLC. Oxford, MS. 
 
Office Manager/Research Assistant 
• Maintain knowledge of current research in the pharmaceutical industry.  
• Database management of contacts and clients.  
• Editing proposals and reports for pharmaceutical marketing research.  
• Scheduling calls and meetings for office personnel.  
• Responsible for client management and accounts payable.  
• Organization and design current filing method.  
• Project coordinator for pricing strategy assessment of major pharmaceutical drug.  
• Recruitment of outside field specialists to participate in medical marketing 
surveys.  
 
1998-2000  Clear Creek I.S.D. League City, TX.  
Health and Fitness Teacher/Athletic Coach 
• Designed, organized, and implemented health classes.  
• Created innovative lessons aligned with state mandated objectives.  
• Provided a positive environment for students.  
• Incorporated community businesses and leaders into class projects.  
• Worked closely with colleagues, integrated ideas, and developed positive 
relationships with fellow teachers.  
• Attended local, regional, and state professional development courses.  
• Acted as school representative for The Association of Texas Professional Educators 
(ATPE).  
 
1997-1998  Pasadena I.S.D. Pasadena, TX.  
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Science Teacher/ Physical Education Teacher 
• Structured, organized, and planned classes.  
• Member of specialized team that designed the current computer technology 
curriculum for the school district.  
• Attended professional meetings and continuing education courses at local, regional, 
and state level.  
• As a first year science teacher, motivated all of my students to enter the district 
Science Fair in which three had district honors.  
 
1997   University of Houston Houston, TX.  
Graduate Student/Teacher Fellow 
• Assisted in construction, implementation, and analysis of various research 
projects in the Health and Human Performance Department.  
• Instructed freshman and sophomore level lecture courses.  
• Planned, organized and instructed aerobic and gymnastics classes.  
• Received excellent scores on student and professor based performance.  
 
1995-1996  Louisiana State University Baton Rouge, LA.  
Women’s Collegiate Gymnastics Team Manager/Program Manager and Team Coach of the 
University Recreational Program 
• Managed and directed the LSU Children’s Recreational Gymnastics Program.  
• Planned, organized, and implemented classes for recreational program.  
• Interviewed potential coaches for recreational program, as well as creating work 
schedule, duties, and coordinating staff meetings.  
• Maintained proper inventory of equipment, supplies, and uniforms for collegiate 
team.  
• Worked closely with the head coach, her assistants, and the collegiate gymnasts to 
ensure all needs were met for the team.  
• Represented LSU Girl’s Competitive Team as their coach at local, regional, and state 
competitions.  
 
1991 – 2000  Dana’s Dance & Gymnastics Santa Fe, TX.  
Competitive Team Girl’s Coach and Recreational Class Instructor 
• Primarily responsible for coaching balance beam, levels one through ten, for the 
competitive girls program.  
• Event coaching also included coaching floor exercise, as well as choreographing 
optional routines.  
• Represented levels, beginning with level four, at local, district and state USAG 
sanctioned events.  
• Assisted in the development, planning, organization and instruction of various girls 
and boys classes.  
• Produced local, district and state event champions.  
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Education 
2006-Present  University of Mississippi University, MS 
• Doctorate of Philosophy: Exercise Science and Health Promotion 
• Dissertation Title: “CERTIFIED PERSONAL TRAINERS AND PHYSICIANS: 
AN EVALUATION OF CONSUMER PREFERENCE, INFLUENCE, AND 
DECISION MAKING ON INTENT TO USE A WEIGHT-LOSS 
MEDICATION”  
 
2000   University of Houston Houston, TX 
• Master of Education in Physical Education 
• Concentration area: Motor Development 
1996   Louisiana State University Baton Rouge, LA 
 Bachelor of Science in Kinesiology 
1993   Alvin Community College Alvin, TX. 
 Associates Degree in General Studies 
Organizations 
 
United States Association for Gymnastics, Member 1991 to Present 
 Level One through Four-USAG: Skill Evaluator: 1990 – 2012 
Safety Certified through USAG: 1990 - 2013 
American College of Sports Medicine Member 2004 to Present 
American Society for Health Professionals, Member 2005 to Present 
Association of Texas Professional Educators (ATPE).  1998 -2000. 
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Honors 
 Graduated with Honors (Sum Cud Laude), University of Mississippi 
 Honors Fellowship, University of Mississippi 
 Dean’s Award for Academic Excellence, University of Mississippi 
 Honors Fellowship, University of Houston 
 Louisiana State University, Partial Athletic Scholarship, Gymnastics 
 Alvin Community College, Full Scholarship 
 Alvin High School, All-American Gymnast: Vault, Beam, Floor 
 Alvin High School, Perfect Scores: (Optionals) Vault and Beam (Compulsory) Vault and 
Beam 
 Alvin High School, All American Cheerleader 
 
Peer Reviewed Publications 
 
Lobb LR, Lobb WB, & Hallam JS.  Perceptions of Anti-Obesity Medications Among Personal 
Trainers.  Journal of Strength and Conditioning Research: 2008; 22(2): 485-489. 
 
Published Abstracts  
 
Lobb LR, Hallam JS, Lobb WB. (2007) Perceptions of Anti-Obesity Medications Among Personal 
Trainers. American College of Sports Medicine (accepted for presentation), New Orleans, LA, 
June 2007. Medicine and Science in Sports and Exercise, (39)5, Supplement. 
 
Hallam JS, Wadsworth DD, Hatchett AG, Lobb L.  (2007) Mediating effects of selected social 
cognitive theory variables on female exercise behavior.  Annuals of Behavioral Medicine, 33, S35.   
 
Hallam JS, Wadsworth DD, Lobb L, Hatchett AG. (2007) Effectiveness of a brief social cognitive 
theory based intervention on exercise adherence to short bout and long bout exercise programs. 
Annuals of Behavioral Medicine, 33, S88.  
Invited Presentations 
“Diabetes Medications, Interactions, and Concerns.”  HealthWorks Seminar Series.  University of 
Mississippi, Employee Wellness Program.  November 1, 2006. 
Poster Presentations 
 
Lobb LR, Lobb WB, & Hallam JS.  Perceptions of Anti-Obesity Medications Among Personal 
Trainers.  Medicine and Science in Sports and Exercise, American College of Sports Medicine.  
New Orleans, LA.  June 2007. 
 
Hallam JS, Wadsworth DD, Hatchett AG, Lobb LR.  Mediating effects of selected social cognitive 
theory variables on female exercise behavior.  Society of Behavioral Medicine, Washington DC, 
March 2007.  
191  
  
Hallam JS, Wadsworth DD, Lobb LR, Hatchett AG.  Effectiveness of a brief social cognitive 
theory based intervention on exercise adherence to short bout and long bout exercise programs.  
Society of Behavioral Medicine, Washington DC, March 2007.  
 
Hallam JS, Blunt GH, Lobb LR, Hatchett AG, Petosa RL.  Confirmatory factor analysis of an 
exercise self-regulation instrument.  American Academy of Health Behavior, Savannah, GA, 
March 2007.  
 
Hallam JS, Lobb LR, Hatchett AG, Blunt GH, Petosa RL Construct validity of an exercise self-
regulation instrument:  exploratory factor analysis and psychometric properties.  American 
Academy of Health Behavior, Savannah, GA, March 2007. 
 
Ford MA, Hallam JS, Lacey KS, Hatchet AG, Lobb L, Owens, SG. Bone mineral density status 
among university employees. American Alliance of Health, Physical Education, Recreation and 
Dance, Salt Lake City, UT, April 2006. 
 
Non Published Papers: Related Field Experience 
 
Applying Social Cognitive Theory to Exercise Behavior.  University of Mississippi, Dr. Jeff 
Hallam.  Spring 2006.  Katherine Mowat, M.S., Jeff Hallam, PhD., Linda Lobb, M.Ed, Andrew 
Hatchett, M.S. 
 
Prevalence of Overweight in Homeschool Children.  University of Mississippi, Dr. Jeff Hallam.  
Fall 2004.  Linda Lobb, M. Ed. 
 
Prevalence of Overweight in Homeschool Children.  University of Mississippi, Dr. Scott Owens.  
Spring 2004.  Linda Lobb, M. Ed 
 
What is Happening to Our Children?  A comprehensive review on the obesity of U. S. children.  
University of Houston, Dr. Buckner.  Spring 1998. Linda R. Lemgruber. 
 
Personal Meaning Model: An Approach to Physical Education.  University of Houston, Dr. 
Jacqueline Goodway.  Fall 1997.  Linda R. Lemgruber. 
 
Research on the Laws of Motion and Stability .  Louisiana State University, Dr. Kirk Olescyski.  
Fall 1995.  Linda R. Lemgruber. 
 
Non Published Independent Study: Related Field Experience 
 
Maximizing Group Conditioning: Level One through Seven Gymnasts.  Fall 2002-Spring 2003. 
Linda Lobb. 
 
Vault Running Progressions and Power Drills.  Fall 2002 - Spring 2003.  Linda Lobb. 
 
Beam Skill Sets: Improving Based on Number Sets.  Fall 2002 -Spring 2003.  Linda Lobb. 
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The Pike versus the Straddle Glide Kip: Focus on abdominal strength.  Fall 2002 - Spring 2003.  
Linda Lobb. 
 
Proper Progressions in Learning Dance Elements: Jumps, Turns and Leaps.  Fall 2002 – Spring 
2003.  Linda Lobb. 
 
Making a Team: Team Motto: Feel the Power.  Fall 2002 - Spring 2003. 
 
Tracking weight loss using aerobics as primary exercise.  University of Houston, Spring and Fall 
1997.  Linda Lemgruber. 
 
Marketing the LSU Recreational Gymnastics Program: What Works?  Louisiana State University, 
July 1995 through December of 1996.  Linda Lemgruber. 
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